id	sid	tid	token	lemma	pos
iajs-3342	1	1	311	311	NUM
iajs-3342	1	2	©	©	NOUN
iajs-3342	1	3	published	publish	VERB
iajs-3342	1	4	by	by	ADP
iajs-3342	1	5	college	college	NOUN
iajs-3342	1	6	of	of	ADP
iajs-3342	1	7	education	education	NOUN
iajs-3342	1	8	for	for	ADP
iajs-3342	1	9	pure	pure	ADJ
iajs-3342	1	10	science	science	NOUN
iajs-3342	1	11	(	(	PUNCT
iajs-3342	1	12	ibn	ibn	PROPN
iajs-3342	1	13	al	al	PROPN
iajs-3342	1	14	-	-	PUNCT
iajs-3342	1	15	haitham	haitham	PROPN
iajs-3342	1	16	)	)	PUNCT
iajs-3342	1	17	,	,	PUNCT
iajs-3342	1	18	university	university	NOUN
iajs-3342	1	19	of	of	ADP
iajs-3342	1	20	baghdad.this	baghdad.this	PRON
iajs-3342	1	21	is	be	AUX
iajs-3342	1	22	an	an	DET
iajs-3342	1	23	open	open	ADJ
iajs-3342	1	24	-	-	PUNCT
iajs-3342	1	25	access	access	NOUN
iajs-3342	1	26	article	article	NOUN
iajs-3342	1	27	distributed	distribute	VERB
iajs-3342	1	28	under	under	ADP
iajs-3342	1	29	the	the	DET
iajs-3342	1	30	terms	term	NOUN
iajs-3342	1	31	of	of	ADP
iajs-3342	1	32	the	the	DET
iajs-3342	1	33	creative	creative	ADJ
iajs-3342	1	34	commons	common	NOUN
iajs-3342	1	35	attribution	attribution	NOUN
iajs-3342	1	36	4.0	4.0	NUM
iajs-3342	1	37	international	international	ADJ
iajs-3342	1	38	license	license	NOUN
iajs-3342	1	39	the	the	DET
iajs-3342	1	40	relationship	relationship	NOUN
iajs-3342	1	41	between	between	ADP
iajs-3342	1	42	nerve	nerve	NOUN
iajs-3342	1	43	growth	growth	NOUN
iajs-3342	1	44	factor	factor	NOUN
iajs-3342	1	45	and	and	CCONJ
iajs-3342	1	46	vitamin	vitamin	NOUN
iajs-3342	1	47	b12	b12	NOUN
iajs-3342	1	48	as	as	ADP
iajs-3342	1	49	a	a	DET
iajs-3342	1	50	predictive	predictive	ADJ
iajs-3342	1	51	marker	marker	NOUN
iajs-3342	1	52	for	for	ADP
iajs-3342	1	53	nerve	nerve	NOUN
iajs-3342	1	54	damage	damage	NOUN
iajs-3342	1	55	in	in	ADP
iajs-3342	1	56	iraqi	iraqi	ADJ
iajs-3342	1	57	patients	patient	NOUN
iajs-3342	1	58	with	with	ADP
iajs-3342	1	59	systemic	systemic	ADJ
iajs-3342	1	60	lupus	lupus	PROPN
iajs-3342	1	61	erythematosus	erythematosus	PROPN
iajs-3342	1	62	zaman	zaman	PROPN
iajs-3342	1	63	b.	b.	PROPN
iajs-3342	1	64	farhan1	farhan1	PROPN
iajs-3342	1	65	*	*	PUNCT
iajs-3342	1	66	and	and	CCONJ
iajs-3342	1	67	eiman	eiman	VERB
iajs-3342	1	68	a	a	DET
iajs-3342	1	69	a.	a.	NOUN
iajs-3342	1	70	abass2	abass2	PUNCT
iajs-3342	2	1	1,2department	1,2department	NUM
iajs-3342	2	2	of	of	ADP
iajs-3342	2	3	chemistry	chemistry	NOUN
iajs-3342	2	4	,	,	PUNCT
iajs-3342	2	5	college	college	NOUN
iajs-3342	2	6	of	of	ADP
iajs-3342	2	7	education	education	NOUN
iajs-3342	2	8	for	for	ADP
iajs-3342	2	9	pure	pure	ADJ
iajs-3342	2	10	sciences	science	NOUN
iajs-3342	2	11	ibn	ibn	PROPN
iajs-3342	2	12	al	al	PROPN
iajs-3342	2	13	-	-	PUNCT
iajs-3342	2	14	haitham	haitham	PROPN
iajs-3342	2	15	,	,	PUNCT
iajs-3342	2	16	university	university	PROPN
iajs-3342	2	17	of	of	ADP
iajs-3342	2	18	baghdad	baghdad	PROPN
iajs-3342	2	19	,	,	PUNCT
iajs-3342	2	20	baghdad	baghdad	PROPN
iajs-3342	2	21	,	,	PUNCT
iajs-3342	2	22	iraq	iraq	PROPN
iajs-3342	2	23	.	.	PUNCT
iajs-3342	3	1	*	*	PUNCT
iajs-3342	3	2	corresponding	correspond	VERB
iajs-3342	3	3	author	author	NOUN
iajs-3342	3	4	.	.	PUNCT
iajs-3342	4	1	received	receive	VERB
iajs-3342	4	2	:	:	PUNCT
iajs-3342	4	3	16	16	NUM
iajs-3342	4	4	march	march	NOUN
iajs-3342	4	5	2023	2023	NUM
iajs-3342	4	6	accepted	accept	VERB
iajs-3342	4	7	:	:	PUNCT
iajs-3342	4	8	31	31	NUM
iajs-3342	4	9	march	march	NOUN
iajs-3342	4	10	2023	2023	NUM
iajs-3342	4	11	published	publish	VERB
iajs-3342	4	12	:	:	PUNCT
iajs-3342	4	13	20	20	NUM
iajs-3342	4	14	july	july	PROPN
iajs-3342	4	15	2024	2024	NUM
iajs-3342	4	16	doi.org/10.30526/37.3.3342	doi.org/10.30526/37.3.3342	NOUN
iajs-3342	4	17	abstract	abstract	ADJ
iajs-3342	4	18	determination	determination	NOUN
iajs-3342	4	19	of	of	ADP
iajs-3342	4	20	serum	serum	NOUN
iajs-3342	4	21	nerve	nerve	NOUN
iajs-3342	4	22	growth	growth	NOUN
iajs-3342	4	23	factor	factor	NOUN
iajs-3342	4	24	(	(	PUNCT
iajs-3342	4	25	ngf	ngf	NOUN
iajs-3342	4	26	)	)	PUNCT
iajs-3342	4	27	and	and	CCONJ
iajs-3342	4	28	vitamin	vitamin	NOUN
iajs-3342	4	29	b12	b12	NOUN
iajs-3342	4	30	in	in	ADP
iajs-3342	4	31	iraqi	iraqi	ADJ
iajs-3342	4	32	female	female	ADJ
iajs-3342	4	33	patients	patient	NOUN
iajs-3342	4	34	with	with	ADP
iajs-3342	4	35	systemic	systemic	ADJ
iajs-3342	4	36	lupus	lupus	NOUN
iajs-3342	4	37	erythematosus	erythematosus	NOUN
iajs-3342	4	38	(	(	PUNCT
iajs-3342	4	39	sle	sle	PROPN
iajs-3342	4	40	)	)	PUNCT
iajs-3342	4	41	and	and	CCONJ
iajs-3342	4	42	assessment	assessment	NOUN
iajs-3342	4	43	of	of	ADP
iajs-3342	4	44	the	the	DET
iajs-3342	4	45	effect	effect	NOUN
iajs-3342	4	46	of	of	ADP
iajs-3342	4	47	disease	disease	NOUN
iajs-3342	4	48	duration	duration	NOUN
iajs-3342	4	49	on	on	ADP
iajs-3342	4	50	the	the	DET
iajs-3342	4	51	development	development	NOUN
iajs-3342	4	52	of	of	ADP
iajs-3342	4	53	nerve	nerve	NOUN
iajs-3342	4	54	damage	damage	NOUN
iajs-3342	4	55	.	.	PUNCT
iajs-3342	5	1	in	in	ADP
iajs-3342	5	2	addition	addition	NOUN
iajs-3342	5	3	,	,	PUNCT
iajs-3342	5	4	ngf	ngf	PROPN
iajs-3342	5	5	may	may	AUX
iajs-3342	5	6	be	be	AUX
iajs-3342	5	7	a	a	DET
iajs-3342	5	8	predictive	predictive	ADJ
iajs-3342	5	9	marker	marker	NOUN
iajs-3342	5	10	for	for	ADP
iajs-3342	5	11	nerve	nerve	NOUN
iajs-3342	5	12	damage	damage	NOUN
iajs-3342	5	13	in	in	ADP
iajs-3342	5	14	sel	sel	ADJ
iajs-3342	5	15	patients	patient	NOUN
iajs-3342	5	16	.	.	PUNCT
iajs-3342	6	1	the	the	DET
iajs-3342	6	2	current	current	ADJ
iajs-3342	6	3	study	study	NOUN
iajs-3342	6	4	included	include	VERB
iajs-3342	6	5	130	130	NUM
iajs-3342	6	6	individuals	individual	NOUN
iajs-3342	6	7	whose	whose	DET
iajs-3342	6	8	ages	age	NOUN
iajs-3342	6	9	ranged	range	VERB
iajs-3342	6	10	from	from	ADP
iajs-3342	6	11	18	18	NUM
iajs-3342	6	12	to	to	PART
iajs-3342	6	13	48	48	NUM
iajs-3342	6	14	years	year	NOUN
iajs-3342	6	15	old	old	ADJ
iajs-3342	6	16	,	,	PUNCT
iajs-3342	6	17	100	100	NUM
iajs-3342	6	18	of	of	ADP
iajs-3342	6	19	whom	whom	PRON
iajs-3342	6	20	were	be	AUX
iajs-3342	6	21	female	female	ADJ
iajs-3342	6	22	patients	patient	NOUN
iajs-3342	6	23	with	with	ADP
iajs-3342	6	24	sle	sle	PROPN
iajs-3342	6	25	and	and	CCONJ
iajs-3342	6	26	30	30	NUM
iajs-3342	6	27	individuals	individual	NOUN
iajs-3342	6	28	as	as	ADP
iajs-3342	6	29	controls	control	NOUN
iajs-3342	6	30	.	.	PUNCT
iajs-3342	7	1	each	each	DET
iajs-3342	7	2	patient	patient	NOUN
iajs-3342	7	3	was	be	AUX
iajs-3342	7	4	diagnosed	diagnose	VERB
iajs-3342	7	5	after	after	ADP
iajs-3342	7	6	undergoing	undergo	VERB
iajs-3342	7	7	a	a	DET
iajs-3342	7	8	thorough	thorough	ADJ
iajs-3342	7	9	clinical	clinical	ADJ
iajs-3342	7	10	evaluation	evaluation	NOUN
iajs-3342	7	11	backed	back	VERB
iajs-3342	7	12	by	by	ADP
iajs-3342	7	13	laboratory	laboratory	NOUN
iajs-3342	7	14	testing	testing	NOUN
iajs-3342	7	15	by	by	ADP
iajs-3342	7	16	a	a	DET
iajs-3342	7	17	board	board	NOUN
iajs-3342	7	18	-	-	PUNCT
iajs-3342	7	19	certified	certify	VERB
iajs-3342	7	20	rheumatologist	rheumatologist	NOUN
iajs-3342	7	21	.	.	PUNCT
iajs-3342	8	1	the	the	DET
iajs-3342	8	2	patients	patient	NOUN
iajs-3342	8	3	were	be	AUX
iajs-3342	8	4	classified	classify	VERB
iajs-3342	8	5	according	accord	VERB
iajs-3342	8	6	to	to	ADP
iajs-3342	8	7	the	the	DET
iajs-3342	8	8	duration	duration	NOUN
iajs-3342	8	9	of	of	ADP
iajs-3342	8	10	disease	disease	NOUN
iajs-3342	8	11	into	into	ADP
iajs-3342	8	12	15	15	NUM
iajs-3342	8	13	patients	patient	NOUN
iajs-3342	8	14	with	with	ADP
iajs-3342	8	15	a	a	DET
iajs-3342	8	16	disease	disease	NOUN
iajs-3342	8	17	duration	duration	NOUN
iajs-3342	8	18	of	of	ADP
iajs-3342	8	19	less	less	ADJ
iajs-3342	8	20	than	than	ADP
iajs-3342	8	21	3	3	NUM
iajs-3342	8	22	months	month	NOUN
iajs-3342	8	23	(	(	PUNCT
iajs-3342	8	24	g1	g1	PROPN
iajs-3342	8	25	)	)	PUNCT
iajs-3342	8	26	,	,	PUNCT
iajs-3342	8	27	29	29	NUM
iajs-3342	8	28	patients	patient	NOUN
iajs-3342	8	29	with	with	ADP
iajs-3342	8	30	a	a	DET
iajs-3342	8	31	disease	disease	NOUN
iajs-3342	8	32	duration	duration	NOUN
iajs-3342	8	33	of	of	ADP
iajs-3342	8	34	1	1	NUM
iajs-3342	8	35	year	year	NOUN
iajs-3342	8	36	(	(	PUNCT
iajs-3342	8	37	g2	g2	PROPN
iajs-3342	8	38	)	)	PUNCT
iajs-3342	8	39	,	,	PUNCT
iajs-3342	8	40	and	and	CCONJ
iajs-3342	8	41	56	56	NUM
iajs-3342	8	42	patients	patient	NOUN
iajs-3342	8	43	with	with	ADP
iajs-3342	8	44	a	a	DET
iajs-3342	8	45	disease	disease	NOUN
iajs-3342	8	46	duration	duration	NOUN
iajs-3342	8	47	of	of	ADP
iajs-3342	8	48	more	more	ADJ
iajs-3342	8	49	than	than	ADP
iajs-3342	8	50	one	one	NUM
iajs-3342	8	51	year	year	NOUN
iajs-3342	8	52	(	(	PUNCT
iajs-3342	8	53	g3	g3	NOUN
iajs-3342	8	54	)	)	PUNCT
iajs-3342	8	55	.	.	PUNCT
iajs-3342	9	1	this	this	DET
iajs-3342	9	2	study	study	NOUN
iajs-3342	9	3	showed	show	VERB
iajs-3342	9	4	a	a	DET
iajs-3342	9	5	significant	significant	ADJ
iajs-3342	9	6	increase	increase	NOUN
iajs-3342	9	7	in	in	ADP
iajs-3342	9	8	serum	serum	NOUN
iajs-3342	9	9	ngf	ngf	ADV
iajs-3342	9	10	and	and	CCONJ
iajs-3342	9	11	a	a	DET
iajs-3342	9	12	significant	significant	ADJ
iajs-3342	9	13	decrease	decrease	NOUN
iajs-3342	9	14	in	in	ADP
iajs-3342	9	15	vitamin	vitamin	NOUN
iajs-3342	9	16	b12	b12	NOUN
iajs-3342	9	17	levels	level	NOUN
iajs-3342	9	18	in	in	ADP
iajs-3342	9	19	sle	sle	PROPN
iajs-3342	9	20	patient	patient	NOUN
iajs-3342	9	21	groups	group	NOUN
iajs-3342	9	22	when	when	SCONJ
iajs-3342	9	23	compared	compare	VERB
iajs-3342	9	24	with	with	ADP
iajs-3342	9	25	control	control	NOUN
iajs-3342	9	26	,	,	PUNCT
iajs-3342	9	27	as	as	ADV
iajs-3342	9	28	well	well	ADV
iajs-3342	9	29	as	as	ADP
iajs-3342	9	30	their	their	PRON
iajs-3342	9	31	level	level	NOUN
iajs-3342	9	32	in	in	ADP
iajs-3342	9	33	sle	sle	PROPN
iajs-3342	9	34	patients	patient	NOUN
iajs-3342	9	35	compared	compare	VERB
iajs-3342	9	36	with	with	ADP
iajs-3342	9	37	control	control	NOUN
iajs-3342	9	38	.	.	PUNCT
iajs-3342	10	1	also	also	ADV
iajs-3342	10	2	,	,	PUNCT
iajs-3342	10	3	there	there	PRON
iajs-3342	10	4	was	be	VERB
iajs-3342	10	5	an	an	DET
iajs-3342	10	6	essential	essential	ADJ
iajs-3342	10	7	negative	negative	ADJ
iajs-3342	10	8	correlation	correlation	NOUN
iajs-3342	10	9	between	between	ADP
iajs-3342	10	10	ngf	ngf	ADV
iajs-3342	10	11	and	and	CCONJ
iajs-3342	10	12	vitamin	vitamin	NOUN
iajs-3342	10	13	b12	b12	NOUN
iajs-3342	10	14	in	in	ADP
iajs-3342	10	15	sle	sle	PROPN
iajs-3342	10	16	patients	patient	NOUN
iajs-3342	10	17	and	and	CCONJ
iajs-3342	10	18	controls	control	NOUN
iajs-3342	10	19	.	.	PUNCT
iajs-3342	11	1	the	the	DET
iajs-3342	11	2	present	present	ADJ
iajs-3342	11	3	results	result	NOUN
iajs-3342	11	4	found	find	VERB
iajs-3342	11	5	that	that	SCONJ
iajs-3342	11	6	the	the	DET
iajs-3342	11	7	serum	serum	NOUN
iajs-3342	11	8	ngf	ngf	PROPN
iajs-3342	11	9	levels	level	NOUN
iajs-3342	11	10	in	in	ADP
iajs-3342	11	11	sle	sle	PROPN
iajs-3342	11	12	patients	patient	NOUN
iajs-3342	11	13	considerably	considerably	ADV
iajs-3342	11	14	increased	increase	VERB
iajs-3342	11	15	with	with	ADP
iajs-3342	11	16	the	the	DET
iajs-3342	11	17	duration	duration	NOUN
iajs-3342	11	18	of	of	ADP
iajs-3342	11	19	the	the	DET
iajs-3342	11	20	disease	disease	NOUN
iajs-3342	11	21	.	.	PUNCT
iajs-3342	12	1	therefore	therefore	ADV
iajs-3342	12	2	,	,	PUNCT
iajs-3342	12	3	ngf	ngf	ADV
iajs-3342	12	4	may	may	AUX
iajs-3342	12	5	be	be	AUX
iajs-3342	12	6	a	a	DET
iajs-3342	12	7	diagnostic	diagnostic	ADJ
iajs-3342	12	8	and	and	CCONJ
iajs-3342	12	9	follow	follow	VERB
iajs-3342	12	10	-	-	PUNCT
iajs-3342	12	11	up	up	NOUN
iajs-3342	12	12	marker	marker	NOUN
iajs-3342	12	13	of	of	ADP
iajs-3342	12	14	the	the	DET
iajs-3342	12	15	development	development	NOUN
iajs-3342	12	16	of	of	ADP
iajs-3342	12	17	disease	disease	NOUN
iajs-3342	12	18	.	.	PUNCT
iajs-3342	13	1	in	in	ADP
iajs-3342	13	2	addition	addition	NOUN
iajs-3342	13	3	,	,	PUNCT
iajs-3342	13	4	the	the	DET
iajs-3342	13	5	significant	significant	ADJ
iajs-3342	13	6	negative	negative	ADJ
iajs-3342	13	7	correlation	correlation	NOUN
iajs-3342	13	8	between	between	ADP
iajs-3342	13	9	ngf	ngf	ADV
iajs-3342	13	10	and	and	CCONJ
iajs-3342	13	11	vitamin	vitamin	NOUN
iajs-3342	13	12	b12	b12	NOUN
iajs-3342	13	13	indicates	indicate	VERB
iajs-3342	13	14	that	that	SCONJ
iajs-3342	13	15	sle	sle	PROPN
iajs-3342	13	16	patients	patient	NOUN
iajs-3342	13	17	may	may	AUX
iajs-3342	13	18	be	be	AUX
iajs-3342	13	19	prone	prone	ADJ
iajs-3342	13	20	to	to	ADP
iajs-3342	13	21	nerve	nerve	NOUN
iajs-3342	13	22	damage	damage	NOUN
iajs-3342	13	23	,	,	PUNCT
iajs-3342	13	24	and	and	CCONJ
iajs-3342	13	25	ngf	ngf	ADV
iajs-3342	13	26	may	may	AUX
iajs-3342	13	27	be	be	AUX
iajs-3342	13	28	a	a	DET
iajs-3342	13	29	predictive	predictive	ADJ
iajs-3342	13	30	biochemical	biochemical	ADJ
iajs-3342	13	31	marker	marker	NOUN
iajs-3342	13	32	for	for	ADP
iajs-3342	13	33	the	the	DET
iajs-3342	13	34	development	development	NOUN
iajs-3342	13	35	of	of	ADP
iajs-3342	13	36	nerve	nerve	NOUN
iajs-3342	13	37	damage	damage	NOUN
iajs-3342	13	38	in	in	ADP
iajs-3342	13	39	sle	sle	PROPN
iajs-3342	13	40	patients	patient	NOUN
iajs-3342	13	41	.	.	PUNCT
iajs-3342	14	1	keywords	keyword	NOUN
iajs-3342	14	2	:	:	PUNCT
iajs-3342	14	3	systemic	systemic	ADJ
iajs-3342	14	4	lupus	lupus	PROPN
iajs-3342	14	5	erythematosus	erythematosus	PROPN
iajs-3342	14	6	,	,	PUNCT
iajs-3342	14	7	nerve	nerve	NOUN
iajs-3342	14	8	damage	damage	NOUN
iajs-3342	14	9	,	,	PUNCT
iajs-3342	14	10	nerve	nerve	NOUN
iajs-3342	14	11	growth	growth	NOUN
iajs-3342	14	12	factor	factor	NOUN
iajs-3342	14	13	,	,	PUNCT
iajs-3342	14	14	vitamin	vitamin	NOUN
iajs-3342	14	15	b12	b12	NOUN
iajs-3342	14	16	.	.	PUNCT
iajs-3342	15	1	1	1	X
iajs-3342	15	2	.	.	X
iajs-3342	15	3	introduction	introduction	NOUN
iajs-3342	15	4	lupus	lupus	NOUN
iajs-3342	15	5	is	be	AUX
iajs-3342	15	6	an	an	DET
iajs-3342	15	7	autoimmune	autoimmune	ADJ
iajs-3342	15	8	disorder	disorder	NOUN
iajs-3342	15	9	in	in	ADP
iajs-3342	15	10	which	which	PRON
iajs-3342	15	11	the	the	DET
iajs-3342	15	12	body	body	NOUN
iajs-3342	15	13	's	's	PART
iajs-3342	15	14	immune	immune	ADJ
iajs-3342	15	15	system	system	NOUN
iajs-3342	15	16	mistakenly	mistakenly	ADV
iajs-3342	15	17	attacks	attack	VERB
iajs-3342	15	18	and	and	CCONJ
iajs-3342	15	19	kills	kill	VERB
iajs-3342	15	20	healthy	healthy	ADJ
iajs-3342	15	21	cells	cell	NOUN
iajs-3342	15	22	and	and	CCONJ
iajs-3342	15	23	tissues	tissue	NOUN
iajs-3342	15	24	.	.	PUNCT
iajs-3342	16	1	types	type	NOUN
iajs-3342	16	2	of	of	ADP
iajs-3342	16	3	lupus	lupus	NOUN
iajs-3342	16	4	include	include	VERB
iajs-3342	16	5	systemic	systemic	ADJ
iajs-3342	16	6	lupus	lupus	NOUN
iajs-3342	16	7	erythematosus	erythematosus	NOUN
iajs-3342	16	8	(	(	PUNCT
iajs-3342	16	9	sle	sle	PROPN
iajs-3342	16	10	)	)	PUNCT
iajs-3342	16	11	,	,	PUNCT
iajs-3342	16	12	which	which	PRON
iajs-3342	16	13	is	be	AUX
iajs-3342	16	14	a	a	DET
iajs-3342	16	15	chronic	chronic	ADJ
iajs-3342	16	16	inflammatory	inflammatory	ADJ
iajs-3342	16	17	disorder	disorder	NOUN
iajs-3342	16	18	that	that	PRON
iajs-3342	16	19	has	have	VERB
iajs-3342	16	20	a	a	DET
iajs-3342	16	21	disastrous	disastrous	ADJ
iajs-3342	16	22	impact	impact	NOUN
iajs-3342	16	23	on	on	ADP
iajs-3342	16	24	almost	almost	ADV
iajs-3342	16	25	every	every	PRON
iajs-3342	16	26	organ	organ	NOUN
iajs-3342	16	27	and	and	CCONJ
iajs-3342	16	28	tissue	tissue	NOUN
iajs-3342	16	29	in	in	ADP
iajs-3342	16	30	the	the	DET
iajs-3342	16	31	body	body	NOUN
iajs-3342	16	32	[	[	X
iajs-3342	16	33	1	1	NUM
iajs-3342	16	34	]	]	PUNCT
iajs-3342	16	35	.	.	PUNCT
iajs-3342	17	1	due	due	ADP
iajs-3342	17	2	to	to	ADP
iajs-3342	17	3	mistaking	mistake	VERB
iajs-3342	17	4	good	good	ADJ
iajs-3342	17	5	tissue	tissue	NOUN
iajs-3342	17	6	for	for	ADP
iajs-3342	17	7	harmful	harmful	ADJ
iajs-3342	17	8	invaders	invader	NOUN
iajs-3342	17	9	,	,	PUNCT
iajs-3342	17	10	the	the	DET
iajs-3342	17	11	body	body	NOUN
iajs-3342	17	12	's	's	PART
iajs-3342	17	13	immune	immune	ADJ
iajs-3342	17	14	system	system	NOUN
iajs-3342	17	15	causes	cause	VERB
iajs-3342	17	16	the	the	DET
iajs-3342	17	17	autoimmune	autoimmune	ADJ
iajs-3342	17	18	disease	disease	NOUN
iajs-3342	17	19	lupus	lupus	NOUN
iajs-3342	17	20	.	.	PUNCT
iajs-3342	18	1	several	several	ADJ
iajs-3342	18	2	physiological	physiological	ADJ
iajs-3342	18	3	processes	process	NOUN
iajs-3342	18	4	are	be	AUX
iajs-3342	18	5	negatively	negatively	ADV
iajs-3342	18	6	impacted	impact	VERB
iajs-3342	18	7	[	[	PUNCT
iajs-3342	18	8	2	2	NUM
iajs-3342	18	9	]	]	PUNCT
iajs-3342	18	10	.	.	PUNCT
iajs-3342	19	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3342	19	2	https://orcid.org/0009-0000-3527-3250	https://orcid.org/0009-0000-3527-3250	PROPN
iajs-3342	19	3	https://orcid.org/0000-0002-6100-9696	https://orcid.org/0000-0002-6100-9696	PROPN
iajs-3342	19	4	mailto:drbiochem2007@gmail.com	mailto:drbiochem2007@gmail.com	PROPN
iajs-3342	19	5	mailto:zamzamaltaie@gmail.com	mailto:zamzamaltaie@gmail.com	PROPN
iajs-3342	19	6	ihjpas	ihjpas	PROPN
iajs-3342	19	7	.	.	PUNCT
iajs-3342	20	1	2024	2024	NUM
iajs-3342	20	2	,	,	PUNCT
iajs-3342	20	3	37	37	NUM
iajs-3342	20	4	(	(	PUNCT
iajs-3342	20	5	3	3	NUM
iajs-3342	20	6	)	)	PUNCT
iajs-3342	20	7	312	312	NUM
iajs-3342	20	8	since	since	SCONJ
iajs-3342	20	9	lupus	lupus	NOUN
iajs-3342	20	10	affects	affect	VERB
iajs-3342	20	11	every	every	DET
iajs-3342	20	12	part	part	NOUN
iajs-3342	20	13	of	of	ADP
iajs-3342	20	14	the	the	DET
iajs-3342	20	15	body	body	NOUN
iajs-3342	20	16	,	,	PUNCT
iajs-3342	20	17	prompt	prompt	ADJ
iajs-3342	20	18	diagnosis	diagnosis	NOUN
iajs-3342	20	19	and	and	CCONJ
iajs-3342	20	20	treatment	treatment	NOUN
iajs-3342	20	21	are	be	AUX
iajs-3342	20	22	essential	essential	ADJ
iajs-3342	20	23	for	for	ADP
iajs-3342	20	24	reducing	reduce	VERB
iajs-3342	20	25	tissue	tissue	NOUN
iajs-3342	20	26	damage	damage	NOUN
iajs-3342	20	27	and	and	CCONJ
iajs-3342	20	28	enhancing	enhance	VERB
iajs-3342	20	29	health	health	NOUN
iajs-3342	20	30	outcomes	outcome	NOUN
iajs-3342	20	31	[	[	X
iajs-3342	20	32	3	3	NUM
iajs-3342	20	33	]	]	PUNCT
iajs-3342	20	34	.	.	PUNCT
iajs-3342	21	1	sle	sle	PROPN
iajs-3342	21	2	is	be	AUX
iajs-3342	21	3	influenced	influence	VERB
iajs-3342	21	4	by	by	ADP
iajs-3342	21	5	both	both	CCONJ
iajs-3342	21	6	environmental	environmental	ADJ
iajs-3342	21	7	and	and	CCONJ
iajs-3342	21	8	genetic	genetic	ADJ
iajs-3342	21	9	factors	factor	NOUN
iajs-3342	21	10	[	[	X
iajs-3342	21	11	4	4	NUM
iajs-3342	21	12	]	]	PUNCT
iajs-3342	21	13	.	.	PUNCT
iajs-3342	22	1	pregnant	pregnant	ADJ
iajs-3342	22	2	women	woman	NOUN
iajs-3342	22	3	and	and	CCONJ
iajs-3342	22	4	young	young	ADJ
iajs-3342	22	5	women	woman	NOUN
iajs-3342	22	6	are	be	AUX
iajs-3342	22	7	more	more	ADV
iajs-3342	22	8	vulnerable	vulnerable	ADJ
iajs-3342	22	9	to	to	ADP
iajs-3342	22	10	developing	develop	VERB
iajs-3342	22	11	sle	sle	PROPN
iajs-3342	22	12	.	.	PUNCT
iajs-3342	23	1	an	an	DET
iajs-3342	23	2	increased	increase	VERB
iajs-3342	23	3	risk	risk	NOUN
iajs-3342	23	4	of	of	ADP
iajs-3342	23	5	developing	develop	VERB
iajs-3342	23	6	sle	sle	NOUN
iajs-3342	23	7	may	may	AUX
iajs-3342	23	8	be	be	AUX
iajs-3342	23	9	traced	trace	VERB
iajs-3342	23	10	back	back	ADV
iajs-3342	23	11	to	to	ADP
iajs-3342	23	12	hormones	hormone	NOUN
iajs-3342	23	13	in	in	ADP
iajs-3342	23	14	a	a	DET
iajs-3342	23	15	variety	variety	NOUN
iajs-3342	23	16	of	of	ADP
iajs-3342	23	17	ways	way	NOUN
iajs-3342	23	18	,	,	PUNCT
iajs-3342	23	19	not	not	PART
iajs-3342	23	20	only	only	ADV
iajs-3342	23	21	the	the	DET
iajs-3342	23	22	disruption	disruption	NOUN
iajs-3342	23	23	of	of	ADP
iajs-3342	23	24	homeostasis	homeostasis	NOUN
iajs-3342	23	25	of	of	ADP
iajs-3342	23	26	a	a	DET
iajs-3342	23	27	particular	particular	ADJ
iajs-3342	23	28	hormone	hormone	NOUN
iajs-3342	23	29	.	.	PUNCT
iajs-3342	24	1	according	accord	VERB
iajs-3342	24	2	to	to	ADP
iajs-3342	24	3	the	the	DET
iajs-3342	24	4	findings	finding	NOUN
iajs-3342	24	5	of	of	ADP
iajs-3342	24	6	mcmurray	mcmurray	PROPN
iajs-3342	24	7	rw	rw	PROPN
iajs-3342	24	8	et	et	PROPN
iajs-3342	24	9	al	al	PROPN
iajs-3342	24	10	.	.	PUNCT
iajs-3342	25	1	meta	meta	VERB
iajs-3342	25	2	-	-	PUNCT
iajs-3342	25	3	analysis	analysis	NOUN
iajs-3342	25	4	[	[	X
iajs-3342	25	5	5	5	NUM
iajs-3342	25	6	]	]	PUNCT
iajs-3342	25	7	.	.	PUNCT
iajs-3342	26	1	most	most	ADJ
iajs-3342	26	2	patients	patient	NOUN
iajs-3342	26	3	in	in	ADP
iajs-3342	26	4	community	community	NOUN
iajs-3342	26	5	-	-	PUNCT
iajs-3342	26	6	based	base	VERB
iajs-3342	26	7	caucasian	caucasian	ADJ
iajs-3342	26	8	registries	registry	NOUN
iajs-3342	26	9	are	be	AUX
iajs-3342	26	10	middle	middle	ADJ
iajs-3342	26	11	-	-	PUNCT
iajs-3342	26	12	aged	aged	ADJ
iajs-3342	26	13	women	woman	NOUN
iajs-3342	26	14	,	,	PUNCT
iajs-3342	26	15	and	and	CCONJ
iajs-3342	26	16	almost	almost	ADV
iajs-3342	26	17	half	half	NOUN
iajs-3342	26	18	of	of	ADP
iajs-3342	26	19	all	all	DET
iajs-3342	26	20	cases	case	NOUN
iajs-3342	26	21	are	be	AUX
iajs-3342	26	22	considered	consider	VERB
iajs-3342	26	23	to	to	PART
iajs-3342	26	24	be	be	AUX
iajs-3342	26	25	relatively	relatively	ADV
iajs-3342	26	26	mild	mild	ADJ
iajs-3342	26	27	when	when	SCONJ
iajs-3342	26	28	first	first	ADV
iajs-3342	26	29	diagnosed	diagnose	VERB
iajs-3342	26	30	[	[	X
iajs-3342	26	31	6	6	NUM
iajs-3342	26	32	]	]	PUNCT
iajs-3342	26	33	.	.	PUNCT
iajs-3342	27	1	chronic	chronic	ADJ
iajs-3342	27	2	multi	multi	ADJ
iajs-3342	27	3	-	-	ADJ
iajs-3342	27	4	organ	organ	ADJ
iajs-3342	27	5	autoimmune	autoimmune	ADJ
iajs-3342	27	6	illness	illness	NOUN
iajs-3342	27	7	,	,	PUNCT
iajs-3342	27	8	also	also	ADV
iajs-3342	27	9	known	know	VERB
iajs-3342	27	10	as	as	ADP
iajs-3342	27	11	sle	sle	PROPN
iajs-3342	27	12	.	.	PUNCT
iajs-3342	28	1	the	the	DET
iajs-3342	28	2	immune	immune	ADJ
iajs-3342	28	3	system	system	NOUN
iajs-3342	28	4	's	's	PART
iajs-3342	28	5	sensitivity	sensitivity	NOUN
iajs-3342	28	6	to	to	ADP
iajs-3342	28	7	self	self	NOUN
iajs-3342	28	8	-	-	PUNCT
iajs-3342	28	9	antigens	antigen	NOUN
iajs-3342	28	10	is	be	AUX
iajs-3342	28	11	broken	break	VERB
iajs-3342	28	12	,	,	PUNCT
iajs-3342	28	13	causing	cause	VERB
iajs-3342	28	14	the	the	DET
iajs-3342	28	15	production	production	NOUN
iajs-3342	28	16	of	of	ADP
iajs-3342	28	17	excessive	excessive	ADJ
iajs-3342	28	18	auto	auto	NOUN
iajs-3342	28	19	-	-	PUNCT
iajs-3342	28	20	antibodies	antibody	NOUN
iajs-3342	28	21	.	.	PUNCT
iajs-3342	29	1	when	when	SCONJ
iajs-3342	29	2	this	this	PRON
iajs-3342	29	3	happens	happen	VERB
iajs-3342	29	4	,	,	PUNCT
iajs-3342	29	5	immune	immune	ADJ
iajs-3342	29	6	complexes	complex	NOUN
iajs-3342	29	7	are	be	AUX
iajs-3342	29	8	released	release	VERB
iajs-3342	29	9	into	into	ADP
iajs-3342	29	10	the	the	DET
iajs-3342	29	11	bloodstream	bloodstream	NOUN
iajs-3342	29	12	,	,	PUNCT
iajs-3342	29	13	and	and	CCONJ
iajs-3342	29	14	tissue	tissue	NOUN
iajs-3342	29	15	damage	damage	NOUN
iajs-3342	29	16	occurs	occur	VERB
iajs-3342	29	17	as	as	ADP
iajs-3342	29	18	a	a	DET
iajs-3342	29	19	result	result	NOUN
iajs-3342	29	20	of	of	ADP
iajs-3342	29	21	an	an	DET
iajs-3342	29	22	immune	immune	ADJ
iajs-3342	29	23	response	response	NOUN
iajs-3342	30	1	[	[	X
iajs-3342	30	2	7	7	NUM
iajs-3342	30	3	]	]	PUNCT
iajs-3342	30	4	.	.	PUNCT
iajs-3342	31	1	one	one	NUM
iajs-3342	31	2	of	of	ADP
iajs-3342	31	3	the	the	DET
iajs-3342	31	4	most	most	ADV
iajs-3342	31	5	typical	typical	ADJ
iajs-3342	31	6	indicators	indicator	NOUN
iajs-3342	31	7	of	of	ADP
iajs-3342	31	8	lupus	lupus	NOUN
iajs-3342	31	9	is	be	AUX
iajs-3342	31	10	the	the	DET
iajs-3342	31	11	presence	presence	NOUN
iajs-3342	31	12	of	of	ADP
iajs-3342	31	13	abnormal	abnormal	ADJ
iajs-3342	31	14	antibodies	antibody	NOUN
iajs-3342	31	15	in	in	ADP
iajs-3342	31	16	the	the	DET
iajs-3342	31	17	blood	blood	NOUN
iajs-3342	31	18	.	.	PUNCT
iajs-3342	32	1	sle	sle	PROPN
iajs-3342	32	2	has	have	VERB
iajs-3342	32	3	unknown	unknown	ADJ
iajs-3342	32	4	causes	cause	NOUN
iajs-3342	32	5	;	;	PUNCT
iajs-3342	32	6	however	however	ADV
iajs-3342	32	7	,	,	PUNCT
iajs-3342	32	8	genetics	genetic	NOUN
iajs-3342	32	9	,	,	PUNCT
iajs-3342	32	10	infections	infection	NOUN
iajs-3342	32	11	,	,	PUNCT
iajs-3342	32	12	sun	sun	NOUN
iajs-3342	32	13	exposure	exposure	NOUN
iajs-3342	32	14	,	,	PUNCT
iajs-3342	32	15	and	and	CCONJ
iajs-3342	32	16	medicines	medicine	NOUN
iajs-3342	32	17	are	be	AUX
iajs-3342	32	18	all	all	PRON
iajs-3342	32	19	possible	possible	ADJ
iajs-3342	32	20	contributors	contributor	NOUN
iajs-3342	32	21	[	[	X
iajs-3342	32	22	8	8	NUM
iajs-3342	32	23	]	]	PUNCT
iajs-3342	32	24	.	.	PUNCT
iajs-3342	33	1	antinuclear	antinuclear	PROPN
iajs-3342	33	2	(	(	PUNCT
iajs-3342	33	3	ana	ana	PROPN
iajs-3342	33	4	)	)	PUNCT
iajs-3342	33	5	and	and	CCONJ
iajs-3342	33	6	anti	anti	ADJ
iajs-3342	33	7	-	-	ADJ
iajs-3342	33	8	doublestranded	doublestranded	ADJ
iajs-3342	33	9	(	(	PUNCT
iajs-3342	33	10	ds	ds	ADJ
iajs-3342	33	11	)	)	PUNCT
iajs-3342	33	12	dna	dna	NOUN
iajs-3342	33	13	antibodies	antibodie	VERB
iajs-3342	33	14	,	,	PUNCT
iajs-3342	33	15	which	which	PRON
iajs-3342	33	16	are	be	AUX
iajs-3342	33	17	currently	currently	ADV
iajs-3342	33	18	used	use	VERB
iajs-3342	33	19	for	for	ADP
iajs-3342	33	20	diagnosis	diagnosis	NOUN
iajs-3342	33	21	,	,	PUNCT
iajs-3342	33	22	lack	lack	VERB
iajs-3342	33	23	specificity	specificity	NOUN
iajs-3342	33	24	and	and	CCONJ
iajs-3342	33	25	sensitivity	sensitivity	NOUN
iajs-3342	33	26	,	,	PUNCT
iajs-3342	33	27	respectively	respectively	ADV
iajs-3342	33	28	,	,	PUNCT
iajs-3342	33	29	and	and	CCONJ
iajs-3342	33	30	add	add	VERB
iajs-3342	33	31	to	to	ADP
iajs-3342	33	32	the	the	DET
iajs-3342	33	33	difficulties	difficulty	NOUN
iajs-3342	33	34	in	in	ADP
iajs-3342	33	35	the	the	DET
iajs-3342	33	36	diagnosis	diagnosis	NOUN
iajs-3342	33	37	of	of	ADP
iajs-3342	33	38	sel	sel	NOUN
iajs-3342	34	1	[	[	X
iajs-3342	34	2	9	9	NUM
iajs-3342	34	3	]	]	PUNCT
iajs-3342	34	4	.	.	PUNCT
iajs-3342	35	1	the	the	DET
iajs-3342	35	2	central	central	ADJ
iajs-3342	35	3	nervous	nervous	ADJ
iajs-3342	35	4	system	system	NOUN
iajs-3342	35	5	(	(	PUNCT
iajs-3342	35	6	cns	cns	NOUN
iajs-3342	35	7	)	)	PUNCT
iajs-3342	35	8	may	may	AUX
iajs-3342	35	9	be	be	AUX
iajs-3342	35	10	affected	affect	VERB
iajs-3342	35	11	by	by	ADP
iajs-3342	35	12	sle	sle	PROPN
iajs-3342	35	13	,	,	PUNCT
iajs-3342	35	14	a	a	DET
iajs-3342	35	15	systemic	systemic	ADJ
iajs-3342	35	16	autoimmune	autoimmune	ADJ
iajs-3342	35	17	illness	illness	NOUN
iajs-3342	35	18	with	with	ADP
iajs-3342	35	19	various	various	ADJ
iajs-3342	35	20	immunologic	immunologic	ADJ
iajs-3342	35	21	abnormalities	abnormality	NOUN
iajs-3342	35	22	.	.	PUNCT
iajs-3342	36	1	both	both	CCONJ
iajs-3342	36	2	the	the	DET
iajs-3342	36	3	cns	cns	NOUN
iajs-3342	36	4	and	and	CCONJ
iajs-3342	36	5	peripheral	peripheral	ADJ
iajs-3342	36	6	nervous	nervous	ADJ
iajs-3342	36	7	system	system	NOUN
iajs-3342	36	8	(	(	PUNCT
iajs-3342	36	9	pns	pns	NOUN
iajs-3342	36	10	)	)	PUNCT
iajs-3342	36	11	are	be	AUX
iajs-3342	36	12	involved	involve	VERB
iajs-3342	36	13	in	in	ADP
iajs-3342	36	14	the	the	DET
iajs-3342	36	15	effects	effect	NOUN
iajs-3342	36	16	of	of	ADP
iajs-3342	36	17	sle	sle	PROPN
iajs-3342	36	18	.	.	PUNCT
iajs-3342	37	1	the	the	DET
iajs-3342	37	2	involvement	involvement	NOUN
iajs-3342	37	3	of	of	ADP
iajs-3342	37	4	the	the	DET
iajs-3342	37	5	nervous	nervous	ADJ
iajs-3342	37	6	system	system	NOUN
iajs-3342	37	7	in	in	ADP
iajs-3342	37	8	sle	sle	PROPN
iajs-3342	37	9	continues	continue	VERB
iajs-3342	37	10	to	to	PART
iajs-3342	37	11	be	be	AUX
iajs-3342	37	12	a	a	DET
iajs-3342	37	13	leading	leading	ADJ
iajs-3342	37	14	cause	cause	NOUN
iajs-3342	37	15	of	of	ADP
iajs-3342	37	16	morbidity	morbidity	NOUN
iajs-3342	37	17	and	and	CCONJ
iajs-3342	37	18	death	death	NOUN
iajs-3342	38	1	[	[	X
iajs-3342	38	2	10	10	NUM
iajs-3342	38	3	]	]	PUNCT
iajs-3342	38	4	.	.	PUNCT
iajs-3342	39	1	nerve	nerve	NOUN
iajs-3342	39	2	growth	growth	NOUN
iajs-3342	39	3	factor	factor	NOUN
iajs-3342	39	4	(	(	PUNCT
iajs-3342	39	5	ngf	ngf	ADV
iajs-3342	39	6	)	)	PUNCT
iajs-3342	39	7	is	be	AUX
iajs-3342	39	8	a	a	DET
iajs-3342	39	9	neurotrophic	neurotrophic	ADJ
iajs-3342	39	10	protein	protein	NOUN
iajs-3342	39	11	thought	think	VERB
iajs-3342	39	12	to	to	PART
iajs-3342	39	13	be	be	AUX
iajs-3342	39	14	critical	critical	ADJ
iajs-3342	39	15	for	for	ADP
iajs-3342	39	16	the	the	DET
iajs-3342	39	17	development	development	NOUN
iajs-3342	39	18	of	of	ADP
iajs-3342	39	19	sympathetic	sympathetic	ADJ
iajs-3342	39	20	and	and	CCONJ
iajs-3342	39	21	sensory	sensory	ADJ
iajs-3342	39	22	afferent	afferent	ADJ
iajs-3342	39	23	neurons	neuron	NOUN
iajs-3342	39	24	.	.	PUNCT
iajs-3342	40	1	synaptic	synaptic	ADJ
iajs-3342	40	2	plasticity	plasticity	NOUN
iajs-3342	40	3	,	,	PUNCT
iajs-3342	40	4	neurotransmitter	neurotransmitter	NOUN
iajs-3342	40	5	release	release	NOUN
iajs-3342	40	6	,	,	PUNCT
iajs-3342	40	7	axonal	axonal	ADJ
iajs-3342	40	8	tract	tract	NOUN
iajs-3342	40	9	formation	formation	NOUN
iajs-3342	40	10	,	,	PUNCT
iajs-3342	40	11	and	and	CCONJ
iajs-3342	40	12	gene	gene	NOUN
iajs-3342	40	13	transcription	transcription	NOUN
iajs-3342	40	14	are	be	AUX
iajs-3342	40	15	all	all	PRON
iajs-3342	40	16	affected	affect	VERB
iajs-3342	40	17	by	by	ADP
iajs-3342	40	18	nerve	nerve	NOUN
iajs-3342	40	19	growth	growth	NOUN
iajs-3342	40	20	factors	factor	NOUN
iajs-3342	40	21	[	[	X
iajs-3342	40	22	11	11	NUM
iajs-3342	40	23	]	]	PUNCT
iajs-3342	40	24	.	.	PUNCT
iajs-3342	41	1	ngf	ngf	ADV
iajs-3342	41	2	,	,	PUNCT
iajs-3342	41	3	the	the	DET
iajs-3342	41	4	first	first	ADJ
iajs-3342	41	5	neurotrophic	neurotrophic	ADJ
iajs-3342	41	6	factor	factor	NOUN
iajs-3342	41	7	discovered	discover	VERB
iajs-3342	41	8	,	,	PUNCT
iajs-3342	41	9	plays	play	VERB
iajs-3342	41	10	a	a	DET
iajs-3342	41	11	significant	significant	ADJ
iajs-3342	41	12	role	role	NOUN
iajs-3342	41	13	in	in	ADP
iajs-3342	41	14	the	the	DET
iajs-3342	41	15	development	development	NOUN
iajs-3342	41	16	of	of	ADP
iajs-3342	41	17	the	the	DET
iajs-3342	41	18	brain	brain	NOUN
iajs-3342	41	19	's	's	PART
iajs-3342	41	20	neural	neural	ADJ
iajs-3342	41	21	systems	system	NOUN
iajs-3342	41	22	.	.	PUNCT
iajs-3342	42	1	adult	adult	VERB
iajs-3342	42	2	endogenous	endogenous	ADJ
iajs-3342	42	3	ngf	ngf	ADJ
iajs-3342	42	4	secretion	secretion	NOUN
iajs-3342	42	5	is	be	AUX
iajs-3342	42	6	involved	involve	VERB
iajs-3342	42	7	in	in	ADP
iajs-3342	42	8	a	a	DET
iajs-3342	42	9	wide	wide	ADJ
iajs-3342	42	10	range	range	NOUN
iajs-3342	42	11	of	of	ADP
iajs-3342	42	12	physiologic	physiologic	ADJ
iajs-3342	42	13	functions	function	NOUN
iajs-3342	42	14	,	,	PUNCT
iajs-3342	42	15	including	include	VERB
iajs-3342	42	16	the	the	DET
iajs-3342	42	17	genetic	genetic	ADJ
iajs-3342	42	18	and	and	CCONJ
iajs-3342	42	19	functional	functional	ADJ
iajs-3342	42	20	maintenance	maintenance	NOUN
iajs-3342	42	21	of	of	ADP
iajs-3342	42	22	sympathetic	sympathetic	ADJ
iajs-3342	42	23	and	and	CCONJ
iajs-3342	42	24	sensory	sensory	ADJ
iajs-3342	42	25	fibers	fiber	NOUN
iajs-3342	42	26	in	in	ADP
iajs-3342	42	27	the	the	DET
iajs-3342	42	28	peripheral	peripheral	ADJ
iajs-3342	42	29	nervous	nervous	ADJ
iajs-3342	42	30	system	system	NOUN
iajs-3342	42	31	[	[	X
iajs-3342	42	32	12	12	NUM
iajs-3342	42	33	]	]	PUNCT
iajs-3342	42	34	.	.	PUNCT
iajs-3342	43	1	vitamin	vitamin	NOUN
iajs-3342	43	2	b12	b12	NOUN
iajs-3342	43	3	(	(	PUNCT
iajs-3342	43	4	vit	vit	NOUN
iajs-3342	43	5	.	.	PUNCT
iajs-3342	43	6	b12	b12	NOUN
iajs-3342	43	7	)	)	PUNCT
iajs-3342	43	8	,	,	PUNCT
iajs-3342	43	9	or	or	CCONJ
iajs-3342	43	10	cobalamin	cobalamin	NOUN
iajs-3342	43	11	,	,	PUNCT
iajs-3342	43	12	is	be	AUX
iajs-3342	43	13	a	a	DET
iajs-3342	43	14	water	water	NOUN
iajs-3342	43	15	-	-	PUNCT
iajs-3342	43	16	soluble	soluble	ADJ
iajs-3342	43	17	vitamin	vitamin	NOUN
iajs-3342	43	18	essential	essential	ADJ
iajs-3342	43	19	for	for	ADP
iajs-3342	43	20	normal	normal	ADJ
iajs-3342	43	21	cellular	cellular	ADJ
iajs-3342	43	22	metabolism	metabolism	NOUN
iajs-3342	43	23	and	and	CCONJ
iajs-3342	43	24	for	for	ADP
iajs-3342	43	25	maintaining	maintain	VERB
iajs-3342	43	26	a	a	DET
iajs-3342	43	27	healthy	healthy	ADJ
iajs-3342	43	28	nervous	nervous	ADJ
iajs-3342	43	29	system	system	NOUN
iajs-3342	43	30	[	[	X
iajs-3342	43	31	13	13	NUM
iajs-3342	43	32	]	]	PUNCT
iajs-3342	43	33	.	.	PUNCT
iajs-3342	44	1	it	it	PRON
iajs-3342	44	2	is	be	AUX
iajs-3342	44	3	crucial	crucial	ADJ
iajs-3342	44	4	for	for	ADP
iajs-3342	44	5	healthy	healthy	ADJ
iajs-3342	44	6	nerves	nerve	NOUN
iajs-3342	44	7	and	and	CCONJ
iajs-3342	44	8	vital	vital	ADJ
iajs-3342	44	9	in	in	ADP
iajs-3342	44	10	dna	dna	PROPN
iajs-3342	44	11	synthesis	synthesis	NOUN
iajs-3342	44	12	,	,	PUNCT
iajs-3342	44	13	meaning	mean	VERB
iajs-3342	44	14	it	it	PRON
iajs-3342	44	15	helps	help	VERB
iajs-3342	44	16	cells	cell	NOUN
iajs-3342	44	17	divide	divide	VERB
iajs-3342	44	18	.	.	PUNCT
iajs-3342	45	1	clinical	clinical	ADJ
iajs-3342	45	2	symptoms	symptom	NOUN
iajs-3342	45	3	of	of	ADP
iajs-3342	45	4	vit	vit	NOUN
iajs-3342	45	5	.	.	PUNCT
iajs-3342	46	1	b12	b12	NOUN
iajs-3342	46	2	deficiency	deficiency	NOUN
iajs-3342	46	3	mainly	mainly	ADV
iajs-3342	46	4	include	include	VERB
iajs-3342	46	5	anemia	anemia	NOUN
iajs-3342	46	6	and	and	CCONJ
iajs-3342	46	7	demyelination	demyelination	NOUN
iajs-3342	46	8	of	of	ADP
iajs-3342	46	9	the	the	DET
iajs-3342	46	10	neurological	neurological	ADJ
iajs-3342	46	11	system	system	NOUN
iajs-3342	46	12	[	[	X
iajs-3342	46	13	14	14	NUM
iajs-3342	46	14	]	]	SYM
iajs-3342	46	15	.	.	PUNCT
iajs-3342	47	1	2	2	X
iajs-3342	47	2	.	.	X
iajs-3342	47	3	materials	material	NOUN
iajs-3342	47	4	and	and	CCONJ
iajs-3342	47	5	methods	method	NOUN
iajs-3342	47	6	2.1	2.1	NUM
iajs-3342	47	7	.	.	PUNCT
iajs-3342	48	1	study	study	NOUN
iajs-3342	48	2	design	design	VERB
iajs-3342	48	3	a	a	DET
iajs-3342	48	4	cross	cross	ADJ
iajs-3342	48	5	-	-	ADJ
iajs-3342	48	6	sectional	sectional	ADJ
iajs-3342	48	7	sample	sample	NOUN
iajs-3342	48	8	was	be	AUX
iajs-3342	48	9	analyzed	analyze	VERB
iajs-3342	48	10	on	on	ADP
iajs-3342	48	11	patients	patient	NOUN
iajs-3342	48	12	at	at	ADP
iajs-3342	48	13	the	the	DET
iajs-3342	48	14	rheumatology	rheumatology	NOUN
iajs-3342	48	15	unit	unit	NOUN
iajs-3342	48	16	of	of	ADP
iajs-3342	48	17	baghdad	baghdad	PROPN
iajs-3342	48	18	teaching	teaching	NOUN
iajs-3342	48	19	hospital	hospital	NOUN
iajs-3342	48	20	,	,	PUNCT
iajs-3342	48	21	medical	medical	ADJ
iajs-3342	48	22	city	city	NOUN
iajs-3342	48	23	(	(	PUNCT
iajs-3342	48	24	baghdad	baghdad	PROPN
iajs-3342	48	25	)	)	PUNCT
iajs-3342	48	26	between	between	ADP
iajs-3342	48	27	september	september	PROPN
iajs-3342	48	28	2022	2022	NUM
iajs-3342	48	29	and	and	CCONJ
iajs-3342	48	30	february	february	PROPN
iajs-3342	48	31	2023	2023	NUM
iajs-3342	48	32	.	.	PUNCT
iajs-3342	49	1	the	the	DET
iajs-3342	49	2	present	present	ADJ
iajs-3342	49	3	research	research	NOUN
iajs-3342	49	4	comprised	comprise	VERB
iajs-3342	49	5	130	130	NUM
iajs-3342	49	6	participants	participant	NOUN
iajs-3342	49	7	,	,	PUNCT
iajs-3342	49	8	ranging	range	VERB
iajs-3342	49	9	in	in	ADP
iajs-3342	49	10	age	age	NOUN
iajs-3342	49	11	from	from	ADP
iajs-3342	49	12	18	18	NUM
iajs-3342	49	13	to	to	ADP
iajs-3342	49	14	48	48	NUM
iajs-3342	49	15	.	.	PUNCT
iajs-3342	50	1	one	one	NUM
iajs-3342	50	2	hundred	hundred	NUM
iajs-3342	50	3	of	of	ADP
iajs-3342	50	4	them	they	PRON
iajs-3342	50	5	were	be	AUX
iajs-3342	50	6	female	female	ADJ
iajs-3342	50	7	patients	patient	NOUN
iajs-3342	50	8	with	with	ADP
iajs-3342	50	9	sle	sle	PROPN
iajs-3342	50	10	,	,	PUNCT
iajs-3342	50	11	and	and	CCONJ
iajs-3342	50	12	30	30	NUM
iajs-3342	50	13	additional	additional	ADJ
iajs-3342	50	14	participants	participant	NOUN
iajs-3342	50	15	served	serve	VERB
iajs-3342	50	16	as	as	ADP
iajs-3342	50	17	healthy	healthy	ADJ
iajs-3342	50	18	controls	control	NOUN
iajs-3342	50	19	.	.	PUNCT
iajs-3342	51	1	a	a	DET
iajs-3342	51	2	rheumatologist	rheumatologist	NOUN
iajs-3342	51	3	diagnosed	diagnose	VERB
iajs-3342	51	4	each	each	DET
iajs-3342	51	5	case	case	NOUN
iajs-3342	51	6	of	of	ADP
iajs-3342	51	7	sle	sle	PROPN
iajs-3342	51	8	after	after	SCONJ
iajs-3342	51	9	thorough	thorough	ADJ
iajs-3342	51	10	clinical	clinical	ADJ
iajs-3342	51	11	evaluations	evaluation	NOUN
iajs-3342	51	12	backed	back	VERB
iajs-3342	51	13	up	up	ADP
iajs-3342	51	14	by	by	ADP
iajs-3342	51	15	laboratory	laboratory	NOUN
iajs-3342	51	16	findings	finding	NOUN
iajs-3342	51	17	.	.	PUNCT
iajs-3342	52	1	the	the	DET
iajs-3342	52	2	patients	patient	NOUN
iajs-3342	52	3	were	be	AUX
iajs-3342	52	4	classified	classify	VERB
iajs-3342	52	5	according	accord	VERB
iajs-3342	52	6	to	to	ADP
iajs-3342	52	7	the	the	DET
iajs-3342	52	8	duration	duration	NOUN
iajs-3342	52	9	of	of	ADP
iajs-3342	52	10	the	the	DET
iajs-3342	52	11	disease	disease	NOUN
iajs-3342	52	12	into	into	ADP
iajs-3342	52	13	:	:	PUNCT
iajs-3342	52	14	1g1=	1g1=	NUM
iajs-3342	52	15	15	15	NUM
iajs-3342	52	16	patients	patient	NOUN
iajs-3342	52	17	with	with	ADP
iajs-3342	52	18	a	a	DET
iajs-3342	52	19	disease	disease	NOUN
iajs-3342	52	20	duration	duration	NOUN
iajs-3342	52	21	of	of	ADP
iajs-3342	52	22	less	less	ADJ
iajs-3342	52	23	than	than	ADP
iajs-3342	52	24	3	3	NUM
iajs-3342	52	25	months	month	NOUN
iajs-3342	52	26	.	.	PUNCT
iajs-3342	53	1	2g2=	2g2=	NUM
iajs-3342	53	2	29	29	NUM
iajs-3342	53	3	patients	patient	NOUN
iajs-3342	53	4	with	with	ADP
iajs-3342	53	5	a	a	DET
iajs-3342	53	6	disease	disease	NOUN
iajs-3342	53	7	duration	duration	NOUN
iajs-3342	53	8	of	of	ADP
iajs-3342	53	9	more	more	ADJ
iajs-3342	53	10	than	than	ADP
iajs-3342	53	11	3	3	NUM
iajs-3342	53	12	months	month	NOUN
iajs-3342	53	13	to	to	ADP
iajs-3342	53	14	1	1	NUM
iajs-3342	53	15	year	year	NOUN
iajs-3342	53	16	.	.	PUNCT
iajs-3342	54	1	3g3=	3g3=	NUM
iajs-3342	54	2	56	56	NUM
iajs-3342	54	3	patients	patient	NOUN
iajs-3342	54	4	with	with	ADP
iajs-3342	54	5	a	a	DET
iajs-3342	54	6	disease	disease	NOUN
iajs-3342	54	7	duration	duration	NOUN
iajs-3342	54	8	of	of	ADP
iajs-3342	54	9	more	more	ADJ
iajs-3342	54	10	than	than	ADP
iajs-3342	54	11	one	one	NUM
iajs-3342	54	12	year	year	NOUN
iajs-3342	54	13	.	.	PUNCT
iajs-3342	55	1	2.2	2.2	NUM
iajs-3342	55	2	sample	sample	NOUN
iajs-3342	55	3	collection	collection	NOUN
iajs-3342	55	4	human	human	ADJ
iajs-3342	55	5	venous	venous	ADJ
iajs-3342	55	6	blood	blood	NOUN
iajs-3342	55	7	was	be	AUX
iajs-3342	55	8	collected	collect	VERB
iajs-3342	55	9	from	from	ADP
iajs-3342	55	10	both	both	DET
iajs-3342	55	11	patients	patient	NOUN
iajs-3342	55	12	and	and	CCONJ
iajs-3342	55	13	healthy	healthy	ADJ
iajs-3342	55	14	subjects	subject	NOUN
iajs-3342	55	15	.	.	PUNCT
iajs-3342	56	1	the	the	DET
iajs-3342	56	2	serum	serum	NOUN
iajs-3342	56	3	was	be	AUX
iajs-3342	56	4	then	then	ADV
iajs-3342	56	5	frozen	freeze	VERB
iajs-3342	56	6	for	for	ADP
iajs-3342	56	7	use	use	NOUN
iajs-3342	56	8	in	in	ADP
iajs-3342	56	9	future	future	ADJ
iajs-3342	56	10	laboratory	laboratory	NOUN
iajs-3342	56	11	evaluations	evaluation	NOUN
iajs-3342	56	12	,	,	PUNCT
iajs-3342	56	13	which	which	PRON
iajs-3342	56	14	included	include	VERB
iajs-3342	56	15	dsdna	dsdna	NOUN
iajs-3342	56	16	,	,	PUNCT
iajs-3342	56	17	ana	ana	PROPN
iajs-3342	56	18	,	,	PUNCT
iajs-3342	56	19	ngf	ngf	ADV
iajs-3342	56	20	,	,	PUNCT
iajs-3342	56	21	ihjpas	ihjpas	PROPN
iajs-3342	56	22	.	.	PUNCT
iajs-3342	57	1	2024	2024	NUM
iajs-3342	57	2	,	,	PUNCT
iajs-3342	57	3	37	37	NUM
iajs-3342	57	4	(	(	PUNCT
iajs-3342	57	5	3	3	NUM
iajs-3342	57	6	)	)	PUNCT
iajs-3342	57	7	313	313	NUM
iajs-3342	57	8	and	and	CCONJ
iajs-3342	57	9	vit	vit	NOUN
iajs-3342	57	10	.	.	PUNCT
iajs-3342	58	1	b12	b12	NOUN
iajs-3342	58	2	in	in	ADP
iajs-3342	58	3	serum	serum	NOUN
iajs-3342	58	4	and	and	CCONJ
iajs-3342	58	5	white	white	ADJ
iajs-3342	58	6	blood	blood	NOUN
iajs-3342	58	7	cells	cell	NOUN
iajs-3342	58	8	(	(	PUNCT
iajs-3342	58	9	wbc	wbc	PROPN
iajs-3342	58	10	)	)	PUNCT
iajs-3342	58	11	,	,	PUNCT
iajs-3342	58	12	red	red	ADJ
iajs-3342	58	13	blood	blood	NOUN
iajs-3342	58	14	cells	cell	NOUN
iajs-3342	58	15	(	(	PUNCT
iajs-3342	58	16	rbc	rbc	PROPN
iajs-3342	58	17	)	)	PUNCT
iajs-3342	58	18	,	,	PUNCT
iajs-3342	58	19	platelets	platelet	NOUN
iajs-3342	58	20	,	,	PUNCT
iajs-3342	58	21	blood	blood	NOUN
iajs-3342	58	22	hemoglobin	hemoglobin	NOUN
iajs-3342	58	23	(	(	PUNCT
iajs-3342	58	24	hgb	hgb	PROPN
iajs-3342	58	25	)	)	PUNCT
iajs-3342	58	26	,	,	PUNCT
iajs-3342	58	27	platelets	platelet	NOUN
iajs-3342	58	28	(	(	PUNCT
iajs-3342	58	29	plt	plt	NOUN
iajs-3342	58	30	)	)	PUNCT
iajs-3342	58	31	,	,	PUNCT
iajs-3342	58	32	and	and	CCONJ
iajs-3342	58	33	erythrocyte	erythrocyte	NOUN
iajs-3342	58	34	sedimentation	sedimentation	NOUN
iajs-3342	58	35	rate	rate	NOUN
iajs-3342	58	36	(	(	PUNCT
iajs-3342	58	37	esr	esr	PROPN
iajs-3342	58	38	)	)	PUNCT
iajs-3342	58	39	in	in	ADP
iajs-3342	58	40	whole	whole	ADJ
iajs-3342	58	41	blood	blood	NOUN
iajs-3342	58	42	.	.	PUNCT
iajs-3342	59	1	the	the	DET
iajs-3342	59	2	ethics	ethic	NOUN
iajs-3342	59	3	of	of	ADP
iajs-3342	59	4	scientific	scientific	ADJ
iajs-3342	59	5	research	research	NOUN
iajs-3342	59	6	apply	apply	VERB
iajs-3342	59	7	to	to	ADP
iajs-3342	59	8	the	the	DET
iajs-3342	59	9	collection	collection	NOUN
iajs-3342	59	10	of	of	ADP
iajs-3342	59	11	samples	sample	NOUN
iajs-3342	59	12	and	and	CCONJ
iajs-3342	59	13	data	datum	NOUN
iajs-3342	59	14	.	.	PUNCT
iajs-3342	60	1	all	all	DET
iajs-3342	60	2	participants	participant	NOUN
iajs-3342	60	3	gave	give	VERB
iajs-3342	60	4	their	their	PRON
iajs-3342	60	5	informed	informed	ADJ
iajs-3342	60	6	permission	permission	NOUN
iajs-3342	60	7	before	before	ADP
iajs-3342	60	8	participating	participate	VERB
iajs-3342	60	9	.	.	PUNCT
iajs-3342	61	1	2.3	2.3	NUM
iajs-3342	61	2	exclusion	exclusion	NOUN
iajs-3342	61	3	criteria	criterion	NOUN
iajs-3342	61	4	all	all	DET
iajs-3342	61	5	patients	patient	NOUN
iajs-3342	61	6	were	be	AUX
iajs-3342	61	7	free	free	ADJ
iajs-3342	61	8	from	from	ADP
iajs-3342	61	9	other	other	ADJ
iajs-3342	61	10	autoimmune	autoimmune	ADJ
iajs-3342	61	11	diseases	disease	NOUN
iajs-3342	61	12	such	such	ADJ
iajs-3342	61	13	as	as	ADP
iajs-3342	61	14	(	(	PUNCT
iajs-3342	61	15	rheumatoid	rheumatoid	VERB
iajs-3342	61	16	arthritis	arthritis	NOUN
iajs-3342	61	17	and	and	CCONJ
iajs-3342	61	18	scleroderma	scleroderma	NOUN
iajs-3342	61	19	)	)	PUNCT
iajs-3342	61	20	,	,	PUNCT
iajs-3342	61	21	thyroid	thyroid	NOUN
iajs-3342	61	22	diseases	disease	NOUN
iajs-3342	61	23	,	,	PUNCT
iajs-3342	61	24	hematological	hematological	ADJ
iajs-3342	61	25	diseases	disease	NOUN
iajs-3342	61	26	,	,	PUNCT
iajs-3342	61	27	pregnant	pregnant	ADJ
iajs-3342	61	28	women	woman	NOUN
iajs-3342	61	29	,	,	PUNCT
iajs-3342	61	30	and	and	CCONJ
iajs-3342	61	31	tumors	tumor	NOUN
iajs-3342	61	32	.	.	PUNCT
iajs-3342	62	1	2.4	2.4	NUM
iajs-3342	62	2	methods	method	NOUN
iajs-3342	62	3	the	the	DET
iajs-3342	62	4	blood	blood	NOUN
iajs-3342	62	5	samples	sample	NOUN
iajs-3342	62	6	,	,	PUNCT
iajs-3342	62	7	which	which	PRON
iajs-3342	62	8	were	be	AUX
iajs-3342	62	9	drawn	draw	VERB
iajs-3342	62	10	from	from	ADP
iajs-3342	62	11	all	all	PRON
iajs-3342	62	12	of	of	ADP
iajs-3342	62	13	the	the	DET
iajs-3342	62	14	patients	patient	NOUN
iajs-3342	62	15	and	and	CCONJ
iajs-3342	62	16	the	the	DET
iajs-3342	62	17	control	control	NOUN
iajs-3342	62	18	group	group	NOUN
iajs-3342	62	19	,	,	PUNCT
iajs-3342	62	20	were	be	AUX
iajs-3342	62	21	divided	divide	VERB
iajs-3342	62	22	into	into	ADP
iajs-3342	62	23	whole	whole	ADJ
iajs-3342	62	24	blood	blood	NOUN
iajs-3342	62	25	and	and	CCONJ
iajs-3342	62	26	were	be	AUX
iajs-3342	62	27	used	use	VERB
iajs-3342	62	28	to	to	PART
iajs-3342	62	29	measure	measure	VERB
iajs-3342	62	30	the	the	DET
iajs-3342	62	31	wbc	wbc	PROPN
iajs-3342	62	32	,	,	PUNCT
iajs-3342	62	33	rbc	rbc	PROPN
iajs-3342	62	34	,	,	PUNCT
iajs-3342	62	35	hgb	hgb	PROPN
iajs-3342	62	36	,	,	PUNCT
iajs-3342	62	37	and	and	CCONJ
iajs-3342	62	38	plt	plt	NOUN
iajs-3342	62	39	using	use	VERB
iajs-3342	62	40	an	an	DET
iajs-3342	62	41	automated	automate	VERB
iajs-3342	62	42	cbc	cbc	NOUN
iajs-3342	62	43	analyzer	analyzer	NOUN
iajs-3342	62	44	.	.	PUNCT
iajs-3342	63	1	the	the	DET
iajs-3342	63	2	serum	serum	NOUN
iajs-3342	63	3	was	be	AUX
iajs-3342	63	4	then	then	ADV
iajs-3342	63	5	frozen	freeze	VERB
iajs-3342	63	6	until	until	SCONJ
iajs-3342	63	7	it	it	PRON
iajs-3342	63	8	was	be	AUX
iajs-3342	63	9	needed	need	VERB
iajs-3342	63	10	for	for	ADP
iajs-3342	63	11	the	the	DET
iajs-3342	63	12	analysis	analysis	NOUN
iajs-3342	63	13	.	.	PUNCT
iajs-3342	64	1	according	accord	VERB
iajs-3342	64	2	to	to	ADP
iajs-3342	64	3	the	the	DET
iajs-3342	64	4	prescribed	prescribed	ADJ
iajs-3342	64	5	procedure	procedure	NOUN
iajs-3342	64	6	,	,	PUNCT
iajs-3342	64	7	the	the	DET
iajs-3342	64	8	westergren	westergren	NOUN
iajs-3342	64	9	technique	technique	NOUN
iajs-3342	64	10	was	be	AUX
iajs-3342	64	11	used	use	VERB
iajs-3342	64	12	to	to	PART
iajs-3342	64	13	measure	measure	VERB
iajs-3342	64	14	the	the	DET
iajs-3342	64	15	esr	esr	NOUN
iajs-3342	64	16	.	.	PROPN
iajs-3342	65	1	after	after	ADP
iajs-3342	65	2	obtaining	obtain	VERB
iajs-3342	65	3	the	the	DET
iajs-3342	65	4	patients	patient	NOUN
iajs-3342	65	5	'	'	PART
iajs-3342	65	6	serum	serum	NOUN
iajs-3342	65	7	using	use	VERB
iajs-3342	65	8	the	the	DET
iajs-3342	65	9	alegria	alegria	PROPN
iajs-3342	65	10	device	device	NOUN
iajs-3342	65	11	,	,	PUNCT
iajs-3342	65	12	ana	ana	PROPN
iajs-3342	65	13	and	and	CCONJ
iajs-3342	65	14	dsdna	dsdna	PROPN
iajs-3342	65	15	determinations	determination	NOUN
iajs-3342	65	16	were	be	AUX
iajs-3342	65	17	made	make	VERB
iajs-3342	65	18	.	.	PUNCT
iajs-3342	66	1	the	the	DET
iajs-3342	66	2	results	result	NOUN
iajs-3342	66	3	were	be	AUX
iajs-3342	66	4	provided	provide	VERB
iajs-3342	66	5	in	in	ADP
iajs-3342	66	6	iu	iu	NOUN
iajs-3342	66	7	/	/	SYM
iajs-3342	66	8	ml	ml	NOUN
iajs-3342	66	9	for	for	ADP
iajs-3342	66	10	ana	ana	PROPN
iajs-3342	66	11	and	and	CCONJ
iajs-3342	66	12	dsdna	dsdna	NOUN
iajs-3342	66	13	.	.	PUNCT
iajs-3342	67	1	the	the	DET
iajs-3342	67	2	ngf	ngf	NOUN
iajs-3342	67	3	was	be	AUX
iajs-3342	67	4	determined	determine	VERB
iajs-3342	67	5	by	by	ADP
iajs-3342	67	6	an	an	DET
iajs-3342	67	7	enzyme	enzyme	NOUN
iajs-3342	67	8	-	-	PUNCT
iajs-3342	67	9	linked	link	VERB
iajs-3342	67	10	immune	immune	NOUN
iajs-3342	67	11	-	-	PUNCT
iajs-3342	67	12	sorbent	sorbent	NOUN
iajs-3342	67	13	assay	assay	NOUN
iajs-3342	67	14	(	(	PUNCT
iajs-3342	67	15	elisa	elisa	NOUN
iajs-3342	67	16	)	)	PUNCT
iajs-3342	67	17	kit	kit	NOUN
iajs-3342	67	18	purchased	purchase	VERB
iajs-3342	67	19	from	from	ADP
iajs-3342	67	20	(	(	PUNCT
iajs-3342	67	21	fine	fine	ADJ
iajs-3342	67	22	test	test	NOUN
iajs-3342	67	23	,	,	PUNCT
iajs-3342	67	24	china	china	PROPN
iajs-3342	67	25	)	)	PUNCT
iajs-3342	67	26	.	.	PUNCT
iajs-3342	68	1	this	this	DET
iajs-3342	68	2	kit	kit	NOUN
iajs-3342	68	3	was	be	AUX
iajs-3342	68	4	based	base	VERB
iajs-3342	68	5	on	on	ADP
iajs-3342	68	6	a	a	DET
iajs-3342	68	7	sandwich	sandwich	NOUN
iajs-3342	68	8	enzyme	enzyme	NOUN
iajs-3342	68	9	-	-	PUNCT
iajs-3342	68	10	linked	link	VERB
iajs-3342	68	11	immune	immune	NOUN
iajs-3342	68	12	-	-	PUNCT
iajs-3342	68	13	sorbent	sorbent	NOUN
iajs-3342	68	14	assay	assay	NOUN
iajs-3342	68	15	reader	reader	NOUN
iajs-3342	68	16	and	and	CCONJ
iajs-3342	68	17	then	then	ADV
iajs-3342	68	18	the	the	DET
iajs-3342	68	19	concentration	concentration	NOUN
iajs-3342	68	20	technology	technology	NOUN
iajs-3342	68	21	.	.	PUNCT
iajs-3342	69	1	the	the	DET
iajs-3342	69	2	serum	serum	NOUN
iajs-3342	69	3	of	of	ADP
iajs-3342	69	4	vit	vit	NOUN
iajs-3342	69	5	.	.	PUNCT
iajs-3342	70	1	b12	b12	NOUN
iajs-3342	70	2	was	be	AUX
iajs-3342	70	3	assayed	assay	VERB
iajs-3342	70	4	by	by	ADP
iajs-3342	70	5	the	the	DET
iajs-3342	70	6	enzyme	enzyme	NOUN
iajs-3342	70	7	-	-	PUNCT
iajs-3342	70	8	linked	link	VERB
iajs-3342	70	9	immunesorbent	immunesorbent	NOUN
iajs-3342	70	10	assay	assay	PROPN
iajs-3342	70	11	(	(	PUNCT
iajs-3342	70	12	elisa	elisa	NOUN
iajs-3342	70	13	)	)	PUNCT
iajs-3342	70	14	kit	kit	NOUN
iajs-3342	70	15	from	from	ADP
iajs-3342	70	16	my	my	PRON
iajs-3342	70	17	biosource	biosource	NOUN
iajs-3342	70	18	,	,	PUNCT
iajs-3342	70	19	usa	usa	PROPN
iajs-3342	70	20	.	.	PROPN
iajs-3342	71	1	this	this	DET
iajs-3342	71	2	kit	kit	NOUN
iajs-3342	71	3	was	be	AUX
iajs-3342	71	4	based	base	VERB
iajs-3342	71	5	on	on	ADP
iajs-3342	71	6	the	the	DET
iajs-3342	71	7	competitive	competitive	ADJ
iajs-3342	71	8	elisa	elisa	NOUN
iajs-3342	71	9	detection	detection	NOUN
iajs-3342	71	10	method	method	NOUN
iajs-3342	71	11	.	.	PUNCT
iajs-3342	72	1	2.5	2.5	NUM
iajs-3342	72	2	statistical	statistical	ADJ
iajs-3342	72	3	analysis	analysis	NOUN
iajs-3342	72	4	the	the	DET
iajs-3342	72	5	data	datum	NOUN
iajs-3342	72	6	were	be	AUX
iajs-3342	72	7	expressed	express	VERB
iajs-3342	72	8	as	as	ADP
iajs-3342	72	9	the	the	DET
iajs-3342	72	10	mean	mean	PROPN
iajs-3342	72	11	±	±	NOUN
iajs-3342	72	12	standard	standard	NOUN
iajs-3342	72	13	error	error	NOUN
iajs-3342	72	14	of	of	ADP
iajs-3342	72	15	the	the	DET
iajs-3342	72	16	mean	mean	NOUN
iajs-3342	72	17	(	(	PUNCT
iajs-3342	72	18	sem	sem	NOUN
iajs-3342	72	19	)	)	PUNCT
iajs-3342	72	20	.	.	PUNCT
iajs-3342	73	1	several	several	ADJ
iajs-3342	73	2	statistical	statistical	ADJ
iajs-3342	73	3	tests	test	NOUN
iajs-3342	73	4	,	,	PUNCT
iajs-3342	73	5	including	include	VERB
iajs-3342	73	6	the	the	DET
iajs-3342	73	7	student	student	NOUN
iajs-3342	73	8	t	t	PROPN
iajs-3342	73	9	-	-	PUNCT
iajs-3342	73	10	test	test	NOUN
iajs-3342	73	11	,	,	PUNCT
iajs-3342	73	12	the	the	DET
iajs-3342	73	13	lsd	lsd	NOUN
iajs-3342	73	14	test	test	NOUN
iajs-3342	73	15	,	,	PUNCT
iajs-3342	73	16	and	and	CCONJ
iajs-3342	73	17	the	the	DET
iajs-3342	73	18	correlation	correlation	NOUN
iajs-3342	73	19	coefficient	coefficient	NOUN
iajs-3342	73	20	,	,	PUNCT
iajs-3342	73	21	were	be	AUX
iajs-3342	73	22	used	use	VERB
iajs-3342	73	23	to	to	PART
iajs-3342	73	24	examine	examine	VERB
iajs-3342	73	25	the	the	DET
iajs-3342	73	26	differences	difference	NOUN
iajs-3342	73	27	between	between	ADP
iajs-3342	73	28	the	the	DET
iajs-3342	73	29	patient	patient	ADJ
iajs-3342	73	30	and	and	CCONJ
iajs-3342	73	31	control	control	NOUN
iajs-3342	73	32	groups	group	NOUN
iajs-3342	73	33	.	.	PUNCT
iajs-3342	74	1	as	as	ADP
iajs-3342	74	2	a	a	DET
iajs-3342	74	3	rule	rule	NOUN
iajs-3342	74	4	of	of	ADP
iajs-3342	74	5	thumb	thumb	NOUN
iajs-3342	74	6	,	,	PUNCT
iajs-3342	74	7	p	p	NOUN
iajs-3342	74	8	-	-	PUNCT
iajs-3342	74	9	values	value	NOUN
iajs-3342	74	10	of	of	ADP
iajs-3342	74	11	≥	≥	NOUN
iajs-3342	74	12	0.05	0.05	NUM
iajs-3342	74	13	were	be	AUX
iajs-3342	74	14	considered	consider	VERB
iajs-3342	74	15	not	not	PART
iajs-3342	74	16	statistically	statistically	ADV
iajs-3342	74	17	significant	significant	ADJ
iajs-3342	74	18	,	,	PUNCT
iajs-3342	74	19	whereas	whereas	SCONJ
iajs-3342	74	20	p	p	NOUN
iajs-3342	74	21	-	-	PUNCT
iajs-3342	74	22	values	value	NOUN
iajs-3342	74	23	of	of	ADP
iajs-3342	74	24	0.05	0.05	NUM
iajs-3342	74	25	were	be	AUX
iajs-3342	74	26	supposed	suppose	VERB
iajs-3342	74	27	to	to	PART
iajs-3342	74	28	be	be	AUX
iajs-3342	74	29	so	so	ADV
iajs-3342	74	30	.	.	PUNCT
iajs-3342	75	1	the	the	DET
iajs-3342	75	2	receiver	receiver	ADJ
iajs-3342	75	3	operating	operate	VERB
iajs-3342	75	4	characteristics	characteristic	NOUN
iajs-3342	75	5	(	(	PUNCT
iajs-3342	75	6	roc	roc	PROPN
iajs-3342	75	7	)	)	PUNCT
iajs-3342	75	8	curve	curve	NOUN
iajs-3342	75	9	was	be	AUX
iajs-3342	75	10	used	use	VERB
iajs-3342	75	11	to	to	PART
iajs-3342	75	12	determine	determine	VERB
iajs-3342	75	13	the	the	DET
iajs-3342	75	14	cutoff	cutoff	NOUN
iajs-3342	75	15	value	value	NOUN
iajs-3342	75	16	,	,	PUNCT
iajs-3342	75	17	sensitivity	sensitivity	NOUN
iajs-3342	75	18	,	,	PUNCT
iajs-3342	75	19	and	and	CCONJ
iajs-3342	75	20	specificity	specificity	NOUN
iajs-3342	75	21	.	.	PUNCT
iajs-3342	76	1	3	3	X
iajs-3342	76	2	.	.	NOUN
iajs-3342	76	3	results	result	VERB
iajs-3342	76	4	the	the	DET
iajs-3342	76	5	clinical	clinical	ADJ
iajs-3342	76	6	parameters	parameter	NOUN
iajs-3342	76	7	of	of	ADP
iajs-3342	76	8	the	the	DET
iajs-3342	76	9	study	study	NOUN
iajs-3342	76	10	groups	group	NOUN
iajs-3342	76	11	are	be	AUX
iajs-3342	76	12	shown	show	VERB
iajs-3342	76	13	in	in	ADP
iajs-3342	76	14	table	table	NOUN
iajs-3342	76	15	1	1	NUM
iajs-3342	76	16	.	.	PUNCT
iajs-3342	77	1	the	the	DET
iajs-3342	77	2	measurement	measurement	NOUN
iajs-3342	77	3	of	of	ADP
iajs-3342	77	4	dsdna	dsdna	NOUN
iajs-3342	77	5	,	,	PUNCT
iajs-3342	77	6	ana	ana	PROPN
iajs-3342	77	7	,	,	PUNCT
iajs-3342	77	8	ngf	ngf	ADV
iajs-3342	77	9	,	,	PUNCT
iajs-3342	77	10	and	and	CCONJ
iajs-3342	77	11	vit	vit	NOUN
iajs-3342	77	12	.	.	PUNCT
iajs-3342	78	1	b12	b12	NOUN
iajs-3342	78	2	.	.	PUNCT
iajs-3342	79	1	esr	esr	PROPN
iajs-3342	79	2	,	,	PUNCT
iajs-3342	79	3	hbg	hbg	PROPN
iajs-3342	79	4	,	,	PUNCT
iajs-3342	79	5	wbc	wbc	PROPN
iajs-3342	79	6	,	,	PUNCT
iajs-3342	79	7	rbc	rbc	PROPN
iajs-3342	79	8	,	,	PUNCT
iajs-3342	79	9	and	and	CCONJ
iajs-3342	79	10	platelet	platelet	NOUN
iajs-3342	79	11	levels	level	NOUN
iajs-3342	79	12	were	be	AUX
iajs-3342	79	13	detected	detect	VERB
iajs-3342	79	14	in	in	ADP
iajs-3342	79	15	sle	sle	PROPN
iajs-3342	79	16	patients	patient	NOUN
iajs-3342	79	17	with	with	ADP
iajs-3342	79	18	a	a	DET
iajs-3342	79	19	disease	disease	NOUN
iajs-3342	79	20	duration	duration	NOUN
iajs-3342	79	21	of	of	ADP
iajs-3342	79	22	less	less	ADJ
iajs-3342	79	23	than	than	ADP
iajs-3342	79	24	3	3	NUM
iajs-3342	79	25	months	month	NOUN
iajs-3342	79	26	(	(	PUNCT
iajs-3342	79	27	g1	g1	PROPN
iajs-3342	79	28	)	)	PUNCT
iajs-3342	79	29	,	,	PUNCT
iajs-3342	79	30	sle	sle	PROPN
iajs-3342	79	31	patients	patient	VERB
iajs-3342	79	32	with	with	ADP
iajs-3342	79	33	a	a	DET
iajs-3342	79	34	disease	disease	NOUN
iajs-3342	79	35	duration	duration	NOUN
iajs-3342	79	36	of	of	ADP
iajs-3342	79	37	more	more	ADJ
iajs-3342	79	38	than	than	ADP
iajs-3342	79	39	3	3	NUM
iajs-3342	79	40	months	month	NOUN
iajs-3342	79	41	(	(	PUNCT
iajs-3342	79	42	1	1	NUM
iajs-3342	79	43	year	year	NOUN
iajs-3342	79	44	)	)	PUNCT
iajs-3342	79	45	(	(	PUNCT
iajs-3342	79	46	g2	g2	PROPN
iajs-3342	79	47	)	)	PUNCT
iajs-3342	79	48	,	,	PUNCT
iajs-3342	79	49	sle	sle	PROPN
iajs-3342	79	50	patients	patient	VERB
iajs-3342	79	51	with	with	ADP
iajs-3342	79	52	a	a	DET
iajs-3342	79	53	disease	disease	NOUN
iajs-3342	79	54	duration	duration	NOUN
iajs-3342	79	55	of	of	ADP
iajs-3342	79	56	more	more	ADJ
iajs-3342	79	57	than	than	ADP
iajs-3342	79	58	one	one	NUM
iajs-3342	79	59	year	year	NOUN
iajs-3342	79	60	(	(	PUNCT
iajs-3342	79	61	g3	g3	NOUN
iajs-3342	79	62	)	)	PUNCT
iajs-3342	79	63	,	,	PUNCT
iajs-3342	79	64	as	as	ADV
iajs-3342	79	65	well	well	ADV
iajs-3342	79	66	as	as	ADP
iajs-3342	79	67	control	control	NOUN
iajs-3342	79	68	(	(	PUNCT
iajs-3342	79	69	c	c	NOUN
iajs-3342	79	70	)	)	PUNCT
iajs-3342	79	71	.	.	PUNCT
iajs-3342	80	1	the	the	DET
iajs-3342	80	2	results	result	NOUN
iajs-3342	80	3	in	in	ADP
iajs-3342	80	4	the	the	DET
iajs-3342	80	5	current	current	ADJ
iajs-3342	80	6	study	study	NOUN
iajs-3342	80	7	display	display	VERB
iajs-3342	80	8	a	a	DET
iajs-3342	80	9	significant	significant	ADJ
iajs-3342	80	10	(	(	PUNCT
iajs-3342	80	11	p	p	NOUN
iajs-3342	80	12	≤0.05	≤0.05	NOUN
iajs-3342	80	13	)	)	PUNCT
iajs-3342	80	14	increase	increase	NOUN
iajs-3342	80	15	in	in	ADP
iajs-3342	80	16	dsdna	dsdna	NOUN
iajs-3342	80	17	and	and	CCONJ
iajs-3342	80	18	ana	ana	PROPN
iajs-3342	80	19	levels	level	NOUN
iajs-3342	80	20	in	in	ADP
iajs-3342	80	21	g1	g1	PROPN
iajs-3342	80	22	,	,	PUNCT
iajs-3342	80	23	g2	g2	PROPN
iajs-3342	80	24	,	,	PUNCT
iajs-3342	80	25	and	and	CCONJ
iajs-3342	80	26	g3	g3	NOUN
iajs-3342	80	27	patient	patient	NOUN
iajs-3342	80	28	groups	group	NOUN
iajs-3342	80	29	compared	compare	VERB
iajs-3342	80	30	with	with	ADP
iajs-3342	80	31	the	the	DET
iajs-3342	80	32	control	control	NOUN
iajs-3342	80	33	(	(	PUNCT
iajs-3342	80	34	c	c	NOUN
iajs-3342	80	35	)	)	PUNCT
iajs-3342	80	36	group	group	NOUN
iajs-3342	80	37	,	,	PUNCT
iajs-3342	80	38	as	as	ADV
iajs-3342	80	39	well	well	ADV
iajs-3342	80	40	as	as	ADP
iajs-3342	80	41	no	no	DET
iajs-3342	80	42	significant	significant	ADJ
iajs-3342	80	43	(	(	PUNCT
iajs-3342	80	44	p	p	X
iajs-3342	80	45	>	>	X
iajs-3342	80	46	0.05	0.05	NUM
iajs-3342	80	47	)	)	PUNCT
iajs-3342	80	48	differences	difference	NOUN
iajs-3342	80	49	in	in	ADP
iajs-3342	80	50	dsdna	dsdna	NOUN
iajs-3342	80	51	and	and	CCONJ
iajs-3342	80	52	ana	ana	PROPN
iajs-3342	80	53	levels	level	NOUN
iajs-3342	80	54	between	between	ADP
iajs-3342	80	55	patient	patient	ADJ
iajs-3342	80	56	groups	group	NOUN
iajs-3342	80	57	when	when	SCONJ
iajs-3342	80	58	comparing	compare	VERB
iajs-3342	80	59	between	between	ADP
iajs-3342	80	60	them	they	PRON
iajs-3342	80	61	.	.	PUNCT
iajs-3342	81	1	the	the	DET
iajs-3342	81	2	data	datum	NOUN
iajs-3342	81	3	presented	present	VERB
iajs-3342	81	4	in	in	ADP
iajs-3342	81	5	table	table	NOUN
iajs-3342	81	6	1	1	NUM
iajs-3342	81	7	elucidate	elucidate	VERB
iajs-3342	81	8	a	a	DET
iajs-3342	81	9	notable	notable	ADJ
iajs-3342	81	10	significance	significance	NOUN
iajs-3342	81	11	.	.	PUNCT
iajs-3342	82	1	(	(	PUNCT
iajs-3342	82	2	p	p	NOUN
iajs-3342	82	3	≤0.05	≤0.05	NOUN
iajs-3342	82	4	)	)	PUNCT
iajs-3342	82	5	increase	increase	NOUN
iajs-3342	82	6	in	in	ADP
iajs-3342	82	7	serum	serum	NOUN
iajs-3342	82	8	ngf	ngf	ADV
iajs-3342	82	9	and	and	CCONJ
iajs-3342	82	10	a	a	DET
iajs-3342	82	11	significant	significant	ADJ
iajs-3342	82	12	(	(	PUNCT
iajs-3342	82	13	p	p	NOUN
iajs-3342	82	14	≤	≤	NUM
iajs-3342	82	15	0.05	0.05	NUM
iajs-3342	82	16	)	)	PUNCT
iajs-3342	82	17	decrease	decrease	NOUN
iajs-3342	82	18	in	in	ADP
iajs-3342	82	19	vit	vit	NOUN
iajs-3342	82	20	.	.	PUNCT
iajs-3342	83	1	b12	b12	NOUN
iajs-3342	83	2	levels	level	NOUN
iajs-3342	83	3	among	among	ADP
iajs-3342	83	4	patient	patient	ADJ
iajs-3342	83	5	groups	group	NOUN
iajs-3342	83	6	(	(	PUNCT
iajs-3342	83	7	g1	g1	PROPN
iajs-3342	83	8	,	,	PUNCT
iajs-3342	83	9	g2	g2	PROPN
iajs-3342	83	10	,	,	PUNCT
iajs-3342	83	11	and	and	CCONJ
iajs-3342	83	12	g3	g3	NOUN
iajs-3342	83	13	)	)	PUNCT
iajs-3342	83	14	compared	compare	VERB
iajs-3342	83	15	to	to	ADP
iajs-3342	83	16	the	the	DET
iajs-3342	83	17	control	control	NOUN
iajs-3342	83	18	group	group	NOUN
iajs-3342	83	19	(	(	PUNCT
iajs-3342	83	20	c	c	NOUN
iajs-3342	83	21	)	)	PUNCT
iajs-3342	83	22	.	.	PUNCT
iajs-3342	84	1	additionally	additionally	ADV
iajs-3342	84	2	,	,	PUNCT
iajs-3342	84	3	there	there	PRON
iajs-3342	84	4	was	be	VERB
iajs-3342	84	5	no	no	DET
iajs-3342	84	6	significant	significant	ADJ
iajs-3342	84	7	difference	difference	NOUN
iajs-3342	84	8	(	(	PUNCT
iajs-3342	84	9	p	p	X
iajs-3342	84	10	>	>	X
iajs-3342	84	11	0.05	0.05	NUM
iajs-3342	84	12	)	)	PUNCT
iajs-3342	84	13	in	in	ADP
iajs-3342	84	14	ngf	ngf	ADJ
iajs-3342	84	15	levels	level	NOUN
iajs-3342	84	16	between	between	ADP
iajs-3342	84	17	patients	patient	NOUN
iajs-3342	84	18	in	in	ADP
iajs-3342	84	19	groups	group	NOUN
iajs-3342	84	20	g1	g1	PROPN
iajs-3342	84	21	and	and	CCONJ
iajs-3342	84	22	g2	g2	PROPN
iajs-3342	84	23	,	,	PUNCT
iajs-3342	84	24	as	as	ADV
iajs-3342	84	25	well	well	ADV
iajs-3342	84	26	as	as	ADP
iajs-3342	84	27	between	between	ADP
iajs-3342	84	28	g1	g1	NOUN
iajs-3342	84	29	and	and	CCONJ
iajs-3342	84	30	g3	g3	NOUN
iajs-3342	84	31	.	.	PUNCT
iajs-3342	85	1	in	in	ADP
iajs-3342	85	2	contrast	contrast	NOUN
iajs-3342	85	3	,	,	PUNCT
iajs-3342	85	4	a	a	DET
iajs-3342	85	5	significant	significant	ADJ
iajs-3342	85	6	difference	difference	NOUN
iajs-3342	85	7	in	in	ADP
iajs-3342	85	8	ngf	ngf	ADJ
iajs-3342	85	9	level	level	NOUN
iajs-3342	85	10	was	be	AUX
iajs-3342	85	11	found	find	VERB
iajs-3342	85	12	between	between	ADP
iajs-3342	85	13	g2	g2	PROPN
iajs-3342	85	14	and	and	CCONJ
iajs-3342	85	15	g3	g3	PROPN
iajs-3342	85	16	.	.	PUNCT
iajs-3342	86	1	in	in	ADP
iajs-3342	86	2	the	the	DET
iajs-3342	86	3	current	current	ADJ
iajs-3342	86	4	study	study	NOUN
iajs-3342	86	5	,	,	PUNCT
iajs-3342	86	6	the	the	DET
iajs-3342	86	7	level	level	NOUN
iajs-3342	86	8	of	of	ADP
iajs-3342	86	9	ngf	ngf	ADV
iajs-3342	86	10	in	in	ADP
iajs-3342	86	11	the	the	DET
iajs-3342	86	12	patient	patient	NOUN
iajs-3342	86	13	group	group	NOUN
iajs-3342	86	14	(	(	PUNCT
iajs-3342	86	15	g2	g2	PROPN
iajs-3342	86	16	)	)	PUNCT
iajs-3342	86	17	was	be	AUX
iajs-3342	86	18	higher	high	ADJ
iajs-3342	86	19	than	than	ADP
iajs-3342	86	20	in	in	ADP
iajs-3342	86	21	g1	g1	NOUN
iajs-3342	86	22	and	and	CCONJ
iajs-3342	86	23	g3	g3	NOUN
iajs-3342	86	24	.	.	PUNCT
iajs-3342	87	1	there	there	PRON
iajs-3342	87	2	were	be	VERB
iajs-3342	87	3	no	no	DET
iajs-3342	87	4	significant	significant	ADJ
iajs-3342	87	5	(	(	PUNCT
iajs-3342	87	6	p	p	X
iajs-3342	87	7	>	>	X
iajs-3342	87	8	0.05	0.05	NUM
iajs-3342	87	9	)	)	PUNCT
iajs-3342	87	10	differences	difference	NOUN
iajs-3342	87	11	in	in	ADP
iajs-3342	87	12	vit	vit	NOUN
iajs-3342	87	13	.	.	PUNCT
iajs-3342	88	1	b12	b12	NOUN
iajs-3342	88	2	levels	level	NOUN
iajs-3342	88	3	between	between	ADP
iajs-3342	88	4	patient	patient	ADJ
iajs-3342	88	5	groups	group	NOUN
iajs-3342	88	6	(	(	PUNCT
iajs-3342	88	7	g1	g1	PROPN
iajs-3342	88	8	,	,	PUNCT
iajs-3342	88	9	g2	g2	PROPN
iajs-3342	88	10	,	,	PUNCT
iajs-3342	88	11	and	and	CCONJ
iajs-3342	88	12	g3	g3	NOUN
iajs-3342	88	13	)	)	PUNCT
iajs-3342	88	14	when	when	SCONJ
iajs-3342	88	15	comparing	compare	VERB
iajs-3342	88	16	them	they	PRON
iajs-3342	88	17	.	.	PUNCT
iajs-3342	89	1	the	the	DET
iajs-3342	89	2	results	result	NOUN
iajs-3342	89	3	in	in	ADP
iajs-3342	89	4	this	this	DET
iajs-3342	89	5	study	study	NOUN
iajs-3342	89	6	showed	show	VERB
iajs-3342	89	7	a	a	DET
iajs-3342	89	8	significant	significant	ADJ
iajs-3342	89	9	(	(	PUNCT
iajs-3342	89	10	p	p	NOUN
iajs-3342	89	11	≤0.05	≤0.05	NOUN
iajs-3342	89	12	)	)	PUNCT
iajs-3342	89	13	increase	increase	NOUN
iajs-3342	89	14	in	in	ADP
iajs-3342	89	15	esr	esr	PROPN
iajs-3342	89	16	levels	level	NOUN
iajs-3342	89	17	in	in	ADP
iajs-3342	89	18	g1	g1	PROPN
iajs-3342	89	19	,	,	PUNCT
iajs-3342	89	20	g2	g2	PROPN
iajs-3342	89	21	,	,	PUNCT
iajs-3342	89	22	and	and	CCONJ
iajs-3342	89	23	g3	g3	PROPN
iajs-3342	89	24	when	when	SCONJ
iajs-3342	89	25	compared	compare	VERB
iajs-3342	89	26	to	to	ADP
iajs-3342	89	27	the	the	DET
iajs-3342	89	28	control	control	NOUN
iajs-3342	89	29	group	group	NOUN
iajs-3342	89	30	(	(	PUNCT
iajs-3342	89	31	c	c	NOUN
iajs-3342	89	32	)	)	PUNCT
iajs-3342	89	33	,	,	PUNCT
iajs-3342	89	34	and	and	CCONJ
iajs-3342	89	35	there	there	PRON
iajs-3342	89	36	were	be	VERB
iajs-3342	89	37	significant	significant	ADJ
iajs-3342	89	38	variations	variation	NOUN
iajs-3342	89	39	ihjpas	ihjpa	NOUN
iajs-3342	89	40	.	.	PUNCT
iajs-3342	90	1	2024	2024	NUM
iajs-3342	90	2	,	,	PUNCT
iajs-3342	90	3	37	37	NUM
iajs-3342	90	4	(	(	PUNCT
iajs-3342	90	5	3	3	NUM
iajs-3342	90	6	)	)	PUNCT
iajs-3342	90	7	314	314	NUM
iajs-3342	90	8	in	in	ADP
iajs-3342	90	9	esr	esr	PROPN
iajs-3342	90	10	levels	level	NOUN
iajs-3342	90	11	between	between	ADP
iajs-3342	90	12	patient	patient	ADJ
iajs-3342	90	13	groups	group	NOUN
iajs-3342	90	14	(	(	PUNCT
iajs-3342	90	15	g1	g1	PROPN
iajs-3342	90	16	,	,	PUNCT
iajs-3342	90	17	g2	g2	PROPN
iajs-3342	90	18	)	)	PUNCT
iajs-3342	90	19	and	and	CCONJ
iajs-3342	90	20	(	(	PUNCT
iajs-3342	90	21	g1	g1	PROPN
iajs-3342	90	22	,	,	PUNCT
iajs-3342	90	23	g3	g3	PROPN
iajs-3342	90	24	)	)	PUNCT
iajs-3342	90	25	.	.	PUNCT
iajs-3342	91	1	the	the	DET
iajs-3342	91	2	current	current	ADJ
iajs-3342	91	3	study	study	NOUN
iajs-3342	91	4	showed	show	VERB
iajs-3342	91	5	a	a	DET
iajs-3342	91	6	significant	significant	ADJ
iajs-3342	91	7	(	(	PUNCT
iajs-3342	91	8	p≤0.05	p≤0.05	NOUN
iajs-3342	91	9	)	)	PUNCT
iajs-3342	91	10	decrease	decrease	NOUN
iajs-3342	91	11	in	in	ADP
iajs-3342	91	12	hbg	hbg	PROPN
iajs-3342	91	13	and	and	CCONJ
iajs-3342	91	14	wbc	wbc	PROPN
iajs-3342	91	15	levels	level	NOUN
iajs-3342	91	16	in	in	ADP
iajs-3342	91	17	patient	patient	ADJ
iajs-3342	91	18	groups	group	NOUN
iajs-3342	91	19	(	(	PUNCT
iajs-3342	91	20	g1	g1	PROPN
iajs-3342	91	21	,	,	PUNCT
iajs-3342	91	22	g2	g2	PROPN
iajs-3342	91	23	,	,	PUNCT
iajs-3342	91	24	and	and	CCONJ
iajs-3342	91	25	g3	g3	NOUN
iajs-3342	91	26	)	)	PUNCT
iajs-3342	91	27	compared	compare	VERB
iajs-3342	91	28	to	to	ADP
iajs-3342	91	29	the	the	DET
iajs-3342	91	30	control	control	NOUN
iajs-3342	91	31	group	group	NOUN
iajs-3342	91	32	(	(	PUNCT
iajs-3342	91	33	c	c	NOUN
iajs-3342	91	34	)	)	PUNCT
iajs-3342	91	35	and	and	CCONJ
iajs-3342	91	36	no	no	DET
iajs-3342	91	37	significant	significant	ADJ
iajs-3342	91	38	(	(	PUNCT
iajs-3342	91	39	p	p	X
iajs-3342	91	40	>	>	X
iajs-3342	91	41	0.05	0.05	NUM
iajs-3342	91	42	)	)	PUNCT
iajs-3342	91	43	differences	difference	NOUN
iajs-3342	91	44	in	in	ADP
iajs-3342	91	45	hbg	hbg	PROPN
iajs-3342	91	46	value	value	NOUN
iajs-3342	91	47	between	between	ADP
iajs-3342	91	48	patient	patient	ADJ
iajs-3342	91	49	groups	group	NOUN
iajs-3342	91	50	.	.	PUNCT
iajs-3342	92	1	at	at	ADP
iajs-3342	92	2	the	the	DET
iajs-3342	92	3	same	same	ADJ
iajs-3342	92	4	time	time	NOUN
iajs-3342	92	5	,	,	PUNCT
iajs-3342	92	6	there	there	PRON
iajs-3342	92	7	were	be	VERB
iajs-3342	92	8	significant	significant	ADJ
iajs-3342	92	9	variations	variation	NOUN
iajs-3342	92	10	in	in	ADP
iajs-3342	92	11	wbc	wbc	PROPN
iajs-3342	92	12	levels	level	NOUN
iajs-3342	92	13	between	between	ADP
iajs-3342	92	14	patient	patient	ADJ
iajs-3342	92	15	groups	group	NOUN
iajs-3342	92	16	(	(	PUNCT
iajs-3342	92	17	g1	g1	PROPN
iajs-3342	92	18	and	and	CCONJ
iajs-3342	92	19	g2	g2	PROPN
iajs-3342	92	20	)	)	PUNCT
iajs-3342	92	21	and	and	CCONJ
iajs-3342	92	22	(	(	PUNCT
iajs-3342	92	23	g2	g2	PROPN
iajs-3342	92	24	and	and	CCONJ
iajs-3342	92	25	g3	g3	PROPN
iajs-3342	92	26	)	)	PUNCT
iajs-3342	92	27	.	.	PUNCT
iajs-3342	93	1	in	in	ADP
iajs-3342	93	2	table	table	NOUN
iajs-3342	93	3	1	1	NUM
iajs-3342	93	4	,	,	PUNCT
iajs-3342	93	5	there	there	PRON
iajs-3342	93	6	were	be	VERB
iajs-3342	93	7	no	no	DET
iajs-3342	93	8	remarkable	remarkable	ADJ
iajs-3342	93	9	(	(	PUNCT
iajs-3342	93	10	p	p	X
iajs-3342	93	11	>	>	X
iajs-3342	93	12	0.05	0.05	NUM
iajs-3342	93	13	)	)	PUNCT
iajs-3342	93	14	differences	difference	NOUN
iajs-3342	93	15	in	in	ADP
iajs-3342	93	16	rbc	rbc	PROPN
iajs-3342	93	17	and	and	CCONJ
iajs-3342	93	18	plt	plt	NOUN
iajs-3342	93	19	levels	level	NOUN
iajs-3342	93	20	in	in	ADP
iajs-3342	93	21	patient	patient	ADJ
iajs-3342	93	22	groups	group	NOUN
iajs-3342	93	23	g1	g1	PROPN
iajs-3342	93	24	,	,	PUNCT
iajs-3342	93	25	g2	g2	PROPN
iajs-3342	93	26	,	,	PUNCT
iajs-3342	93	27	and	and	CCONJ
iajs-3342	93	28	g3	g3	PROPN
iajs-3342	93	29	when	when	SCONJ
iajs-3342	93	30	compared	compare	VERB
iajs-3342	93	31	with	with	ADP
iajs-3342	93	32	the	the	DET
iajs-3342	93	33	control	control	NOUN
iajs-3342	93	34	group	group	NOUN
iajs-3342	93	35	(	(	PUNCT
iajs-3342	93	36	c	c	NOUN
iajs-3342	93	37	)	)	PUNCT
iajs-3342	93	38	.	.	PUNCT
iajs-3342	94	1	table	table	NOUN
iajs-3342	95	1	1	1	NUM
iajs-3342	95	2	.	.	PUNCT
iajs-3342	96	1	mean	mean	PROPN
iajs-3342	96	2	±	±	NUM
iajs-3342	96	3	sem	sem	NOUN
iajs-3342	96	4	of	of	ADP
iajs-3342	96	5	levels	level	NOUN
iajs-3342	96	6	of	of	ADP
iajs-3342	96	7	studied	study	VERB
iajs-3342	96	8	parameters	parameter	NOUN
iajs-3342	96	9	in	in	ADP
iajs-3342	96	10	control	control	NOUN
iajs-3342	96	11	(	(	PUNCT
iajs-3342	96	12	c	c	NOUN
iajs-3342	96	13	)	)	PUNCT
iajs-3342	96	14	,	,	PUNCT
iajs-3342	96	15	and	and	CCONJ
iajs-3342	96	16	sle	sle	PROPN
iajs-3342	96	17	patients	patient	NOUN
iajs-3342	96	18	groups	group	NOUN
iajs-3342	96	19	g1	g1	PROPN
iajs-3342	96	20	,	,	PUNCT
iajs-3342	96	21	g2	g2	PROPN
iajs-3342	96	22	,	,	PUNCT
iajs-3342	96	23	and	and	CCONJ
iajs-3342	96	24	g3	g3	PROPN
iajs-3342	96	25	.	.	PUNCT
iajs-3342	97	1	a	a	DET
iajs-3342	97	2	lsd	lsd	NOUN
iajs-3342	97	3	test	test	NOUN
iajs-3342	97	4	between	between	ADP
iajs-3342	97	5	four	four	NUM
iajs-3342	97	6	groups	group	NOUN
iajs-3342	97	7	and	and	CCONJ
iajs-3342	97	8	control	control	NOUN
iajs-3342	97	9	,	,	PUNCT
iajs-3342	97	10	b	b	PROPN
iajs-3342	97	11	lsd	lsd	NOUN
iajs-3342	97	12	test	test	NOUN
iajs-3342	97	13	between	between	ADP
iajs-3342	97	14	g1	g1	PROPN
iajs-3342	97	15	and	and	CCONJ
iajs-3342	97	16	g2	g2	PROPN
iajs-3342	97	17	patients	patient	NOUN
iajs-3342	97	18	,	,	PUNCT
iajs-3342	97	19	c	c	PROPN
iajs-3342	97	20	lsd	lsd	PROPN
iajs-3342	97	21	test	test	NOUN
iajs-3342	97	22	between	between	ADP
iajs-3342	97	23	g1	g1	PROPN
iajs-3342	97	24	and	and	CCONJ
iajs-3342	97	25	g3	g3	NOUN
iajs-3342	97	26	patients	patient	NOUN
iajs-3342	97	27	,	,	PUNCT
iajs-3342	97	28	d	d	PROPN
iajs-3342	97	29	lsd	lsd	NOUN
iajs-3342	97	30	test	test	NOUN
iajs-3342	97	31	between	between	ADP
iajs-3342	97	32	g2	g2	PROPN
iajs-3342	97	33	and	and	CCONJ
iajs-3342	97	34	g3	g3	PROPN
iajs-3342	97	35	patients	patient	NOUN
iajs-3342	97	36	.	.	PUNCT
iajs-3342	98	1	significant	significant	ADJ
iajs-3342	98	2	:	:	PUNCT
iajs-3342	98	3	*	*	PUNCT
iajs-3342	98	4	p	p	X
iajs-3342	98	5	≤	≤	NOUN
iajs-3342	98	6	0.05	0.05	NUM
iajs-3342	98	7	;	;	PUNCT
iajs-3342	98	8	no	no	DET
iajs-3342	98	9	significant	significant	ADJ
iajs-3342	98	10	:	:	PUNCT
iajs-3342	98	11	p˃0.05	p˃0.05	NOUN
iajs-3342	98	12	.	.	PUNCT
iajs-3342	98	13	table	table	NOUN
iajs-3342	98	14	2	2	NUM
iajs-3342	98	15	shows	show	VERB
iajs-3342	98	16	a	a	DET
iajs-3342	98	17	notable	notable	ADJ
iajs-3342	98	18	inverse	inverse	NOUN
iajs-3342	98	19	correlation	correlation	NOUN
iajs-3342	98	20	between	between	ADP
iajs-3342	98	21	serum	serum	NOUN
iajs-3342	98	22	ngf	ngf	PROPN
iajs-3342	98	23	levels	level	NOUN
iajs-3342	98	24	and	and	CCONJ
iajs-3342	98	25	dsdna	dsdna	NOUN
iajs-3342	98	26	,	,	PUNCT
iajs-3342	98	27	vitamin	vitamin	NOUN
iajs-3342	98	28	b12	b12	NOUN
iajs-3342	98	29	,	,	PUNCT
iajs-3342	98	30	and	and	CCONJ
iajs-3342	98	31	wbc	wbc	PROPN
iajs-3342	98	32	count	count	NOUN
iajs-3342	98	33	.	.	PUNCT
iajs-3342	99	1	additionally	additionally	ADV
iajs-3342	99	2	,	,	PUNCT
iajs-3342	99	3	a	a	DET
iajs-3342	99	4	meaningful	meaningful	ADJ
iajs-3342	99	5	positive	positive	ADJ
iajs-3342	99	6	correlation	correlation	NOUN
iajs-3342	99	7	was	be	AUX
iajs-3342	99	8	observed	observe	VERB
iajs-3342	99	9	between	between	ADP
iajs-3342	99	10	ngf	ngf	PROPN
iajs-3342	99	11	levels	level	NOUN
iajs-3342	99	12	and	and	CCONJ
iajs-3342	99	13	ana	ana	PROPN
iajs-3342	99	14	,	,	PUNCT
iajs-3342	99	15	rbc	rbc	PROPN
iajs-3342	99	16	count	count	NOUN
iajs-3342	99	17	,	,	PUNCT
iajs-3342	99	18	and	and	CCONJ
iajs-3342	99	19	plt	plt	NOUN
iajs-3342	99	20	count	count	NOUN
iajs-3342	99	21	in	in	ADP
iajs-3342	99	22	the	the	DET
iajs-3342	99	23	control	control	NOUN
iajs-3342	99	24	group	group	NOUN
iajs-3342	99	25	.	.	PUNCT
iajs-3342	100	1	ngf	ngf	PROPN
iajs-3342	100	2	was	be	AUX
iajs-3342	100	3	correlated	correlate	VERB
iajs-3342	100	4	with	with	ADP
iajs-3342	100	5	esr	esr	PROPN
iajs-3342	100	6	by	by	ADP
iajs-3342	100	7	no	no	DET
iajs-3342	100	8	significant	significant	ADJ
iajs-3342	100	9	positive	positive	ADJ
iajs-3342	100	10	relationship	relationship	NOUN
iajs-3342	100	11	in	in	ADP
iajs-3342	100	12	the	the	DET
iajs-3342	100	13	control	control	NOUN
iajs-3342	100	14	group	group	NOUN
iajs-3342	100	15	.	.	PUNCT
iajs-3342	101	1	in	in	ADP
iajs-3342	101	2	patients	patient	NOUN
iajs-3342	101	3	'	'	PART
iajs-3342	101	4	groups	group	NOUN
iajs-3342	101	5	,	,	PUNCT
iajs-3342	101	6	there	there	PRON
iajs-3342	101	7	was	be	VERB
iajs-3342	101	8	a	a	DET
iajs-3342	101	9	significant	significant	ADJ
iajs-3342	101	10	positive	positive	ADJ
iajs-3342	101	11	correlation	correlation	NOUN
iajs-3342	101	12	between	between	ADP
iajs-3342	101	13	serum	serum	NOUN
iajs-3342	101	14	ngf	ngf	ADV
iajs-3342	101	15	and	and	CCONJ
iajs-3342	101	16	dsdna	dsdna	PROPN
iajs-3342	101	17	and	and	CCONJ
iajs-3342	101	18	ana	ana	PROPN
iajs-3342	101	19	,	,	PUNCT
iajs-3342	101	20	and	and	CCONJ
iajs-3342	101	21	there	there	PRON
iajs-3342	101	22	was	be	VERB
iajs-3342	101	23	also	also	ADV
iajs-3342	101	24	a	a	DET
iajs-3342	101	25	significant	significant	ADJ
iajs-3342	101	26	negative	negative	ADJ
iajs-3342	101	27	correlation	correlation	NOUN
iajs-3342	101	28	between	between	ADP
iajs-3342	101	29	ngf	ngf	NOUN
iajs-3342	101	30	and	and	CCONJ
iajs-3342	101	31	vit	vit	NOUN
iajs-3342	101	32	.	.	PUNCT
iajs-3342	102	1	b12	b12	NOUN
iajs-3342	102	2	in	in	ADP
iajs-3342	102	3	sle	sle	PROPN
iajs-3342	102	4	patients	patient	NOUN
iajs-3342	102	5	'	'	PART
iajs-3342	102	6	groups	group	NOUN
iajs-3342	102	7	.	.	PUNCT
iajs-3342	103	1	the	the	DET
iajs-3342	103	2	current	current	ADJ
iajs-3342	103	3	study	study	NOUN
iajs-3342	103	4	shows	show	VERB
iajs-3342	103	5	no	no	DET
iajs-3342	103	6	remarkable	remarkable	ADJ
iajs-3342	103	7	negative	negative	ADJ
iajs-3342	103	8	relationship	relationship	NOUN
iajs-3342	103	9	between	between	ADP
iajs-3342	103	10	ngf	ngf	NOUN
iajs-3342	103	11	and	and	CCONJ
iajs-3342	103	12	esr	esr	PROPN
iajs-3342	103	13	,	,	PUNCT
iajs-3342	103	14	hgb	hgb	PROPN
iajs-3342	103	15	,	,	PUNCT
iajs-3342	103	16	rbc	rbc	PROPN
iajs-3342	103	17	,	,	PUNCT
iajs-3342	103	18	and	and	CCONJ
iajs-3342	103	19	plt	plt	NOUN
iajs-3342	103	20	,	,	PUNCT
iajs-3342	103	21	in	in	ADP
iajs-3342	103	22	addition	addition	NOUN
iajs-3342	103	23	to	to	ADP
iajs-3342	103	24	no	no	DET
iajs-3342	103	25	significant	significant	ADJ
iajs-3342	103	26	positive	positive	ADJ
iajs-3342	103	27	correlation	correlation	NOUN
iajs-3342	103	28	with	with	ADP
iajs-3342	103	29	wbc	wbc	PROPN
iajs-3342	103	30	in	in	ADP
iajs-3342	103	31	sle	sle	PROPN
iajs-3342	103	32	patient	patient	NOUN
iajs-3342	103	33	groups	group	NOUN
iajs-3342	103	34	.	.	PUNCT
iajs-3342	104	1	table	table	NOUN
iajs-3342	104	2	3	3	NUM
iajs-3342	104	3	and	and	CCONJ
iajs-3342	104	4	figure	figure	VERB
iajs-3342	104	5	1	1	NUM
iajs-3342	104	6	show	show	VERB
iajs-3342	104	7	the	the	DET
iajs-3342	104	8	results	result	NOUN
iajs-3342	104	9	of	of	ADP
iajs-3342	104	10	an	an	DET
iajs-3342	104	11	roc	roc	NOUN
iajs-3342	104	12	analysis	analysis	NOUN
iajs-3342	104	13	for	for	ADP
iajs-3342	104	14	the	the	DET
iajs-3342	104	15	ngf	ngf	NOUN
iajs-3342	104	16	marker	marker	NOUN
iajs-3342	104	17	,	,	PUNCT
iajs-3342	104	18	which	which	PRON
iajs-3342	104	19	demonstrates	demonstrate	VERB
iajs-3342	104	20	that	that	SCONJ
iajs-3342	104	21	it	it	PRON
iajs-3342	104	22	is	be	AUX
iajs-3342	104	23	an	an	DET
iajs-3342	104	24	excellent	excellent	ADJ
iajs-3342	104	25	diagnostic	diagnostic	ADJ
iajs-3342	104	26	marker	marker	NOUN
iajs-3342	104	27	for	for	ADP
iajs-3342	104	28	sle	sle	PROPN
iajs-3342	104	29	disease	disease	PROPN
iajs-3342	104	30	.	.	PUNCT
iajs-3342	105	1	the	the	DET
iajs-3342	105	2	test	test	NOUN
iajs-3342	105	3	indicated	indicate	VERB
iajs-3342	105	4	a	a	DET
iajs-3342	105	5	cutoff	cutoff	NOUN
iajs-3342	105	6	value	value	NOUN
iajs-3342	105	7	of	of	ADP
iajs-3342	105	8	99	99	NUM
iajs-3342	105	9	%	%	NOUN
iajs-3342	105	10	sensitivity	sensitivity	NOUN
iajs-3342	105	11	and	and	CCONJ
iajs-3342	105	12	100	100	NUM
iajs-3342	105	13	%	%	NOUN
iajs-3342	105	14	specificity	specificity	NOUN
iajs-3342	105	15	.	.	PUNCT
iajs-3342	106	1	parameters	parameter	NOUN
iajs-3342	106	2	c	c	PROPN
iajs-3342	106	3	no.(30	no.(30	PROPN
iajs-3342	106	4	)	)	PUNCT
iajs-3342	106	5	g1	g1	PROPN
iajs-3342	106	6	no.(15	no.(15	NOUN
iajs-3342	106	7	)	)	PUNCT
iajs-3342	106	8	g2	g2	PROPN
iajs-3342	106	9	no.(29	no.(29	PROPN
iajs-3342	106	10	)	)	PUNCT
iajs-3342	106	11	g3	g3	PROPN
iajs-3342	106	12	no.(56	no.(56	PROPN
iajs-3342	106	13	)	)	PUNCT
iajs-3342	106	14	dsdna	dsdna	NOUN
iajs-3342	106	15	(	(	PUNCT
iajs-3342	106	16	iu	iu	NOUN
iajs-3342	106	17	/	/	SYM
iajs-3342	106	18	ml	ml	NOUN
iajs-3342	106	19	)	)	PUNCT
iajs-3342	106	20	7.0±0.61	7.0±0.61	NUM
iajs-3342	107	1	80.52±5.85a	80.52±5.85a	NUM
iajs-3342	108	1	81.79±5.39a	81.79±5.39a	NUM
iajs-3342	109	1	74.83±1.70a	74.83±1.70a	NUM
iajs-3342	109	2	ana	ana	PROPN
iajs-3342	109	3	(	(	PUNCT
iajs-3342	109	4	u\ml	u\ml	PROPN
iajs-3342	109	5	)	)	PUNCT
iajs-3342	109	6	0.32±0.03	0.32±0.03	NOUN
iajs-3342	109	7	1.92±0.16a	1.92±0.16a	NUM
iajs-3342	109	8	1.64±0.13a	1.64±0.13a	NUM
iajs-3342	109	9	2.14±0.36a	2.14±0.36a	NUM
iajs-3342	109	10	ngf	ngf	ADV
iajs-3342	109	11	(	(	PUNCT
iajs-3342	109	12	pg\ml	pg\ml	PROPN
iajs-3342	109	13	)	)	PUNCT
iajs-3342	109	14	87.06±2.52	87.06±2.52	NUM
iajs-3342	109	15	210.83±20.1a	210.83±20.1a	NUM
iajs-3342	109	16	239.96±20.95a	239.96±20.95a	PROPN
iajs-3342	109	17	201.39±10.69ad	201.39±10.69ad	NUM
iajs-3342	109	18	vit.b12	vit.b12	NOUN
iajs-3342	109	19	(	(	PUNCT
iajs-3342	109	20	ng\ml	ng\ml	ADJ
iajs-3342	109	21	)	)	PUNCT
iajs-3342	109	22	31.12±1.21	31.12±1.21	NUM
iajs-3342	109	23	4.73±0.24a	4.73±0.24a	NUM
iajs-3342	109	24	4.69±0.14a	4.69±0.14a	NUM
iajs-3342	109	25	4.91±0.11a	4.91±0.11a	ADJ
iajs-3342	109	26	esr	esr	X
iajs-3342	109	27	(	(	PUNCT
iajs-3342	109	28	mm\h	mm\h	NOUN
iajs-3342	109	29	)	)	PUNCT
iajs-3342	109	30	5.38±0.35	5.38±0.35	NOUN
iajs-3342	109	31	40.66±2.76a	40.66±2.76a	NUM
iajs-3342	109	32	26.95±2.89ab	26.95±2.89ab	NUM
iajs-3342	109	33	31.37±8.38ac	31.37±8.38ac	NUM
iajs-3342	109	34	hgb	hgb	PROPN
iajs-3342	109	35	(	(	PUNCT
iajs-3342	109	36	106\ul	106\ul	PROPN
iajs-3342	109	37	)	)	PUNCT
iajs-3342	109	38	13.1±0.20	13.1±0.20	NUM
iajs-3342	109	39	11.66±0.92a	11.66±0.92a	NUM
iajs-3342	109	40	12.23±0.23a	12.23±0.23a	NUM
iajs-3342	109	41	11.77±0.20a	11.77±0.20a	NUM
iajs-3342	109	42	wbc	wbc	PROPN
iajs-3342	109	43	(	(	PUNCT
iajs-3342	109	44	103\ul	103\ul	PROPN
iajs-3342	109	45	)	)	PUNCT
iajs-3342	109	46	10.19±0.246	10.19±0.246	PROPN
iajs-3342	109	47	6.43±0.85a	6.43±0.85a	NUM
iajs-3342	109	48	8.46±0.50ab	8.46±0.50ab	NUM
iajs-3342	109	49	6.64±0.33ad	6.64±0.33ad	NUM
iajs-3342	109	50	rbc	rbc	PROPN
iajs-3342	109	51	(	(	PUNCT
iajs-3342	109	52	103\ul	103\ul	NOUN
iajs-3342	109	53	)	)	PUNCT
iajs-3342	109	54	4.37±0.48	4.37±0.48	NOUN
iajs-3342	109	55	4.36±0.11	4.36±0.11	NUM
iajs-3342	109	56	4.41±0.10	4.41±0.10	ADJ
iajs-3342	109	57	4.40±0.12	4.40±0.12	ADJ
iajs-3342	109	58	plt	plt	NOUN
iajs-3342	109	59	(	(	PUNCT
iajs-3342	109	60	103\ul	103\ul	PROPN
iajs-3342	109	61	)	)	PUNCT
iajs-3342	109	62	254.60±5.04	254.60±5.04	NUM
iajs-3342	109	63	273.66±27.93	273.66±27.93	NUM
iajs-3342	109	64	243.95±11.26	243.95±11.26	NUM
iajs-3342	109	65	243.69±8.09	243.69±8.09	NUM
iajs-3342	109	66	ihjpas	ihjpa	NOUN
iajs-3342	109	67	.	.	PUNCT
iajs-3342	109	68	2024	2024	NUM
iajs-3342	109	69	,	,	PUNCT
iajs-3342	109	70	37	37	NUM
iajs-3342	109	71	(	(	PUNCT
iajs-3342	109	72	3	3	NUM
iajs-3342	109	73	)	)	PUNCT
iajs-3342	109	74	315	315	NUM
iajs-3342	109	75	table	table	NOUN
iajs-3342	109	76	2	2	NUM
iajs-3342	109	77	.	.	PUNCT
iajs-3342	109	78	pearson	pearson	PROPN
iajs-3342	109	79	correlation	correlation	PROPN
iajs-3342	109	80	coefficient	coefficient	NOUN
iajs-3342	109	81	(	(	PUNCT
iajs-3342	109	82	r	r	NOUN
iajs-3342	109	83	)	)	PUNCT
iajs-3342	109	84	and	and	CCONJ
iajs-3342	109	85	p	p	NOUN
iajs-3342	109	86	-	-	PUNCT
iajs-3342	109	87	value	value	NOUN
iajs-3342	109	88	between	between	ADP
iajs-3342	109	89	ngf	ngf	ADV
iajs-3342	109	90	and	and	CCONJ
iajs-3342	109	91	all	all	DET
iajs-3342	109	92	studied	study	VERB
iajs-3342	109	93	parameters	parameter	NOUN
iajs-3342	109	94	in	in	ADP
iajs-3342	109	95	control	control	NOUN
iajs-3342	109	96	and	and	CCONJ
iajs-3342	109	97	sle	sle	PROPN
iajs-3342	109	98	patients	patient	NOUN
iajs-3342	109	99	groups	group	NOUN
iajs-3342	109	100	.	.	PUNCT
iajs-3342	110	1	parameters	parameter	NOUN
iajs-3342	110	2	control	control	VERB
iajs-3342	110	3	patients	patient	NOUN
iajs-3342	110	4	groups	group	NOUN
iajs-3342	110	5	r	r	X
iajs-3342	110	6	p	p	ADJ
iajs-3342	110	7	-	-	PUNCT
iajs-3342	110	8	value	value	NOUN
iajs-3342	110	9	r	r	NOUN
iajs-3342	110	10	p	p	NOUN
iajs-3342	110	11	-	-	PUNCT
iajs-3342	110	12	value	value	NOUN
iajs-3342	110	13	dsdna(iu\ml	dsdna(iu\ml	NOUN
iajs-3342	110	14	)	)	PUNCT
iajs-3342	110	15	-0.234	-0.234	PUNCT
iajs-3342	110	16	.000	.000	NUM
iajs-3342	110	17	0.110	0.110	NUM
iajs-3342	110	18	.000	.000	NUM
iajs-3342	110	19	ana(u\ml	ana(u\ml	NUM
iajs-3342	110	20	)	)	PUNCT
iajs-3342	110	21	0.173	0.173	NUM
iajs-3342	110	22	.000	.000	NUM
iajs-3342	110	23	0.066	0.066	NUM
iajs-3342	110	24	.000	.000	NUM
iajs-3342	110	25	vit.b12(ng\ml	vit.b12(ng\ml	NUM
iajs-3342	110	26	)	)	PUNCT
iajs-3342	110	27	-0.671	-0.671	NUM
iajs-3342	110	28	.000	.000	NUM
iajs-3342	110	29	-0.295	-0.295	X
iajs-3342	110	30	.003	.003	NUM
iajs-3342	110	31	esr(mm\h	esr(mm\h	ADJ
iajs-3342	110	32	)	)	PUNCT
iajs-3342	110	33	-0.040	-0.040	NUM
iajs-3342	110	34	.382	.382	NUM
iajs-3342	110	35	-0.087	-0.087	PUNCT
iajs-3342	110	36	.396	.396	NUM
iajs-3342	110	37	hgb(106\ul	hgb(106\ul	NOUN
iajs-3342	110	38	)	)	PUNCT
iajs-3342	110	39	0.267	0.267	NUM
iajs-3342	110	40	.154	.154	NUM
iajs-3342	110	41	-0.018	-0.018	NUM
iajs-3342	110	42	.859	.859	NUM
iajs-3342	110	43	wbc(103\ul	wbc(103\ul	NOUN
iajs-3342	110	44	)	)	PUNCT
iajs-3342	110	45	-0.355	-0.355	PUNCT
iajs-3342	110	46	.055	.055	NUM
iajs-3342	110	47	0.052	0.052	NUM
iajs-3342	110	48	.610	.610	NUM
iajs-3342	110	49	rbc(103\ul	rbc(103\ul	NOUN
iajs-3342	110	50	)	)	PUNCT
iajs-3342	110	51	0.728	0.728	NUM
iajs-3342	110	52	.000	.000	NUM
iajs-3342	110	53	-0.114	-0.114	NOUN
iajs-3342	110	54	.263	.263	NUM
iajs-3342	110	55	plt(103\ul	plt(103\ul	NOUN
iajs-3342	110	56	)	)	PUNCT
iajs-3342	110	57	0.000	0.000	NUM
iajs-3342	110	58	.000	.000	NUM
iajs-3342	110	59	-0.140	-0.140	PROPN
iajs-3342	110	60	.167	.167	NUM
iajs-3342	110	61	significant	significant	ADJ
iajs-3342	110	62	:	:	PUNCT
iajs-3342	110	63	*	*	PUNCT
iajs-3342	110	64	p	p	X
iajs-3342	110	65	≤	≤	NOUN
iajs-3342	110	66	0.05	0.05	NUM
iajs-3342	110	67	;	;	PUNCT
iajs-3342	110	68	no	no	DET
iajs-3342	110	69	significant	significant	ADJ
iajs-3342	110	70	:	:	PUNCT
iajs-3342	110	71	p˃0.05	p˃0.05	NOUN
iajs-3342	110	72	table	table	NOUN
iajs-3342	110	73	3	3	NUM
iajs-3342	110	74	.	.	X
iajs-3342	110	75	sensitivity	sensitivity	NOUN
iajs-3342	110	76	,	,	PUNCT
iajs-3342	110	77	specificity	specificity	NOUN
iajs-3342	110	78	&	&	CCONJ
iajs-3342	110	79	cut	cut	PROPN
iajs-3342	110	80	-	-	PUNCT
iajs-3342	110	81	off	off	ADP
iajs-3342	110	82	value	value	NOUN
iajs-3342	110	83	of	of	ADP
iajs-3342	110	84	ngf	ngf	ADV
iajs-3342	110	85	for	for	ADP
iajs-3342	110	86	diagnosis	diagnosis	NOUN
iajs-3342	110	87	of	of	ADP
iajs-3342	110	88	sle	sle	PROPN
iajs-3342	110	89	.	.	PUNCT
iajs-3342	111	1	test	test	NOUN
iajs-3342	111	2	results	result	NOUN
iajs-3342	111	3	area	area	NOUN
iajs-3342	111	4	under	under	ADP
iajs-3342	111	5	curve%	curve%	PUNCT
iajs-3342	111	6	sensitivity	sensitivity	NOUN
iajs-3342	111	7	%	%	NOUN
iajs-3342	111	8	specificity	specificity	NOUN
iajs-3342	111	9	%	%	NOUN
iajs-3342	111	10	cut	cut	VERB
iajs-3342	111	11	-	-	PUNCT
iajs-3342	111	12	off	off	ADP
iajs-3342	111	13	value	value	NOUN
iajs-3342	111	14	asymptotic	asymptotic	ADJ
iajs-3342	111	15	sig	sig	NOUN
iajs-3342	111	16	.	.	PUNCT
iajs-3342	112	1	accuracy	accuracy	NOUN
iajs-3342	112	2	lower	lower	ADV
iajs-3342	112	3	bound	bind	VERB
iajs-3342	112	4	upper	upper	ADJ
iajs-3342	112	5	bound	bind	VERB
iajs-3342	112	6	ngf	ngf	ADV
iajs-3342	112	7	99.3	99.3	NUM
iajs-3342	112	8	%	%	NOUN
iajs-3342	112	9	99	99	NUM
iajs-3342	112	10	%	%	NOUN
iajs-3342	112	11	100	100	NUM
iajs-3342	112	12	%	%	NOUN
iajs-3342	112	13	105.9	105.9	NUM
iajs-3342	112	14	.000	.000	NUM
iajs-3342	112	15	0.98	0.98	NUM
iajs-3342	112	16	1.0	1.0	NUM
iajs-3342	112	17	figure	figure	NOUN
iajs-3342	112	18	1	1	NUM
iajs-3342	112	19	.	.	PUNCT
iajs-3342	113	1	the	the	DET
iajs-3342	113	2	roc	roc	PROPN
iajs-3342	113	3	curve	curve	NOUN
iajs-3342	113	4	of	of	ADP
iajs-3342	113	5	ngf	ngf	ADV
iajs-3342	113	6	in	in	ADP
iajs-3342	113	7	sle	sle	PROPN
iajs-3342	113	8	and	and	CCONJ
iajs-3342	113	9	control	control	NOUN
iajs-3342	113	10	groups	group	NOUN
iajs-3342	113	11	4	4	NUM
iajs-3342	113	12	.	.	PUNCT
iajs-3342	113	13	discussions	discussion	NOUN
iajs-3342	113	14	systemic	systemic	ADJ
iajs-3342	113	15	lupus	lupus	NOUN
iajs-3342	113	16	erythematosus	erythematosus	NOUN
iajs-3342	113	17	is	be	AUX
iajs-3342	113	18	one	one	NUM
iajs-3342	113	19	of	of	ADP
iajs-3342	113	20	the	the	DET
iajs-3342	113	21	most	most	ADV
iajs-3342	113	22	gender	gender	NOUN
iajs-3342	113	23	-	-	PUNCT
iajs-3342	113	24	differentiated	differentiate	VERB
iajs-3342	113	25	autoimmune	autoimmune	ADJ
iajs-3342	113	26	illnesses	illness	NOUN
iajs-3342	113	27	,	,	PUNCT
iajs-3342	113	28	affecting	affect	VERB
iajs-3342	113	29	primarily	primarily	ADV
iajs-3342	113	30	females	female	NOUN
iajs-3342	113	31	between	between	ADP
iajs-3342	113	32	the	the	DET
iajs-3342	113	33	ages	age	NOUN
iajs-3342	113	34	of	of	ADP
iajs-3342	113	35	15	15	NUM
iajs-3342	113	36	and	and	CCONJ
iajs-3342	113	37	44	44	NUM
iajs-3342	113	38	(	(	PUNCT
iajs-3342	113	39	the	the	DET
iajs-3342	113	40	childbearing	childbearing	NOUN
iajs-3342	113	41	years	year	NOUN
iajs-3342	113	42	)	)	PUNCT
iajs-3342	113	43	ihjpas	ihjpas	PROPN
iajs-3342	113	44	.	.	PUNCT
iajs-3342	114	1	2024	2024	NUM
iajs-3342	114	2	,	,	PUNCT
iajs-3342	114	3	37	37	NUM
iajs-3342	114	4	(	(	PUNCT
iajs-3342	114	5	3	3	NUM
iajs-3342	114	6	)	)	PUNCT
iajs-3342	114	7	316	316	NUM
iajs-3342	115	1	[	[	X
iajs-3342	115	2	15	15	NUM
iajs-3342	115	3	]	]	PUNCT
iajs-3342	115	4	.	.	PUNCT
iajs-3342	116	1	the	the	DET
iajs-3342	116	2	results	result	NOUN
iajs-3342	116	3	suggest	suggest	VERB
iajs-3342	116	4	that	that	SCONJ
iajs-3342	116	5	both	both	DET
iajs-3342	116	6	women	woman	NOUN
iajs-3342	116	7	's	's	PART
iajs-3342	116	8	age	age	NOUN
iajs-3342	116	9	and	and	CCONJ
iajs-3342	116	10	gender	gender	NOUN
iajs-3342	116	11	have	have	VERB
iajs-3342	116	12	a	a	DET
iajs-3342	116	13	role	role	NOUN
iajs-3342	116	14	in	in	ADP
iajs-3342	116	15	the	the	DET
iajs-3342	116	16	development	development	NOUN
iajs-3342	116	17	of	of	ADP
iajs-3342	116	18	sle	sle	PROPN
iajs-3342	116	19	.	.	PUNCT
iajs-3342	117	1	while	while	SCONJ
iajs-3342	117	2	the	the	DET
iajs-3342	117	3	incidence	incidence	NOUN
iajs-3342	117	4	of	of	ADP
iajs-3342	117	5	ana	ana	PROPN
iajs-3342	117	6	positivity	positivity	NOUN
iajs-3342	117	7	is	be	AUX
iajs-3342	117	8	often	often	ADV
iajs-3342	117	9	lower	low	ADJ
iajs-3342	117	10	in	in	ADP
iajs-3342	117	11	cross	cross	ADJ
iajs-3342	117	12	-	-	ADJ
iajs-3342	117	13	sectional	sectional	ADJ
iajs-3342	117	14	research	research	NOUN
iajs-3342	117	15	,	,	PUNCT
iajs-3342	117	16	the	the	DET
iajs-3342	117	17	current	current	ADJ
iajs-3342	117	18	study	study	NOUN
iajs-3342	117	19	confirms	confirm	VERB
iajs-3342	117	20	previous	previous	ADJ
iajs-3342	117	21	findings	finding	NOUN
iajs-3342	117	22	that	that	PRON
iajs-3342	117	23	ana	ana	PROPN
iajs-3342	117	24	positivity	positivity	NOUN
iajs-3342	117	25	in	in	ADP
iajs-3342	117	26	sle	sle	PROPN
iajs-3342	117	27	patients	patient	NOUN
iajs-3342	117	28	surpass	surpass	VERB
iajs-3342	117	29	90	90	NUM
iajs-3342	117	30	%	%	NOUN
iajs-3342	117	31	.	.	PUNCT
iajs-3342	118	1	although	although	SCONJ
iajs-3342	118	2	some	some	DET
iajs-3342	118	3	studies	study	NOUN
iajs-3342	118	4	have	have	AUX
iajs-3342	118	5	claimed	claim	VERB
iajs-3342	118	6	a	a	DET
iajs-3342	118	7	100	100	NUM
iajs-3342	118	8	%	%	NOUN
iajs-3342	118	9	frequency	frequency	NOUN
iajs-3342	118	10	,	,	PUNCT
iajs-3342	118	11	the	the	DET
iajs-3342	118	12	majority	majority	NOUN
iajs-3342	118	13	show	show	VERB
iajs-3342	118	14	a	a	DET
iajs-3342	118	15	lower	low	ADJ
iajs-3342	118	16	percentage	percentage	NOUN
iajs-3342	118	17	,	,	PUNCT
iajs-3342	118	18	from	from	ADP
iajs-3342	118	19	95	95	NUM
iajs-3342	118	20	%	%	NOUN
iajs-3342	118	21	to	to	PART
iajs-3342	118	22	99	99	NUM
iajs-3342	118	23	%	%	NOUN
iajs-3342	118	24	[	[	X
iajs-3342	118	25	16	16	NUM
iajs-3342	118	26	]	]	PUNCT
iajs-3342	118	27	.	.	PUNCT
iajs-3342	119	1	previous	previous	ADJ
iajs-3342	119	2	iraqi	iraqi	ADJ
iajs-3342	119	3	studies	study	NOUN
iajs-3342	119	4	showed	show	VERB
iajs-3342	119	5	a	a	DET
iajs-3342	119	6	significant	significant	ADJ
iajs-3342	119	7	variation	variation	NOUN
iajs-3342	119	8	in	in	ADP
iajs-3342	119	9	ana	ana	PROPN
iajs-3342	119	10	,	,	PUNCT
iajs-3342	119	11	with	with	ADP
iajs-3342	119	12	a	a	DET
iajs-3342	119	13	wide	wide	ADJ
iajs-3342	119	14	range	range	NOUN
iajs-3342	119	15	of	of	ADP
iajs-3342	119	16	frequency	frequency	NOUN
iajs-3342	119	17	variations	variation	NOUN
iajs-3342	119	18	of	of	ADP
iajs-3342	119	19	98	98	NUM
iajs-3342	119	20	%	%	NOUN
iajs-3342	119	21	[	[	X
iajs-3342	119	22	17	17	NUM
iajs-3342	119	23	]	]	PUNCT
iajs-3342	119	24	and	and	CCONJ
iajs-3342	119	25	93	93	NUM
iajs-3342	119	26	%	%	NOUN
iajs-3342	119	27	[	[	X
iajs-3342	119	28	18	18	NUM
iajs-3342	119	29	]	]	PUNCT
iajs-3342	119	30	.	.	PUNCT
iajs-3342	120	1	the	the	DET
iajs-3342	120	2	present	present	ADJ
iajs-3342	120	3	study	study	NOUN
iajs-3342	120	4	showed	show	VERB
iajs-3342	120	5	a	a	DET
iajs-3342	120	6	significant	significant	ADJ
iajs-3342	120	7	increase	increase	NOUN
iajs-3342	120	8	in	in	ADP
iajs-3342	120	9	ana	ana	PROPN
iajs-3342	120	10	and	and	CCONJ
iajs-3342	120	11	dsdna	dsdna	PROPN
iajs-3342	120	12	levels	level	NOUN
iajs-3342	120	13	in	in	ADP
iajs-3342	120	14	patients	patient	NOUN
iajs-3342	120	15	compared	compare	VERB
iajs-3342	120	16	to	to	ADP
iajs-3342	120	17	the	the	DET
iajs-3342	120	18	control	control	NOUN
iajs-3342	120	19	.	.	PUNCT
iajs-3342	121	1	this	this	DET
iajs-3342	121	2	result	result	NOUN
iajs-3342	121	3	agrees	agree	VERB
iajs-3342	121	4	with	with	ADP
iajs-3342	121	5	a	a	DET
iajs-3342	121	6	study	study	NOUN
iajs-3342	121	7	by	by	ADP
iajs-3342	121	8	noor	noor	PROPN
iajs-3342	121	9	ahuda	ahuda	NOUN
iajs-3342	121	10	et	et	PROPN
iajs-3342	121	11	al	al	PROPN
iajs-3342	121	12	.	.	PROPN
iajs-3342	122	1	(	(	PUNCT
iajs-3342	122	2	2020	2020	NUM
iajs-3342	122	3	)	)	PUNCT
iajs-3342	122	4	that	that	PRON
iajs-3342	122	5	found	find	VERB
iajs-3342	122	6	a	a	DET
iajs-3342	122	7	significant	significant	ADJ
iajs-3342	122	8	increase	increase	NOUN
iajs-3342	122	9	in	in	ADP
iajs-3342	122	10	ana	ana	PROPN
iajs-3342	122	11	,	,	PUNCT
iajs-3342	122	12	anti	anti	ADJ
iajs-3342	122	13	-	-	ADJ
iajs-3342	122	14	ds	ds	ADJ
iajs-3342	122	15	dna	dna	NOUN
iajs-3342	122	16	,	,	PUNCT
iajs-3342	122	17	esr	esr	PROPN
iajs-3342	122	18	,	,	PUNCT
iajs-3342	122	19	and	and	CCONJ
iajs-3342	122	20	h	h	NOUN
iajs-3342	122	21	-	-	PUNCT
iajs-3342	122	22	crp	crp	NOUN
iajs-3342	122	23	in	in	ADP
iajs-3342	122	24	groups	group	NOUN
iajs-3342	122	25	of	of	ADP
iajs-3342	122	26	iraqi	iraqi	ADJ
iajs-3342	122	27	sle	sle	PROPN
iajs-3342	122	28	patients	patient	NOUN
iajs-3342	122	29	in	in	ADP
iajs-3342	122	30	comparison	comparison	NOUN
iajs-3342	122	31	with	with	ADP
iajs-3342	122	32	control	control	NOUN
iajs-3342	123	1	[	[	X
iajs-3342	123	2	19	19	NUM
iajs-3342	123	3	]	]	PUNCT
iajs-3342	123	4	.	.	PUNCT
iajs-3342	124	1	anti	anti	ADJ
iajs-3342	124	2	-	-	ADJ
iajs-3342	124	3	dsdna	dsdna	ADJ
iajs-3342	124	4	antibodies	antibody	NOUN
iajs-3342	124	5	are	be	AUX
iajs-3342	124	6	the	the	DET
iajs-3342	124	7	most	most	ADV
iajs-3342	124	8	heavily	heavily	ADV
iajs-3342	124	9	weighted	weight	VERB
iajs-3342	124	10	criteria	criterion	NOUN
iajs-3342	124	11	in	in	ADP
iajs-3342	124	12	the	the	DET
iajs-3342	124	13	immunologic	immunologic	ADJ
iajs-3342	124	14	domain	domain	NOUN
iajs-3342	124	15	of	of	ADP
iajs-3342	124	16	the	the	DET
iajs-3342	124	17	2019	2019	NUM
iajs-3342	124	18	eular	eular	ADJ
iajs-3342	124	19	/	/	SYM
iajs-3342	124	20	acr	acr	PROPN
iajs-3342	124	21	classification	classification	NOUN
iajs-3342	124	22	.	.	PUNCT
iajs-3342	125	1	they	they	PRON
iajs-3342	125	2	are	be	AUX
iajs-3342	125	3	one	one	NUM
iajs-3342	125	4	of	of	ADP
iajs-3342	125	5	the	the	DET
iajs-3342	125	6	most	most	ADV
iajs-3342	125	7	distinctive	distinctive	ADJ
iajs-3342	125	8	kinds	kind	NOUN
iajs-3342	125	9	of	of	ADP
iajs-3342	125	10	ana	ana	PROPN
iajs-3342	125	11	,	,	PUNCT
iajs-3342	125	12	with	with	ADP
iajs-3342	125	13	a	a	DET
iajs-3342	125	14	high	high	ADJ
iajs-3342	125	15	specificity	specificity	NOUN
iajs-3342	125	16	(	(	PUNCT
iajs-3342	125	17	96	96	NUM
iajs-3342	125	18	%	%	NOUN
iajs-3342	125	19	)	)	PUNCT
iajs-3342	125	20	for	for	ADP
iajs-3342	125	21	sle	sle	PROPN
iajs-3342	125	22	.	.	PUNCT
iajs-3342	126	1	the	the	DET
iajs-3342	126	2	levels	level	NOUN
iajs-3342	126	3	of	of	ADP
iajs-3342	126	4	anti	anti	ADJ
iajs-3342	126	5	-	-	ADJ
iajs-3342	126	6	dsdna	dsdna	ADJ
iajs-3342	126	7	antibodies	antibody	NOUN
iajs-3342	126	8	are	be	AUX
iajs-3342	126	9	highly	highly	ADV
iajs-3342	126	10	linked	link	VERB
iajs-3342	126	11	with	with	ADP
iajs-3342	126	12	disease	disease	NOUN
iajs-3342	126	13	activity	activity	NOUN
iajs-3342	126	14	and	and	CCONJ
iajs-3342	126	15	may	may	AUX
iajs-3342	126	16	change	change	VERB
iajs-3342	126	17	over	over	ADP
iajs-3342	126	18	time	time	NOUN
iajs-3342	126	19	[	[	X
iajs-3342	126	20	20	20	NUM
iajs-3342	126	21	]	]	PUNCT
iajs-3342	126	22	.	.	PUNCT
iajs-3342	127	1	this	this	PRON
iajs-3342	127	2	means	mean	VERB
iajs-3342	127	3	that	that	SCONJ
iajs-3342	127	4	levels	level	NOUN
iajs-3342	127	5	might	might	AUX
iajs-3342	127	6	be	be	AUX
iajs-3342	127	7	undetectable	undetectable	ADJ
iajs-3342	127	8	throughout	throughout	ADP
iajs-3342	127	9	therapy	therapy	NOUN
iajs-3342	127	10	but	but	CCONJ
iajs-3342	127	11	rise	rise	VERB
iajs-3342	127	12	dramatically	dramatically	ADV
iajs-3342	127	13	after	after	ADP
iajs-3342	127	14	a	a	DET
iajs-3342	127	15	flare	flare	NOUN
iajs-3342	127	16	,	,	PUNCT
iajs-3342	127	17	especially	especially	ADV
iajs-3342	127	18	for	for	ADP
iajs-3342	127	19	patients	patient	NOUN
iajs-3342	127	20	with	with	ADP
iajs-3342	127	21	active	active	ADJ
iajs-3342	127	22	nephritis	nephritis	NOUN
iajs-3342	127	23	.	.	PUNCT
iajs-3342	128	1	anti	anti	ADJ
iajs-3342	128	2	-	-	ADJ
iajs-3342	128	3	dsdna	dsdna	ADJ
iajs-3342	128	4	antibodies	antibody	NOUN
iajs-3342	128	5	have	have	AUX
iajs-3342	128	6	limited	limit	VERB
iajs-3342	128	7	diagnostic	diagnostic	ADJ
iajs-3342	128	8	sensitivity	sensitivity	NOUN
iajs-3342	128	9	(	(	PUNCT
iajs-3342	128	10	52	52	NUM
iajs-3342	128	11	%	%	NOUN
iajs-3342	128	12	to	to	PART
iajs-3342	128	13	70	70	NUM
iajs-3342	128	14	%	%	NOUN
iajs-3342	128	15	)	)	PUNCT
iajs-3342	128	16	because	because	SCONJ
iajs-3342	128	17	of	of	ADP
iajs-3342	128	18	their	their	PRON
iajs-3342	128	19	fleeting	fleeting	ADJ
iajs-3342	128	20	presence	presence	NOUN
iajs-3342	128	21	[	[	X
iajs-3342	128	22	21	21	NUM
iajs-3342	128	23	]	]	PUNCT
iajs-3342	128	24	.	.	PUNCT
iajs-3342	129	1	antidsdna	antidsdna	PROPN
iajs-3342	129	2	and	and	CCONJ
iajs-3342	129	3	ana	ana	PROPN
iajs-3342	129	4	are	be	AUX
iajs-3342	129	5	two	two	NUM
iajs-3342	129	6	examples	example	NOUN
iajs-3342	129	7	of	of	ADP
iajs-3342	129	8	autoantibodies	autoantibody	NOUN
iajs-3342	129	9	often	often	ADV
iajs-3342	129	10	seen	see	VERB
iajs-3342	129	11	in	in	ADP
iajs-3342	129	12	patients	patient	NOUN
iajs-3342	129	13	with	with	ADP
iajs-3342	129	14	sle	sle	PROPN
iajs-3342	129	15	.	.	PUNCT
iajs-3342	130	1	as	as	ADP
iajs-3342	130	2	a	a	DET
iajs-3342	130	3	result	result	NOUN
iajs-3342	130	4	,	,	PUNCT
iajs-3342	130	5	sle	sle	PROPN
iajs-3342	130	6	is	be	AUX
iajs-3342	130	7	thought	think	VERB
iajs-3342	130	8	to	to	PART
iajs-3342	130	9	be	be	AUX
iajs-3342	130	10	a	a	DET
iajs-3342	130	11	b	b	NOUN
iajs-3342	130	12	lymphocyte	lymphocyte	ADV
iajs-3342	130	13	-	-	PUNCT
iajs-3342	130	14	mediated	mediate	VERB
iajs-3342	130	15	disease	disease	NOUN
iajs-3342	130	16	[	[	X
iajs-3342	130	17	22	22	NUM
iajs-3342	130	18	]	]	PUNCT
iajs-3342	130	19	.	.	PUNCT
iajs-3342	131	1	although	although	SCONJ
iajs-3342	131	2	circulating	circulate	VERB
iajs-3342	131	3	autoantibodies	autoantibody	NOUN
iajs-3342	131	4	,	,	PUNCT
iajs-3342	131	5	immune	immune	ADJ
iajs-3342	131	6	complex	complex	ADJ
iajs-3342	131	7	deposition	deposition	NOUN
iajs-3342	131	8	,	,	PUNCT
iajs-3342	131	9	and	and	CCONJ
iajs-3342	131	10	complement	complement	VERB
iajs-3342	131	11	protein	protein	NOUN
iajs-3342	131	12	activation	activation	NOUN
iajs-3342	131	13	are	be	AUX
iajs-3342	131	14	all	all	PRON
iajs-3342	131	15	characteristics	characteristic	NOUN
iajs-3342	131	16	of	of	ADP
iajs-3342	131	17	sle	sle	PROPN
iajs-3342	131	18	,	,	PUNCT
iajs-3342	131	19	it	it	PRON
iajs-3342	131	20	is	be	AUX
iajs-3342	131	21	clear	clear	ADJ
iajs-3342	131	22	that	that	SCONJ
iajs-3342	131	23	an	an	DET
iajs-3342	131	24	imbalance	imbalance	NOUN
iajs-3342	131	25	in	in	ADP
iajs-3342	131	26	cytokines	cytokine	NOUN
iajs-3342	131	27	is	be	AUX
iajs-3342	131	28	also	also	ADV
iajs-3342	131	29	a	a	DET
iajs-3342	131	30	significant	significant	ADJ
iajs-3342	131	31	contributing	contribute	VERB
iajs-3342	131	32	factor	factor	NOUN
iajs-3342	131	33	[	[	X
iajs-3342	131	34	23	23	NUM
iajs-3342	131	35	]	]	PUNCT
iajs-3342	131	36	.	.	PUNCT
iajs-3342	132	1	in	in	ADP
iajs-3342	132	2	addition	addition	NOUN
iajs-3342	132	3	,	,	PUNCT
iajs-3342	132	4	autoantibodies	autoantibody	NOUN
iajs-3342	132	5	are	be	AUX
iajs-3342	132	6	usually	usually	ADV
iajs-3342	132	7	present	present	ADJ
iajs-3342	132	8	before	before	SCONJ
iajs-3342	132	9	symptoms	symptom	NOUN
iajs-3342	132	10	appear	appear	VERB
iajs-3342	132	11	[	[	X
iajs-3342	132	12	24	24	NUM
iajs-3342	132	13	]	]	PUNCT
iajs-3342	132	14	.	.	PUNCT
iajs-3342	133	1	the	the	DET
iajs-3342	133	2	term	term	NOUN
iajs-3342	133	3	"	"	PUNCT
iajs-3342	133	4	damage	damage	NOUN
iajs-3342	133	5	"	"	PUNCT
iajs-3342	133	6	refers	refer	VERB
iajs-3342	133	7	to	to	ADP
iajs-3342	133	8	the	the	DET
iajs-3342	133	9	long	long	ADJ
iajs-3342	133	10	-	-	PUNCT
iajs-3342	133	11	term	term	NOUN
iajs-3342	133	12	effects	effect	NOUN
iajs-3342	133	13	of	of	ADP
iajs-3342	133	14	sle	sle	NOUN
iajs-3342	133	15	and	and	CCONJ
iajs-3342	133	16	related	related	ADJ
iajs-3342	133	17	factors	factor	NOUN
iajs-3342	133	18	such	such	ADJ
iajs-3342	133	19	as	as	ADP
iajs-3342	133	20	illness	illness	NOUN
iajs-3342	133	21	and	and	CCONJ
iajs-3342	133	22	treatment	treatment	NOUN
iajs-3342	133	23	.	.	PUNCT
iajs-3342	134	1	the	the	DET
iajs-3342	134	2	pattern	pattern	NOUN
iajs-3342	134	3	of	of	ADP
iajs-3342	134	4	damage	damage	NOUN
iajs-3342	134	5	shows	show	VERB
iajs-3342	134	6	a	a	DET
iajs-3342	134	7	linear	linear	ADJ
iajs-3342	134	8	increase	increase	NOUN
iajs-3342	134	9	over	over	ADP
iajs-3342	134	10	time	time	NOUN
iajs-3342	134	11	[	[	X
iajs-3342	134	12	25	25	NUM
iajs-3342	134	13	]	]	PUNCT
iajs-3342	134	14	.	.	PUNCT
iajs-3342	135	1	definitions	definition	NOUN
iajs-3342	135	2	and	and	CCONJ
iajs-3342	135	3	criteria	criterion	NOUN
iajs-3342	135	4	for	for	ADP
iajs-3342	135	5	the	the	DET
iajs-3342	135	6	classification	classification	NOUN
iajs-3342	135	7	of	of	ADP
iajs-3342	135	8	19	19	NUM
iajs-3342	135	9	cns	cns	NOUN
iajs-3342	135	10	and	and	CCONJ
iajs-3342	135	11	peripheral	peripheral	ADJ
iajs-3342	135	12	nerve	nerve	NOUN
iajs-3342	135	13	syndromes	syndrome	NOUN
iajs-3342	135	14	(	(	PUNCT
iajs-3342	135	15	pns	pns	NOUN
iajs-3342	135	16	)	)	PUNCT
iajs-3342	135	17	have	have	AUX
iajs-3342	135	18	been	be	AUX
iajs-3342	135	19	suggested	suggest	VERB
iajs-3342	135	20	by	by	ADP
iajs-3342	135	21	the	the	DET
iajs-3342	135	22	american	american	PROPN
iajs-3342	135	23	college	college	PROPN
iajs-3342	135	24	of	of	ADP
iajs-3342	135	25	rheumatology	rheumatology	NOUN
iajs-3342	135	26	in	in	ADP
iajs-3342	135	27	the	the	DET
iajs-3342	135	28	context	context	NOUN
iajs-3342	135	29	of	of	ADP
iajs-3342	135	30	sle	sle	PROPN
iajs-3342	135	31	.	.	PUNCT
iajs-3342	136	1	sle	sle	PROPN
iajs-3342	136	2	is	be	AUX
iajs-3342	136	3	often	often	ADV
iajs-3342	136	4	thought	think	VERB
iajs-3342	136	5	to	to	PART
iajs-3342	136	6	present	present	VERB
iajs-3342	136	7	itself	itself	PRON
iajs-3342	136	8	in	in	ADP
iajs-3342	136	9	the	the	DET
iajs-3342	136	10	pns	pns	NOUN
iajs-3342	137	1	[	[	X
iajs-3342	137	2	26	26	NUM
iajs-3342	137	3	]	]	PUNCT
iajs-3342	137	4	.	.	PUNCT
iajs-3342	138	1	the	the	DET
iajs-3342	138	2	clinical	clinical	ADJ
iajs-3342	138	3	manifestation	manifestation	NOUN
iajs-3342	138	4	of	of	ADP
iajs-3342	138	5	pn	pn	PROPN
iajs-3342	138	6	is	be	AUX
iajs-3342	138	7	determined	determine	VERB
iajs-3342	138	8	by	by	ADP
iajs-3342	138	9	the	the	DET
iajs-3342	138	10	nerve	nerve	NOUN
iajs-3342	138	11	's	's	PART
iajs-3342	138	12	diameter	diameter	NOUN
iajs-3342	138	13	,	,	PUNCT
iajs-3342	138	14	the	the	DET
iajs-3342	138	15	nature	nature	NOUN
iajs-3342	138	16	of	of	ADP
iajs-3342	138	17	the	the	DET
iajs-3342	138	18	demyelinating	demyelinating	ADJ
iajs-3342	138	19	or	or	CCONJ
iajs-3342	138	20	axonal	axonal	ADJ
iajs-3342	138	21	damage	damage	NOUN
iajs-3342	138	22	,	,	PUNCT
iajs-3342	138	23	and	and	CCONJ
iajs-3342	138	24	whether	whether	SCONJ
iajs-3342	138	25	or	or	CCONJ
iajs-3342	138	26	not	not	PART
iajs-3342	138	27	it	it	PRON
iajs-3342	138	28	is	be	AUX
iajs-3342	138	29	an	an	DET
iajs-3342	138	30	acute	acute	ADJ
iajs-3342	138	31	or	or	CCONJ
iajs-3342	138	32	chronic	chronic	ADJ
iajs-3342	138	33	occurrence	occurrence	NOUN
iajs-3342	139	1	[	[	X
iajs-3342	139	2	27	27	NUM
iajs-3342	139	3	]	]	PUNCT
iajs-3342	139	4	.	.	PUNCT
iajs-3342	140	1	pathological	pathological	ADJ
iajs-3342	140	2	studies	study	NOUN
iajs-3342	140	3	of	of	ADP
iajs-3342	140	4	the	the	DET
iajs-3342	140	5	peripheral	peripheral	ADJ
iajs-3342	140	6	nerves	nerve	NOUN
iajs-3342	140	7	in	in	ADP
iajs-3342	140	8	sle	sle	PROPN
iajs-3342	140	9	have	have	AUX
iajs-3342	140	10	revealed	reveal	VERB
iajs-3342	140	11	axonal	axonal	ADJ
iajs-3342	140	12	pathological	pathological	ADJ
iajs-3342	140	13	changes	change	NOUN
iajs-3342	140	14	,	,	PUNCT
iajs-3342	140	15	inflammatory	inflammatory	ADJ
iajs-3342	140	16	changes	change	NOUN
iajs-3342	140	17	,	,	PUNCT
iajs-3342	140	18	and	and	CCONJ
iajs-3342	140	19	vasculitis	vasculitis	PROPN
iajs-3342	140	20	,	,	PUNCT
iajs-3342	140	21	which	which	PRON
iajs-3342	140	22	may	may	AUX
iajs-3342	140	23	suggest	suggest	VERB
iajs-3342	140	24	the	the	DET
iajs-3342	140	25	likelihood	likelihood	NOUN
iajs-3342	140	26	of	of	ADP
iajs-3342	140	27	various	various	ADJ
iajs-3342	140	28	pathogenetic	pathogenetic	ADJ
iajs-3342	140	29	components	component	NOUN
iajs-3342	140	30	for	for	ADP
iajs-3342	140	31	the	the	DET
iajs-3342	140	32	different	different	ADJ
iajs-3342	140	33	types	type	NOUN
iajs-3342	140	34	of	of	ADP
iajs-3342	140	35	sle	sle	PROPN
iajs-3342	140	36	-	-	PUNCT
iajs-3342	140	37	related	relate	VERB
iajs-3342	140	38	neuropathy	neuropathy	ADJ
iajs-3342	140	39	but	but	CCONJ
iajs-3342	140	40	do	do	AUX
iajs-3342	140	41	not	not	PART
iajs-3342	140	42	shed	shed	VERB
iajs-3342	140	43	light	light	NOUN
iajs-3342	140	44	on	on	ADP
iajs-3342	140	45	the	the	DET
iajs-3342	140	46	pathogenesis	pathogenesis	NOUN
iajs-3342	140	47	of	of	ADP
iajs-3342	140	48	sle	sle	PROPN
iajs-3342	140	49	-	-	PUNCT
iajs-3342	140	50	related	relate	VERB
iajs-3342	140	51	neuropathy	neuropathy	ADJ
iajs-3342	140	52	[	[	X
iajs-3342	140	53	28	28	NUM
iajs-3342	140	54	]	]	PUNCT
iajs-3342	140	55	.	.	PUNCT
iajs-3342	141	1	the	the	DET
iajs-3342	141	2	primary	primary	ADJ
iajs-3342	141	3	inflammatory	inflammatory	ADJ
iajs-3342	141	4	mediators	mediator	NOUN
iajs-3342	141	5	secreted	secrete	VERB
iajs-3342	141	6	by	by	ADP
iajs-3342	141	7	immune	immune	ADJ
iajs-3342	141	8	cells	cell	NOUN
iajs-3342	141	9	act	act	VERB
iajs-3342	141	10	on	on	ADP
iajs-3342	141	11	sensory	sensory	ADJ
iajs-3342	141	12	neurons	neuron	NOUN
iajs-3342	141	13	,	,	PUNCT
iajs-3342	141	14	causing	cause	VERB
iajs-3342	141	15	peripheral	peripheral	ADJ
iajs-3342	141	16	sensitization	sensitization	NOUN
iajs-3342	141	17	and	and	CCONJ
iajs-3342	141	18	hyperalgesia	hyperalgesia	NOUN
iajs-3342	141	19	.	.	PUNCT
iajs-3342	142	1	in	in	ADP
iajs-3342	142	2	addition	addition	NOUN
iajs-3342	142	3	to	to	ADP
iajs-3342	142	4	the	the	DET
iajs-3342	142	5	ischemic	ischemic	ADJ
iajs-3342	142	6	vascular	vascular	ADJ
iajs-3342	142	7	mechanism	mechanism	NOUN
iajs-3342	142	8	,	,	PUNCT
iajs-3342	142	9	such	such	ADJ
iajs-3342	142	10	as	as	ADP
iajs-3342	142	11	vasa	vasa	NOUN
iajs-3342	142	12	nervorum	nervorum	ADJ
iajs-3342	142	13	vascularity	vascularity	NOUN
iajs-3342	142	14	or	or	CCONJ
iajs-3342	142	15	microthrombi	microthrombi	NOUN
iajs-3342	142	16	connected	connect	VERB
iajs-3342	142	17	to	to	ADP
iajs-3342	142	18	antiphospholipid	antiphospholipid	NOUN
iajs-3342	142	19	antibodies	antibody	NOUN
iajs-3342	142	20	,	,	PUNCT
iajs-3342	142	21	this	this	DET
iajs-3342	142	22	normal	normal	ADJ
iajs-3342	142	23	inflammatory	inflammatory	ADJ
iajs-3342	142	24	response	response	NOUN
iajs-3342	142	25	following	follow	VERB
iajs-3342	142	26	injury	injury	NOUN
iajs-3342	142	27	may	may	AUX
iajs-3342	142	28	promote	promote	VERB
iajs-3342	142	29	the	the	DET
iajs-3342	142	30	pathogenetic	pathogenetic	ADJ
iajs-3342	142	31	activity	activity	NOUN
iajs-3342	142	32	of	of	ADP
iajs-3342	142	33	antineutral	antineutral	ADJ
iajs-3342	142	34	autoantibodies	autoantibody	NOUN
iajs-3342	142	35	.	.	PUNCT
iajs-3342	143	1	the	the	DET
iajs-3342	143	2	other	other	ADJ
iajs-3342	143	3	acceptable	acceptable	ADJ
iajs-3342	143	4	processes	process	NOUN
iajs-3342	143	5	include	include	VERB
iajs-3342	143	6	immunologic	immunologic	ADJ
iajs-3342	143	7	damage	damage	NOUN
iajs-3342	143	8	caused	cause	VERB
iajs-3342	143	9	by	by	ADP
iajs-3342	143	10	a	a	DET
iajs-3342	143	11	direct	direct	ADJ
iajs-3342	143	12	attack	attack	NOUN
iajs-3342	143	13	of	of	ADP
iajs-3342	143	14	antibodies	antibody	NOUN
iajs-3342	143	15	and	and	CCONJ
iajs-3342	143	16	entraining	entraining	NOUN
iajs-3342	143	17	obliteration	obliteration	NOUN
iajs-3342	143	18	of	of	ADP
iajs-3342	143	19	the	the	DET
iajs-3342	143	20	peripheral	peripheral	ADJ
iajs-3342	143	21	nerve	nerve	NOUN
iajs-3342	143	22	component	component	NOUN
iajs-3342	143	23	[	[	X
iajs-3342	143	24	29	29	NUM
iajs-3342	143	25	]	]	PUNCT
iajs-3342	143	26	.	.	PUNCT
iajs-3342	144	1	the	the	DET
iajs-3342	144	2	term	term	NOUN
iajs-3342	144	3	"	"	PUNCT
iajs-3342	144	4	neuropathic	neuropathic	ADJ
iajs-3342	144	5	pain	pain	NOUN
iajs-3342	144	6	"	"	PUNCT
iajs-3342	144	7	refers	refer	VERB
iajs-3342	144	8	to	to	ADP
iajs-3342	144	9	a	a	DET
iajs-3342	144	10	kind	kind	NOUN
iajs-3342	144	11	of	of	ADP
iajs-3342	144	12	pain	pain	NOUN
iajs-3342	144	13	that	that	PRON
iajs-3342	144	14	occurs	occur	VERB
iajs-3342	144	15	as	as	ADP
iajs-3342	144	16	a	a	DET
iajs-3342	144	17	result	result	NOUN
iajs-3342	144	18	of	of	ADP
iajs-3342	144	19	injury	injury	NOUN
iajs-3342	144	20	or	or	CCONJ
iajs-3342	144	21	malfunction	malfunction	NOUN
iajs-3342	144	22	to	to	ADP
iajs-3342	144	23	the	the	DET
iajs-3342	144	24	neurological	neurological	ADJ
iajs-3342	144	25	system	system	NOUN
iajs-3342	144	26	,	,	PUNCT
iajs-3342	144	27	and	and	CCONJ
iajs-3342	144	28	it	it	PRON
iajs-3342	144	29	may	may	AUX
iajs-3342	144	30	appear	appear	VERB
iajs-3342	144	31	on	on	ADP
iajs-3342	144	32	its	its	PRON
iajs-3342	144	33	own	own	ADJ
iajs-3342	144	34	or	or	CCONJ
iajs-3342	144	35	in	in	ADP
iajs-3342	144	36	response	response	NOUN
iajs-3342	144	37	to	to	ADP
iajs-3342	144	38	external	external	ADJ
iajs-3342	144	39	stimuli	stimulus	NOUN
iajs-3342	144	40	.	.	PUNCT
iajs-3342	145	1	with	with	ADP
iajs-3342	145	2	nerve	nerve	NOUN
iajs-3342	145	3	damage	damage	NOUN
iajs-3342	145	4	,	,	PUNCT
iajs-3342	145	5	neuropathic	neuropathic	ADJ
iajs-3342	145	6	pain	pain	NOUN
iajs-3342	145	7	may	may	AUX
iajs-3342	145	8	develop	develop	VERB
iajs-3342	145	9	,	,	PUNCT
iajs-3342	145	10	but	but	CCONJ
iajs-3342	145	11	the	the	DET
iajs-3342	145	12	cns	cns	NOUN
iajs-3342	145	13	may	may	AUX
iajs-3342	145	14	shift	shift	VERB
iajs-3342	145	15	,	,	PUNCT
iajs-3342	145	16	leading	lead	VERB
iajs-3342	145	17	to	to	ADP
iajs-3342	145	18	another	another	DET
iajs-3342	145	19	symptom	symptom	NOUN
iajs-3342	145	20	.	.	PUNCT
iajs-3342	146	1	nerve	nerve	NOUN
iajs-3342	146	2	growth	growth	NOUN
iajs-3342	146	3	factors	factor	NOUN
iajs-3342	146	4	are	be	AUX
iajs-3342	146	5	a	a	DET
iajs-3342	146	6	kind	kind	NOUN
iajs-3342	146	7	of	of	ADP
iajs-3342	146	8	neurotrophic	neurotrophic	ADJ
iajs-3342	146	9	factor	factor	NOUN
iajs-3342	146	10	that	that	PRON
iajs-3342	146	11	promotes	promote	VERB
iajs-3342	146	12	neuronal	neuronal	ADJ
iajs-3342	146	13	survival	survival	NOUN
iajs-3342	146	14	and	and	CCONJ
iajs-3342	146	15	growth	growth	NOUN
iajs-3342	146	16	throughout	throughout	ADP
iajs-3342	146	17	development	development	NOUN
iajs-3342	146	18	,	,	PUNCT
iajs-3342	146	19	preserves	preserve	VERB
iajs-3342	146	20	the	the	DET
iajs-3342	146	21	structural	structural	ADJ
iajs-3342	146	22	and	and	CCONJ
iajs-3342	146	23	functional	functional	ADJ
iajs-3342	146	24	integrity	integrity	NOUN
iajs-3342	146	25	of	of	ADP
iajs-3342	146	26	the	the	DET
iajs-3342	146	27	adult	adult	NOUN
iajs-3342	146	28	nervous	nervous	ADJ
iajs-3342	146	29	system	system	NOUN
iajs-3342	146	30	,	,	PUNCT
iajs-3342	146	31	and	and	CCONJ
iajs-3342	146	32	governs	govern	VERB
iajs-3342	146	33	the	the	DET
iajs-3342	146	34	plasticity	plasticity	NOUN
iajs-3342	146	35	of	of	ADP
iajs-3342	146	36	the	the	DET
iajs-3342	146	37	damaged	damage	VERB
iajs-3342	146	38	or	or	CCONJ
iajs-3342	146	39	diseased	diseased	ADJ
iajs-3342	146	40	adult	adult	NOUN
iajs-3342	146	41	nervous	nervous	ADJ
iajs-3342	146	42	system	system	NOUN
iajs-3342	146	43	[	[	X
iajs-3342	146	44	30	30	NUM
iajs-3342	146	45	]	]	PUNCT
iajs-3342	146	46	.	.	PUNCT
iajs-3342	147	1	peripheral	peripheral	ADJ
iajs-3342	147	2	sensory	sensory	ADJ
iajs-3342	147	3	nerve	nerve	NOUN
iajs-3342	147	4	fibers	fiber	NOUN
iajs-3342	147	5	produce	produce	VERB
iajs-3342	147	6	signaling	signal	VERB
iajs-3342	147	7	molecules	molecule	NOUN
iajs-3342	147	8	to	to	PART
iajs-3342	147	9	regulate	regulate	VERB
iajs-3342	147	10	immune	immune	ADJ
iajs-3342	147	11	response	response	NOUN
iajs-3342	147	12	.	.	PUNCT
iajs-3342	148	1	when	when	SCONJ
iajs-3342	148	2	this	this	PRON
iajs-3342	148	3	happens	happen	VERB
iajs-3342	148	4	,	,	PUNCT
iajs-3342	148	5	it	it	PRON
iajs-3342	148	6	's	be	AUX
iajs-3342	148	7	called	call	VERB
iajs-3342	148	8	neurogenic	neurogenic	ADJ
iajs-3342	148	9	ihjpas	ihjpa	NOUN
iajs-3342	148	10	.	.	PUNCT
iajs-3342	149	1	2024	2024	NUM
iajs-3342	149	2	,	,	PUNCT
iajs-3342	149	3	37	37	NUM
iajs-3342	149	4	(	(	PUNCT
iajs-3342	149	5	3	3	NUM
iajs-3342	149	6	)	)	PUNCT
iajs-3342	149	7	317	317	NUM
iajs-3342	149	8	inflammation	inflammation	NOUN
iajs-3342	149	9	(	(	PUNCT
iajs-3342	149	10	ni	ni	NOUN
iajs-3342	149	11	)	)	PUNCT
iajs-3342	149	12	,	,	PUNCT
iajs-3342	149	13	and	and	CCONJ
iajs-3342	149	14	ngf	ngf	ADV
iajs-3342	149	15	has	have	VERB
iajs-3342	149	16	an	an	DET
iajs-3342	149	17	essential	essential	ADJ
iajs-3342	149	18	function	function	NOUN
iajs-3342	149	19	as	as	ADP
iajs-3342	149	20	a	a	DET
iajs-3342	149	21	mediator	mediator	NOUN
iajs-3342	149	22	.	.	PUNCT
iajs-3342	150	1	it	it	PRON
iajs-3342	150	2	raises	raise	VERB
iajs-3342	150	3	levels	level	NOUN
iajs-3342	150	4	of	of	ADP
iajs-3342	150	5	inflammatory	inflammatory	ADJ
iajs-3342	150	6	peptides	peptide	NOUN
iajs-3342	150	7	such	such	ADJ
iajs-3342	150	8	as	as	ADP
iajs-3342	150	9	substance	substance	NOUN
iajs-3342	150	10	p	p	NOUN
iajs-3342	150	11	and	and	CCONJ
iajs-3342	150	12	calcitonin	calcitonin	ADJ
iajs-3342	150	13	gene	gene	NOUN
iajs-3342	150	14	-	-	PUNCT
iajs-3342	150	15	related	relate	VERB
iajs-3342	150	16	peptides	peptide	NOUN
iajs-3342	150	17	.	.	PUNCT
iajs-3342	151	1	there	there	PRON
iajs-3342	151	2	are	be	VERB
iajs-3342	151	3	two	two	NUM
iajs-3342	151	4	receptors	receptor	NOUN
iajs-3342	151	5	for	for	ADP
iajs-3342	151	6	nerve	nerve	NOUN
iajs-3342	151	7	growth	growth	NOUN
iajs-3342	151	8	factor	factor	NOUN
iajs-3342	151	9	:	:	PUNCT
iajs-3342	151	10	a	a	DET
iajs-3342	151	11	high	high	ADJ
iajs-3342	151	12	-	-	PUNCT
iajs-3342	151	13	affinity	affinity	NOUN
iajs-3342	151	14	tyrosine	tyrosine	NOUN
iajs-3342	151	15	kinase	kinase	VERB
iajs-3342	151	16	a	a	PRON
iajs-3342	151	17	and	and	CCONJ
iajs-3342	151	18	a	a	DET
iajs-3342	151	19	low	low	ADJ
iajs-3342	151	20	-	-	PUNCT
iajs-3342	151	21	affinity	affinity	NOUN
iajs-3342	151	22	p75	p75	ADJ
iajs-3342	151	23	receptor	receptor	NOUN
iajs-3342	151	24	,	,	PUNCT
iajs-3342	151	25	which	which	PRON
iajs-3342	151	26	is	be	AUX
iajs-3342	151	27	frequently	frequently	ADV
iajs-3342	151	28	thought	think	VERB
iajs-3342	151	29	of	of	ADP
iajs-3342	151	30	as	as	ADP
iajs-3342	151	31	a	a	DET
iajs-3342	151	32	co	co	NOUN
iajs-3342	151	33	-	-	NOUN
iajs-3342	151	34	receptor	receptor	NOUN
iajs-3342	151	35	for	for	ADP
iajs-3342	151	36	tropomyosin	tropomyosin	NOUN
iajs-3342	151	37	-	-	PUNCT
iajs-3342	151	38	related	relate	VERB
iajs-3342	151	39	kinase	kinase	PROPN
iajs-3342	151	40	a.	a.	PROPN
iajs-3342	151	41	trka	trka	PROPN
iajs-3342	151	42	,	,	PUNCT
iajs-3342	151	43	a	a	DET
iajs-3342	151	44	neurotrophic	neurotrophic	ADJ
iajs-3342	151	45	factor	factor	NOUN
iajs-3342	151	46	known	know	VERB
iajs-3342	151	47	as	as	ADP
iajs-3342	151	48	ngf	ngf	PROPN
iajs-3342	151	49	has	have	AUX
iajs-3342	151	50	been	be	AUX
iajs-3342	151	51	investigated	investigate	VERB
iajs-3342	151	52	as	as	ADP
iajs-3342	151	53	a	a	DET
iajs-3342	151	54	treatment	treatment	NOUN
iajs-3342	151	55	for	for	ADP
iajs-3342	151	56	diabetic	diabetic	ADJ
iajs-3342	151	57	peripheral	peripheral	ADJ
iajs-3342	151	58	neuropathy	neuropathy	ADJ
iajs-3342	151	59	(	(	PUNCT
iajs-3342	151	60	dpn	dpn	PROPN
iajs-3342	151	61	)	)	PUNCT
iajs-3342	152	1	[	[	X
iajs-3342	152	2	31	31	NUM
iajs-3342	152	3	]	]	PUNCT
iajs-3342	152	4	.	.	PUNCT
iajs-3342	153	1	changes	change	NOUN
iajs-3342	153	2	in	in	ADP
iajs-3342	153	3	ngf	ngf	ADJ
iajs-3342	153	4	levels	level	NOUN
iajs-3342	153	5	are	be	AUX
iajs-3342	153	6	implicated	implicate	VERB
iajs-3342	153	7	in	in	ADP
iajs-3342	153	8	the	the	DET
iajs-3342	153	9	pathophysiology	pathophysiology	NOUN
iajs-3342	153	10	of	of	ADP
iajs-3342	153	11	chronic	chronic	ADJ
iajs-3342	153	12	pain	pain	NOUN
iajs-3342	153	13	syndromes	syndrome	NOUN
iajs-3342	153	14	,	,	PUNCT
iajs-3342	153	15	including	include	VERB
iajs-3342	153	16	neuropathic	neuropathic	ADJ
iajs-3342	153	17	pain	pain	NOUN
iajs-3342	153	18	.	.	PUNCT
iajs-3342	154	1	ngf	ngf	ADV
iajs-3342	154	2	is	be	AUX
iajs-3342	154	3	known	know	VERB
iajs-3342	154	4	to	to	PART
iajs-3342	154	5	impact	impact	VERB
iajs-3342	154	6	the	the	DET
iajs-3342	154	7	phenotype	phenotype	NOUN
iajs-3342	154	8	of	of	ADP
iajs-3342	154	9	adult	adult	NOUN
iajs-3342	154	10	nociceptors	nociceptor	NOUN
iajs-3342	154	11	receptors	receptor	NOUN
iajs-3342	154	12	as	as	ADV
iajs-3342	154	13	well	well	ADV
iajs-3342	154	14	as	as	ADP
iajs-3342	154	15	the	the	DET
iajs-3342	154	16	proper	proper	ADJ
iajs-3342	154	17	development	development	NOUN
iajs-3342	154	18	of	of	ADP
iajs-3342	154	19	the	the	DET
iajs-3342	154	20	embryonic	embryonic	ADJ
iajs-3342	154	21	nervous	nervous	ADJ
iajs-3342	154	22	system	system	NOUN
iajs-3342	154	23	[	[	X
iajs-3342	154	24	32	32	NUM
iajs-3342	154	25	]	]	PUNCT
iajs-3342	154	26	.	.	PUNCT
iajs-3342	155	1	the	the	DET
iajs-3342	155	2	nerve	nerve	NOUN
iajs-3342	155	3	growth	growth	NOUN
iajs-3342	155	4	factor	factor	NOUN
iajs-3342	155	5	is	be	AUX
iajs-3342	155	6	a	a	DET
iajs-3342	155	7	biomarker	biomarker	NOUN
iajs-3342	155	8	reflecting	reflect	VERB
iajs-3342	155	9	damage	damage	NOUN
iajs-3342	155	10	to	to	ADP
iajs-3342	155	11	different	different	ADJ
iajs-3342	155	12	types	type	NOUN
iajs-3342	155	13	of	of	ADP
iajs-3342	155	14	nerves	nerve	NOUN
iajs-3342	155	15	[	[	X
iajs-3342	155	16	33	33	NUM
iajs-3342	155	17	]	]	PUNCT
iajs-3342	155	18	.	.	PUNCT
iajs-3342	156	1	it	it	PRON
iajs-3342	156	2	has	have	AUX
iajs-3342	156	3	also	also	ADV
iajs-3342	156	4	been	be	AUX
iajs-3342	156	5	linked	link	VERB
iajs-3342	156	6	to	to	ADP
iajs-3342	156	7	hyperalgesia	hyperalgesia	NOUN
iajs-3342	156	8	across	across	ADP
iajs-3342	156	9	a	a	DET
iajs-3342	156	10	wide	wide	ADJ
iajs-3342	156	11	range	range	NOUN
iajs-3342	156	12	of	of	ADP
iajs-3342	156	13	painful	painful	ADJ
iajs-3342	156	14	conditions	condition	NOUN
iajs-3342	156	15	,	,	PUNCT
iajs-3342	156	16	as	as	ADV
iajs-3342	156	17	well	well	ADV
iajs-3342	156	18	as	as	ADP
iajs-3342	156	19	the	the	DET
iajs-3342	156	20	genesis	genesis	NOUN
iajs-3342	156	21	of	of	ADP
iajs-3342	156	22	acute	acute	ADJ
iajs-3342	156	23	and	and	CCONJ
iajs-3342	156	24	chronic	chronic	ADJ
iajs-3342	156	25	cases	case	NOUN
iajs-3342	156	26	.	.	PUNCT
iajs-3342	157	1	high	high	ADJ
iajs-3342	157	2	levels	level	NOUN
iajs-3342	157	3	of	of	ADP
iajs-3342	157	4	ngf	ngf	ADV
iajs-3342	157	5	are	be	AUX
iajs-3342	157	6	seen	see	VERB
iajs-3342	157	7	in	in	ADP
iajs-3342	157	8	inflamed	inflame	VERB
iajs-3342	157	9	or	or	CCONJ
iajs-3342	157	10	injured	injured	ADJ
iajs-3342	157	11	tissues	tissue	NOUN
iajs-3342	157	12	,	,	PUNCT
iajs-3342	157	13	where	where	SCONJ
iajs-3342	157	14	it	it	PRON
iajs-3342	157	15	facilitates	facilitate	VERB
iajs-3342	157	16	the	the	DET
iajs-3342	157	17	transmission	transmission	NOUN
iajs-3342	157	18	of	of	ADP
iajs-3342	157	19	pain	pain	NOUN
iajs-3342	157	20	signals	signal	NOUN
iajs-3342	157	21	through	through	ADP
iajs-3342	157	22	nociceptive	nociceptive	ADJ
iajs-3342	157	23	nerve	nerve	NOUN
iajs-3342	157	24	fiber	fiber	NOUN
iajs-3342	157	25	.	.	PUNCT
iajs-3342	158	1	congenital	congenital	ADJ
iajs-3342	158	2	insensitivity	insensitivity	NOUN
iajs-3342	158	3	to	to	ADP
iajs-3342	158	4	pain	pain	NOUN
iajs-3342	158	5	or	or	CCONJ
iajs-3342	158	6	an	an	DET
iajs-3342	158	7	impaired	impaired	ADJ
iajs-3342	158	8	capacity	capacity	NOUN
iajs-3342	158	9	to	to	PART
iajs-3342	158	10	feel	feel	VERB
iajs-3342	158	11	pain	pain	NOUN
iajs-3342	158	12	is	be	AUX
iajs-3342	158	13	the	the	DET
iajs-3342	158	14	result	result	NOUN
iajs-3342	158	15	of	of	ADP
iajs-3342	158	16	mutations	mutation	NOUN
iajs-3342	158	17	in	in	ADP
iajs-3342	158	18	ngf	ngf	ADV
iajs-3342	158	19	or	or	CCONJ
iajs-3342	158	20	its	its	PRON
iajs-3342	158	21	tyrosine	tyrosine	NOUN
iajs-3342	158	22	kinase	kinase	NOUN
iajs-3342	158	23	receptor	receptor	NOUN
iajs-3342	158	24	trka	trka	NOUN
iajs-3342	159	1	[	[	X
iajs-3342	159	2	34	34	NUM
iajs-3342	159	3	]	]	PUNCT
iajs-3342	159	4	.	.	PUNCT
iajs-3342	160	1	this	this	DET
iajs-3342	160	2	study	study	NOUN
iajs-3342	160	3	showed	show	VERB
iajs-3342	160	4	that	that	SCONJ
iajs-3342	160	5	there	there	PRON
iajs-3342	160	6	is	be	VERB
iajs-3342	160	7	a	a	DET
iajs-3342	160	8	significant	significant	ADJ
iajs-3342	160	9	increase	increase	NOUN
iajs-3342	160	10	in	in	ADP
iajs-3342	160	11	the	the	DET
iajs-3342	160	12	level	level	NOUN
iajs-3342	160	13	of	of	ADP
iajs-3342	160	14	ngf	ngf	ADV
iajs-3342	160	15	in	in	ADP
iajs-3342	160	16	sle	sle	PROPN
iajs-3342	160	17	patients	patient	NOUN
iajs-3342	160	18	with	with	ADP
iajs-3342	160	19	the	the	DET
iajs-3342	160	20	duration	duration	NOUN
iajs-3342	160	21	of	of	ADP
iajs-3342	160	22	the	the	DET
iajs-3342	160	23	disease	disease	NOUN
iajs-3342	160	24	,	,	PUNCT
iajs-3342	160	25	and	and	CCONJ
iajs-3342	160	26	this	this	PRON
iajs-3342	160	27	explains	explain	VERB
iajs-3342	160	28	the	the	DET
iajs-3342	160	29	exacerbation	exacerbation	NOUN
iajs-3342	160	30	of	of	ADP
iajs-3342	160	31	pain	pain	NOUN
iajs-3342	160	32	in	in	ADP
iajs-3342	160	33	these	these	DET
iajs-3342	160	34	patients	patient	NOUN
iajs-3342	160	35	with	with	ADP
iajs-3342	160	36	the	the	DET
iajs-3342	160	37	length	length	NOUN
iajs-3342	160	38	of	of	ADP
iajs-3342	160	39	the	the	DET
iajs-3342	160	40	disease	disease	NOUN
iajs-3342	160	41	.	.	PUNCT
iajs-3342	161	1	the	the	DET
iajs-3342	161	2	b	b	NOUN
iajs-3342	161	3	-	-	PUNCT
iajs-3342	161	4	complex	complex	ADJ
iajs-3342	161	5	vitamins	vitamin	NOUN
iajs-3342	161	6	,	,	PUNCT
iajs-3342	161	7	especially	especially	ADV
iajs-3342	161	8	thiamine	thiamine	NOUN
iajs-3342	161	9	(	(	PUNCT
iajs-3342	161	10	b1	b1	NOUN
iajs-3342	161	11	)	)	PUNCT
iajs-3342	161	12	,	,	PUNCT
iajs-3342	161	13	pyridoxine	pyridoxine	NOUN
iajs-3342	161	14	(	(	PUNCT
iajs-3342	161	15	b6	b6	NOUN
iajs-3342	161	16	)	)	PUNCT
iajs-3342	161	17	,	,	PUNCT
iajs-3342	161	18	and	and	CCONJ
iajs-3342	161	19	cobalamin	cobalamin	NOUN
iajs-3342	161	20	(	(	PUNCT
iajs-3342	161	21	b12	b12	NOUN
iajs-3342	161	22	)	)	PUNCT
iajs-3342	161	23	,	,	PUNCT
iajs-3342	161	24	are	be	AUX
iajs-3342	161	25	discussed	discuss	VERB
iajs-3342	161	26	.	.	PUNCT
iajs-3342	162	1	certain	certain	ADJ
iajs-3342	162	2	vitamins	vitamin	NOUN
iajs-3342	162	3	are	be	AUX
iajs-3342	162	4	also	also	ADV
iajs-3342	162	5	referred	refer	VERB
iajs-3342	162	6	to	to	ADP
iajs-3342	162	7	as	as	ADP
iajs-3342	162	8	"	"	PUNCT
iajs-3342	162	9	neurotropic	neurotropic	NOUN
iajs-3342	162	10	"	"	PUNCT
iajs-3342	162	11	vitamins	vitamin	NOUN
iajs-3342	162	12	because	because	SCONJ
iajs-3342	162	13	of	of	ADP
iajs-3342	162	14	their	their	PRON
iajs-3342	162	15	beneficial	beneficial	ADJ
iajs-3342	162	16	effects	effect	NOUN
iajs-3342	162	17	on	on	ADP
iajs-3342	162	18	the	the	DET
iajs-3342	162	19	nervous	nervous	ADJ
iajs-3342	162	20	system	system	NOUN
iajs-3342	162	21	.	.	PUNCT
iajs-3342	163	1	certain	certain	ADJ
iajs-3342	163	2	b	b	NOUN
iajs-3342	163	3	vitamins	vitamin	NOUN
iajs-3342	163	4	are	be	AUX
iajs-3342	163	5	thought	think	VERB
iajs-3342	163	6	to	to	PART
iajs-3342	163	7	play	play	VERB
iajs-3342	163	8	a	a	DET
iajs-3342	163	9	role	role	NOUN
iajs-3342	163	10	in	in	ADP
iajs-3342	163	11	promoting	promote	VERB
iajs-3342	163	12	neuron	neuron	NOUN
iajs-3342	163	13	regeneration	regeneration	NOUN
iajs-3342	163	14	.	.	PUNCT
iajs-3342	164	1	on	on	ADP
iajs-3342	164	2	the	the	DET
iajs-3342	164	3	other	other	ADJ
iajs-3342	164	4	hand	hand	NOUN
iajs-3342	164	5	,	,	PUNCT
iajs-3342	164	6	vit	vit	NOUN
iajs-3342	164	7	.	.	PUNCT
iajs-3342	165	1	b12	b12	NOUN
iajs-3342	165	2	plays	play	VERB
iajs-3342	165	3	a	a	DET
iajs-3342	165	4	crucial	crucial	ADJ
iajs-3342	165	5	role	role	NOUN
iajs-3342	165	6	in	in	ADP
iajs-3342	165	7	remyelination	remyelination	NOUN
iajs-3342	165	8	and	and	CCONJ
iajs-3342	165	9	the	the	DET
iajs-3342	165	10	upkeep	upkeep	NOUN
iajs-3342	165	11	of	of	ADP
iajs-3342	165	12	myelin	myelin	ADJ
iajs-3342	165	13	sheaths	sheath	NOUN
iajs-3342	165	14	,	,	PUNCT
iajs-3342	165	15	which	which	PRON
iajs-3342	165	16	greatly	greatly	ADV
iajs-3342	165	17	increases	increase	VERB
iajs-3342	165	18	the	the	DET
iajs-3342	165	19	likelihood	likelihood	NOUN
iajs-3342	165	20	of	of	ADP
iajs-3342	165	21	nerve	nerve	NOUN
iajs-3342	165	22	cell	cell	NOUN
iajs-3342	165	23	survival	survival	NOUN
iajs-3342	165	24	[	[	X
iajs-3342	165	25	35	35	NUM
iajs-3342	165	26	]	]	PUNCT
iajs-3342	165	27	.	.	PUNCT
iajs-3342	166	1	in	in	ADP
iajs-3342	166	2	the	the	DET
iajs-3342	166	3	current	current	ADJ
iajs-3342	166	4	study	study	NOUN
iajs-3342	166	5	,	,	PUNCT
iajs-3342	166	6	there	there	PRON
iajs-3342	166	7	is	be	VERB
iajs-3342	166	8	a	a	DET
iajs-3342	166	9	significant	significant	ADJ
iajs-3342	166	10	decrease	decrease	NOUN
iajs-3342	166	11	in	in	ADP
iajs-3342	166	12	the	the	DET
iajs-3342	166	13	level	level	NOUN
iajs-3342	166	14	of	of	ADP
iajs-3342	166	15	vit	vit	NOUN
iajs-3342	166	16	.	.	PUNCT
iajs-3342	167	1	b12	b12	NOUN
iajs-3342	167	2	in	in	ADP
iajs-3342	167	3	patients	patient	NOUN
iajs-3342	167	4	with	with	ADP
iajs-3342	167	5	sle	sle	PROPN
iajs-3342	167	6	,	,	PUNCT
iajs-3342	167	7	and	and	CCONJ
iajs-3342	167	8	these	these	DET
iajs-3342	167	9	patients	patient	NOUN
iajs-3342	167	10	suffer	suffer	VERB
iajs-3342	167	11	from	from	ADP
iajs-3342	167	12	neuralgia	neuralgia	NOUN
iajs-3342	167	13	,	,	PUNCT
iajs-3342	167	14	especially	especially	ADV
iajs-3342	167	15	arthritis	arthritis	NOUN
iajs-3342	167	16	.	.	PUNCT
iajs-3342	168	1	however	however	ADV
iajs-3342	168	2	,	,	PUNCT
iajs-3342	168	3	to	to	PART
iajs-3342	168	4	elucidate	elucidate	VERB
iajs-3342	168	5	the	the	DET
iajs-3342	168	6	mechanism	mechanism	NOUN
iajs-3342	168	7	of	of	ADP
iajs-3342	168	8	the	the	DET
iajs-3342	168	9	role	role	NOUN
iajs-3342	168	10	of	of	ADP
iajs-3342	168	11	vit	vit	NOUN
iajs-3342	168	12	.	.	PUNCT
iajs-3342	169	1	b12	b12	NOUN
iajs-3342	169	2	and	and	CCONJ
iajs-3342	169	3	ngf	ngf	ADV
iajs-3342	169	4	in	in	ADP
iajs-3342	169	5	maintaining	maintain	VERB
iajs-3342	169	6	neuroprotective	neuroprotective	ADJ
iajs-3342	169	7	functions	function	NOUN
iajs-3342	169	8	,	,	PUNCT
iajs-3342	169	9	more	more	ADJ
iajs-3342	169	10	studies	study	NOUN
iajs-3342	169	11	are	be	AUX
iajs-3342	169	12	needed	need	VERB
iajs-3342	169	13	in	in	ADP
iajs-3342	169	14	this	this	DET
iajs-3342	169	15	field	field	NOUN
iajs-3342	169	16	.	.	PUNCT
iajs-3342	170	1	non	non	ADJ
iajs-3342	170	2	-	-	ADJ
iajs-3342	170	3	specific	specific	ADJ
iajs-3342	170	4	indicators	indicator	NOUN
iajs-3342	170	5	of	of	ADP
iajs-3342	170	6	systemic	systemic	ADJ
iajs-3342	170	7	inflammation	inflammation	NOUN
iajs-3342	170	8	like	like	ADP
iajs-3342	170	9	c	c	NOUN
iajs-3342	170	10	-	-	PUNCT
iajs-3342	170	11	reactive	reactive	ADJ
iajs-3342	170	12	protein	protein	NOUN
iajs-3342	170	13	(	(	PUNCT
iajs-3342	170	14	crp	crp	PROPN
iajs-3342	170	15	)	)	PUNCT
iajs-3342	170	16	and	and	CCONJ
iajs-3342	170	17	esr	esr	PROPN
iajs-3342	170	18	might	might	AUX
iajs-3342	170	19	be	be	AUX
iajs-3342	170	20	effective	effective	ADJ
iajs-3342	170	21	biomarkers	biomarker	NOUN
iajs-3342	170	22	in	in	ADP
iajs-3342	170	23	this	this	DET
iajs-3342	170	24	familiar	familiar	ADJ
iajs-3342	170	25	clinical	clinical	ADJ
iajs-3342	170	26	setting	setting	NOUN
iajs-3342	170	27	.	.	PUNCT
iajs-3342	171	1	inflammation	inflammation	NOUN
iajs-3342	171	2	,	,	PUNCT
iajs-3342	171	3	whether	whether	SCONJ
iajs-3342	171	4	caused	cause	VERB
iajs-3342	171	5	by	by	ADP
iajs-3342	171	6	infection	infection	NOUN
iajs-3342	171	7	,	,	PUNCT
iajs-3342	171	8	cancer	cancer	NOUN
iajs-3342	171	9	,	,	PUNCT
iajs-3342	171	10	or	or	CCONJ
iajs-3342	171	11	an	an	DET
iajs-3342	171	12	autoimmune	autoimmune	ADJ
iajs-3342	171	13	disorder	disorder	NOUN
iajs-3342	171	14	,	,	PUNCT
iajs-3342	171	15	may	may	AUX
iajs-3342	171	16	raise	raise	VERB
iajs-3342	171	17	both	both	DET
iajs-3342	171	18	crp	crp	PROPN
iajs-3342	171	19	and	and	CCONJ
iajs-3342	171	20	esr	esr	PROPN
iajs-3342	171	21	.	.	PUNCT
iajs-3342	172	1	at	at	ADP
iajs-3342	172	2	the	the	DET
iajs-3342	172	3	same	same	ADJ
iajs-3342	172	4	time	time	NOUN
iajs-3342	172	5	,	,	PUNCT
iajs-3342	172	6	sle	sle	PROPN
iajs-3342	172	7	patients	patient	NOUN
iajs-3342	172	8	have	have	AUX
iajs-3342	172	9	been	be	AUX
iajs-3342	172	10	reported	report	VERB
iajs-3342	172	11	to	to	PART
iajs-3342	172	12	have	have	VERB
iajs-3342	172	13	a	a	DET
iajs-3342	172	14	greater	great	ADJ
iajs-3342	172	15	propensity	propensity	NOUN
iajs-3342	172	16	for	for	ADP
iajs-3342	172	17	esr	esr	PROPN
iajs-3342	172	18	elevations	elevation	NOUN
iajs-3342	172	19	than	than	ADP
iajs-3342	172	20	crp	crp	NOUN
iajs-3342	172	21	elevations	elevation	NOUN
iajs-3342	172	22	when	when	SCONJ
iajs-3342	172	23	compared	compare	VERB
iajs-3342	172	24	to	to	PART
iajs-3342	172	25	rheumatoid	rheumatoid	VERB
iajs-3342	172	26	arthritis	arthritis	NOUN
iajs-3342	172	27	patients	patient	NOUN
iajs-3342	172	28	[	[	X
iajs-3342	172	29	36	36	NUM
iajs-3342	172	30	]	]	PUNCT
iajs-3342	172	31	since	since	SCONJ
iajs-3342	172	32	esr	esr	PROPN
iajs-3342	172	33	increases	increase	VERB
iajs-3342	172	34	with	with	ADP
iajs-3342	172	35	both	both	DET
iajs-3342	172	36	lupus	lupus	ADJ
iajs-3342	172	37	activity	activity	NOUN
iajs-3342	172	38	and	and	CCONJ
iajs-3342	172	39	infection	infection	NOUN
iajs-3342	172	40	.	.	PUNCT
iajs-3342	173	1	it	it	PRON
iajs-3342	173	2	lacks	lack	VERB
iajs-3342	173	3	specificity	specificity	NOUN
iajs-3342	173	4	in	in	ADP
iajs-3342	173	5	distinguishing	distinguish	VERB
iajs-3342	173	6	between	between	ADP
iajs-3342	173	7	the	the	DET
iajs-3342	173	8	two	two	NUM
iajs-3342	173	9	.	.	PUNCT
iajs-3342	174	1	however	however	ADV
iajs-3342	174	2	,	,	PUNCT
iajs-3342	174	3	elevated	elevated	ADJ
iajs-3342	174	4	esr	esr	PROPN
iajs-3342	174	5	levels	level	NOUN
iajs-3342	174	6	are	be	AUX
iajs-3342	174	7	closely	closely	ADV
iajs-3342	174	8	linked	link	VERB
iajs-3342	174	9	to	to	ADP
iajs-3342	174	10	disease	disease	NOUN
iajs-3342	174	11	flare	flare	NOUN
iajs-3342	174	12	-	-	PUNCT
iajs-3342	174	13	ups	up	NOUN
iajs-3342	174	14	in	in	ADP
iajs-3342	174	15	sle	sle	PROPN
iajs-3342	174	16	.	.	PUNCT
iajs-3342	175	1	in	in	ADP
iajs-3342	175	2	active	active	ADJ
iajs-3342	175	3	sle	sle	NOUN
iajs-3342	175	4	,	,	PUNCT
iajs-3342	175	5	an	an	DET
iajs-3342	175	6	increased	increase	VERB
iajs-3342	175	7	esr	esr	PROPN
iajs-3342	175	8	has	have	AUX
iajs-3342	175	9	been	be	AUX
iajs-3342	175	10	recognized	recognize	VERB
iajs-3342	175	11	to	to	PART
iajs-3342	175	12	occur	occur	VERB
iajs-3342	175	13	on	on	ADP
iajs-3342	175	14	a	a	DET
iajs-3342	175	15	regular	regular	ADJ
iajs-3342	175	16	basis	basis	NOUN
iajs-3342	175	17	for	for	ADP
iajs-3342	175	18	quite	quite	DET
iajs-3342	175	19	some	some	DET
iajs-3342	175	20	time	time	NOUN
iajs-3342	175	21	.	.	PUNCT
iajs-3342	176	1	both	both	DET
iajs-3342	176	2	alterations	alteration	NOUN
iajs-3342	176	3	in	in	ADP
iajs-3342	176	4	serum	serum	NOUN
iajs-3342	176	5	proteins	protein	NOUN
iajs-3342	176	6	and	and	CCONJ
iajs-3342	176	7	changes	change	NOUN
iajs-3342	176	8	in	in	ADP
iajs-3342	176	9	esr	esr	PROPN
iajs-3342	176	10	might	might	AUX
iajs-3342	176	11	theoretically	theoretically	ADV
iajs-3342	176	12	contribute	contribute	VERB
iajs-3342	176	13	to	to	ADP
iajs-3342	176	14	elevations	elevation	NOUN
iajs-3342	176	15	in	in	ADP
iajs-3342	176	16	esr	esr	PROPN
iajs-3342	176	17	.	.	PUNCT
iajs-3342	177	1	common	common	ADJ
iajs-3342	177	2	examples	example	NOUN
iajs-3342	177	3	of	of	ADP
iajs-3342	177	4	the	the	DET
iajs-3342	177	5	former	former	ADJ
iajs-3342	177	6	group	group	NOUN
iajs-3342	177	7	include	include	VERB
iajs-3342	177	8	hypergammaglobulinemia	hypergammaglobulinemia	NOUN
iajs-3342	177	9	,	,	PUNCT
iajs-3342	177	10	monoclonal	monoclonal	NOUN
iajs-3342	177	11	gammopathy	gammopathy	ADJ
iajs-3342	177	12	,	,	PUNCT
iajs-3342	177	13	and	and	CCONJ
iajs-3342	177	14	elevated	elevated	ADJ
iajs-3342	177	15	fibrinogen	fibrinogen	NOUN
iajs-3342	177	16	.	.	PUNCT
iajs-3342	178	1	the	the	DET
iajs-3342	178	2	primary	primary	ADJ
iajs-3342	178	3	latter	latter	ADJ
iajs-3342	178	4	results	result	NOUN
iajs-3342	178	5	from	from	ADP
iajs-3342	178	6	smaller	small	ADJ
iajs-3342	178	7	and	and	CCONJ
iajs-3342	178	8	fewer	few	ADJ
iajs-3342	178	9	red	red	ADJ
iajs-3342	178	10	blood	blood	NOUN
iajs-3342	178	11	cells	cell	NOUN
iajs-3342	178	12	.	.	PUNCT
iajs-3342	179	1	some	some	PRON
iajs-3342	179	2	of	of	ADP
iajs-3342	179	3	these	these	DET
iajs-3342	179	4	esr	esr	NOUN
iajs-3342	179	5	-	-	ADJ
iajs-3342	179	6	increasing	increase	VERB
iajs-3342	179	7	variables	variable	NOUN
iajs-3342	179	8	are	be	AUX
iajs-3342	179	9	inflammatory	inflammatory	ADJ
iajs-3342	179	10	,	,	PUNCT
iajs-3342	179	11	while	while	SCONJ
iajs-3342	179	12	others	other	NOUN
iajs-3342	179	13	are	be	AUX
iajs-3342	179	14	not	not	PART
iajs-3342	179	15	[	[	X
iajs-3342	179	16	37	37	NUM
iajs-3342	179	17	]	]	PUNCT
iajs-3342	179	18	.	.	PUNCT
iajs-3342	180	1	another	another	DET
iajs-3342	180	2	crucial	crucial	ADJ
iajs-3342	180	3	inflammatory	inflammatory	ADJ
iajs-3342	180	4	component	component	NOUN
iajs-3342	180	5	of	of	ADP
iajs-3342	180	6	esr	esr	PROPN
iajs-3342	180	7	is	be	AUX
iajs-3342	180	8	anemia	anemia	NOUN
iajs-3342	180	9	.	.	PUNCT
iajs-3342	181	1	patients	patient	NOUN
iajs-3342	181	2	with	with	ADP
iajs-3342	181	3	active	active	ADJ
iajs-3342	181	4	lupus	lupus	NOUN
iajs-3342	181	5	often	often	ADV
iajs-3342	181	6	have	have	VERB
iajs-3342	181	7	low	low	ADJ
iajs-3342	181	8	amounts	amount	NOUN
iajs-3342	181	9	of	of	ADP
iajs-3342	181	10	hgb	hgb	PROPN
iajs-3342	181	11	and	and	CCONJ
iajs-3342	181	12	esr	esr	PROPN
iajs-3342	181	13	.	.	PUNCT
iajs-3342	182	1	this	this	PRON
iajs-3342	182	2	is	be	AUX
iajs-3342	182	3	seldom	seldom	ADV
iajs-3342	182	4	attributable	attributable	ADJ
iajs-3342	182	5	to	to	ADP
iajs-3342	182	6	hemolytic	hemolytic	ADJ
iajs-3342	182	7	anemia	anemia	NOUN
iajs-3342	182	8	despite	despite	SCONJ
iajs-3342	182	9	being	be	AUX
iajs-3342	182	10	a	a	DET
iajs-3342	182	11	common	common	ADJ
iajs-3342	182	12	symptom	symptom	NOUN
iajs-3342	182	13	of	of	ADP
iajs-3342	182	14	sle	sle	PROPN
iajs-3342	182	15	.	.	PUNCT
iajs-3342	183	1	hemolytic	hemolytic	ADJ
iajs-3342	183	2	anemia	anemia	NOUN
iajs-3342	183	3	,	,	PUNCT
iajs-3342	183	4	as	as	SCONJ
iajs-3342	183	5	was	be	AUX
iajs-3342	183	6	previously	previously	ADV
iajs-3342	183	7	indicated	indicate	VERB
iajs-3342	183	8	,	,	PUNCT
iajs-3342	183	9	would	would	AUX
iajs-3342	183	10	also	also	ADV
iajs-3342	183	11	fall	fall	VERB
iajs-3342	183	12	under	under	ADP
iajs-3342	183	13	the	the	DET
iajs-3342	183	14	category	category	NOUN
iajs-3342	183	15	of	of	ADP
iajs-3342	183	16	a	a	DET
iajs-3342	183	17	direct	direct	ADJ
iajs-3342	183	18	autoimmune	autoimmune	ADJ
iajs-3342	183	19	characteristic	characteristic	NOUN
iajs-3342	183	20	since	since	SCONJ
iajs-3342	183	21	it	it	PRON
iajs-3342	183	22	is	be	AUX
iajs-3342	183	23	brought	bring	VERB
iajs-3342	183	24	on	on	ADP
iajs-3342	183	25	by	by	ADP
iajs-3342	183	26	antibodies	antibody	NOUN
iajs-3342	183	27	to	to	ADP
iajs-3342	183	28	erythrocytes	erythrocyte	NOUN
iajs-3342	183	29	rather	rather	ADV
iajs-3342	183	30	than	than	ADP
iajs-3342	183	31	being	be	AUX
iajs-3342	183	32	a	a	DET
iajs-3342	183	33	sign	sign	NOUN
iajs-3342	183	34	of	of	ADP
iajs-3342	183	35	inflammation	inflammation	NOUN
iajs-3342	183	36	[	[	X
iajs-3342	183	37	38	38	NUM
iajs-3342	183	38	]	]	PUNCT
iajs-3342	183	39	.	.	PUNCT
iajs-3342	184	1	autoimmune	autoimmune	ADJ
iajs-3342	184	2	cytopenias	cytopenia	NOUN
iajs-3342	184	3	are	be	AUX
iajs-3342	184	4	frequent	frequent	ADJ
iajs-3342	184	5	in	in	ADP
iajs-3342	184	6	sle	sle	PROPN
iajs-3342	184	7	,	,	PUNCT
iajs-3342	184	8	as	as	SCONJ
iajs-3342	184	9	are	be	AUX
iajs-3342	184	10	hematological	hematological	ADJ
iajs-3342	184	11	diseases	disease	NOUN
iajs-3342	184	12	and	and	CCONJ
iajs-3342	184	13	new	new	ADJ
iajs-3342	184	14	haematologic	haematologic	ADJ
iajs-3342	184	15	abnormalities	abnormality	NOUN
iajs-3342	184	16	.	.	PUNCT
iajs-3342	185	1	patients	patient	NOUN
iajs-3342	185	2	ihjpas	ihjpa	VERB
iajs-3342	185	3	.	.	PUNCT
iajs-3342	186	1	2024	2024	NUM
iajs-3342	186	2	,	,	PUNCT
iajs-3342	186	3	37	37	NUM
iajs-3342	186	4	(	(	PUNCT
iajs-3342	186	5	3	3	NUM
iajs-3342	186	6	)	)	PUNCT
iajs-3342	186	7	318	318	NUM
iajs-3342	186	8	with	with	ADP
iajs-3342	186	9	sle	sle	PROPN
iajs-3342	186	10	may	may	AUX
iajs-3342	186	11	have	have	VERB
iajs-3342	186	12	immune	immune	ADJ
iajs-3342	186	13	thrombocytopenia	thrombocytopenia	NOUN
iajs-3342	186	14	and	and	CCONJ
iajs-3342	186	15	hemolytic	hemolytic	ADJ
iajs-3342	186	16	anemia	anemia	NOUN
iajs-3342	186	17	,	,	PUNCT
iajs-3342	186	18	both	both	PRON
iajs-3342	186	19	of	of	ADP
iajs-3342	186	20	which	which	PRON
iajs-3342	186	21	need	need	VERB
iajs-3342	186	22	immunosuppressive	immunosuppressive	ADJ
iajs-3342	186	23	treatment	treatment	NOUN
iajs-3342	186	24	.	.	PUNCT
iajs-3342	187	1	cytopenias	cytopenia	NOUN
iajs-3342	187	2	are	be	AUX
iajs-3342	187	3	widespread	widespread	ADJ
iajs-3342	187	4	throughout	throughout	ADP
iajs-3342	187	5	sle	sle	PROPN
iajs-3342	187	6	,	,	PUNCT
iajs-3342	187	7	and	and	CCONJ
iajs-3342	187	8	the	the	DET
iajs-3342	187	9	most	most	ADV
iajs-3342	187	10	common	common	ADJ
iajs-3342	187	11	causes	cause	NOUN
iajs-3342	187	12	include	include	VERB
iajs-3342	187	13	medications	medication	NOUN
iajs-3342	187	14	,	,	PUNCT
iajs-3342	187	15	infections	infection	NOUN
iajs-3342	187	16	,	,	PUNCT
iajs-3342	187	17	and	and	CCONJ
iajs-3342	187	18	immune	immune	NOUN
iajs-3342	187	19	-	-	PUNCT
iajs-3342	187	20	mediated	mediate	VERB
iajs-3342	187	21	disorders	disorder	NOUN
iajs-3342	187	22	.	.	PUNCT
iajs-3342	188	1	lymphopenia	lymphopenia	NOUN
iajs-3342	188	2	,	,	PUNCT
iajs-3342	188	3	which	which	PRON
iajs-3342	188	4	affected	affect	VERB
iajs-3342	188	5	40.3	40.3	NUM
iajs-3342	188	6	%	%	NOUN
iajs-3342	188	7	of	of	ADP
iajs-3342	188	8	patients	patient	NOUN
iajs-3342	188	9	,	,	PUNCT
iajs-3342	188	10	was	be	AUX
iajs-3342	188	11	the	the	DET
iajs-3342	188	12	most	most	ADV
iajs-3342	188	13	frequent	frequent	ADJ
iajs-3342	188	14	kind	kind	NOUN
iajs-3342	188	15	of	of	ADP
iajs-3342	188	16	white	white	ADJ
iajs-3342	188	17	cell	cell	NOUN
iajs-3342	188	18	abnormality	abnormality	NOUN
iajs-3342	188	19	,	,	PUNCT
iajs-3342	188	20	with	with	ADP
iajs-3342	188	21	leukopenia	leukopenia	PROPN
iajs-3342	188	22	affecting	affect	VERB
iajs-3342	188	23	almost	almost	ADV
iajs-3342	188	24	30	30	NUM
iajs-3342	188	25	%	%	NOUN
iajs-3342	188	26	of	of	ADP
iajs-3342	188	27	patients	patient	NOUN
iajs-3342	188	28	.	.	PUNCT
iajs-3342	189	1	only	only	ADV
iajs-3342	189	2	about	about	ADV
iajs-3342	189	3	11	11	NUM
iajs-3342	189	4	%	%	NOUN
iajs-3342	189	5	of	of	ADP
iajs-3342	189	6	current	current	ADJ
iajs-3342	189	7	patients	patient	NOUN
iajs-3342	189	8	had	have	VERB
iajs-3342	189	9	a	a	DET
iajs-3342	189	10	very	very	ADV
iajs-3342	189	11	uncommon	uncommon	ADJ
iajs-3342	189	12	incidence	incidence	NOUN
iajs-3342	189	13	of	of	ADP
iajs-3342	189	14	thrombocytopenia	thrombocytopenia	NOUN
iajs-3342	189	15	associated	associate	VERB
iajs-3342	189	16	with	with	ADP
iajs-3342	189	17	sle	sle	PROPN
iajs-3342	189	18	.	.	PUNCT
iajs-3342	190	1	in	in	ADP
iajs-3342	190	2	most	most	ADJ
iajs-3342	190	3	cases	case	NOUN
iajs-3342	190	4	,	,	PUNCT
iajs-3342	190	5	the	the	DET
iajs-3342	190	6	immune	immune	ADJ
iajs-3342	190	7	system	system	NOUN
iajs-3342	190	8	is	be	AUX
iajs-3342	190	9	to	to	PART
iajs-3342	190	10	blame	blame	VERB
iajs-3342	190	11	for	for	ADP
iajs-3342	190	12	irregularities	irregularity	NOUN
iajs-3342	190	13	in	in	ADP
iajs-3342	190	14	wbc	wbc	NOUN
iajs-3342	190	15	and	and	CCONJ
iajs-3342	190	16	thrombocytes	thrombocyte	NOUN
iajs-3342	190	17	because	because	SCONJ
iajs-3342	190	18	antibodies	antibody	NOUN
iajs-3342	190	19	kill	kill	VERB
iajs-3342	190	20	off	off	ADP
iajs-3342	190	21	the	the	DET
iajs-3342	190	22	cells	cell	NOUN
iajs-3342	190	23	that	that	PRON
iajs-3342	190	24	produce	produce	VERB
iajs-3342	190	25	them	they	PRON
iajs-3342	190	26	.	.	PUNCT
iajs-3342	191	1	patients	patient	NOUN
iajs-3342	191	2	with	with	ADP
iajs-3342	191	3	sle	sle	PROPN
iajs-3342	191	4	who	who	PRON
iajs-3342	191	5	had	have	VERB
iajs-3342	191	6	high	high	ADJ
iajs-3342	191	7	hematological	hematological	ADJ
iajs-3342	191	8	involvement	involvement	NOUN
iajs-3342	191	9	were	be	AUX
iajs-3342	191	10	also	also	ADV
iajs-3342	191	11	more	more	ADV
iajs-3342	191	12	likely	likely	ADJ
iajs-3342	191	13	to	to	PART
iajs-3342	191	14	have	have	VERB
iajs-3342	191	15	significant	significant	ADJ
iajs-3342	191	16	disease	disease	NOUN
iajs-3342	191	17	in	in	ADP
iajs-3342	191	18	the	the	DET
iajs-3342	191	19	renal	renal	ADJ
iajs-3342	191	20	,	,	PUNCT
iajs-3342	191	21	central	central	ADJ
iajs-3342	191	22	neurological	neurological	ADJ
iajs-3342	191	23	,	,	PUNCT
iajs-3342	191	24	and	and	CCONJ
iajs-3342	191	25	general	general	ADJ
iajs-3342	191	26	systems	system	NOUN
iajs-3342	191	27	but	but	CCONJ
iajs-3342	191	28	not	not	PART
iajs-3342	191	29	in	in	ADP
iajs-3342	191	30	the	the	DET
iajs-3342	191	31	other	other	ADJ
iajs-3342	191	32	systems	system	NOUN
iajs-3342	191	33	,	,	PUNCT
iajs-3342	191	34	according	accord	VERB
iajs-3342	191	35	to	to	ADP
iajs-3342	191	36	a	a	DET
iajs-3342	191	37	study	study	NOUN
iajs-3342	191	38	by	by	ADP
iajs-3342	191	39	sultan	sultan	PROPN
iajs-3342	191	40	the	the	DET
iajs-3342	191	41	majority	majority	NOUN
iajs-3342	191	42	of	of	ADP
iajs-3342	191	43	sle	sle	PROPN
iajs-3342	191	44	patients	patient	NOUN
iajs-3342	191	45	have	have	VERB
iajs-3342	191	46	hematological	hematological	ADJ
iajs-3342	191	47	abnormalities	abnormality	NOUN
iajs-3342	191	48	at	at	ADP
iajs-3342	191	49	the	the	DET
iajs-3342	191	50	time	time	NOUN
iajs-3342	191	51	of	of	ADP
iajs-3342	191	52	diagnosis	diagnosis	NOUN
iajs-3342	191	53	,	,	PUNCT
iajs-3342	191	54	and	and	CCONJ
iajs-3342	191	55	many	many	ADJ
iajs-3342	191	56	of	of	ADP
iajs-3342	191	57	these	these	DET
iajs-3342	191	58	patients	patient	NOUN
iajs-3342	191	59	continue	continue	VERB
iajs-3342	191	60	to	to	PART
iajs-3342	191	61	have	have	VERB
iajs-3342	191	62	abnormalities	abnormality	NOUN
iajs-3342	191	63	throughout	throughout	ADP
iajs-3342	191	64	their	their	PRON
iajs-3342	191	65	follow	follow	VERB
iajs-3342	191	66	-	-	PUNCT
iajs-3342	191	67	up	up	ADP
iajs-3342	191	68	care	care	NOUN
iajs-3342	191	69	for	for	ADP
iajs-3342	191	70	many	many	ADJ
iajs-3342	191	71	years	year	NOUN
iajs-3342	191	72	following	follow	VERB
iajs-3342	191	73	diagnosis	diagnosis	NOUN
iajs-3342	191	74	.	.	PUNCT
iajs-3342	192	1	with	with	ADP
iajs-3342	192	2	63	63	NUM
iajs-3342	192	3	%	%	NOUN
iajs-3342	192	4	of	of	ADP
iajs-3342	192	5	patients	patient	NOUN
iajs-3342	192	6	suffering	suffer	VERB
iajs-3342	192	7	from	from	ADP
iajs-3342	192	8	anemia	anemia	NOUN
iajs-3342	192	9	,	,	PUNCT
iajs-3342	192	10	it	it	PRON
iajs-3342	192	11	was	be	AUX
iajs-3342	192	12	the	the	DET
iajs-3342	192	13	most	most	ADV
iajs-3342	192	14	prevalent	prevalent	ADJ
iajs-3342	192	15	condition	condition	NOUN
iajs-3342	192	16	.	.	PUNCT
iajs-3342	193	1	anemia	anemia	NOUN
iajs-3342	193	2	in	in	ADP
iajs-3342	193	3	sle	sle	PROPN
iajs-3342	193	4	may	may	AUX
iajs-3342	193	5	have	have	VERB
iajs-3342	193	6	a	a	DET
iajs-3342	193	7	variety	variety	NOUN
iajs-3342	193	8	of	of	ADP
iajs-3342	193	9	reasons	reason	NOUN
iajs-3342	193	10	,	,	PUNCT
iajs-3342	193	11	both	both	CCONJ
iajs-3342	193	12	immunological	immunological	ADJ
iajs-3342	193	13	and	and	CCONJ
iajs-3342	193	14	non	non	ADJ
iajs-3342	193	15	-	-	ADJ
iajs-3342	193	16	immune	immune	ADJ
iajs-3342	193	17	.	.	PUNCT
iajs-3342	194	1	the	the	DET
iajs-3342	194	2	abnormalities	abnormality	NOUN
iajs-3342	194	3	,	,	PUNCT
iajs-3342	194	4	such	such	ADJ
iajs-3342	194	5	as	as	ADP
iajs-3342	194	6	anemia	anemia	NOUN
iajs-3342	194	7	,	,	PUNCT
iajs-3342	194	8	leukopenia	leukopenia	NOUN
iajs-3342	194	9	,	,	PUNCT
iajs-3342	194	10	and	and	CCONJ
iajs-3342	194	11	thrombocytopenia	thrombocytopenia	PROPN
iajs-3342	194	12	,	,	PUNCT
iajs-3342	194	13	are	be	AUX
iajs-3342	194	14	linked	link	VERB
iajs-3342	194	15	to	to	ADP
iajs-3342	194	16	specific	specific	ADJ
iajs-3342	194	17	illness	illness	NOUN
iajs-3342	194	18	symptoms	symptom	NOUN
iajs-3342	194	19	and	and	CCONJ
iajs-3342	194	20	organ	organ	NOUN
iajs-3342	194	21	involvement	involvement	NOUN
iajs-3342	194	22	.	.	PUNCT
iajs-3342	195	1	this	this	DET
iajs-3342	195	2	knowledge	knowledge	NOUN
iajs-3342	195	3	might	might	AUX
iajs-3342	195	4	improve	improve	VERB
iajs-3342	195	5	the	the	DET
iajs-3342	195	6	management	management	NOUN
iajs-3342	195	7	strategy	strategy	NOUN
iajs-3342	195	8	for	for	ADP
iajs-3342	195	9	patients	patient	NOUN
iajs-3342	195	10	with	with	ADP
iajs-3342	195	11	sle	sle	PROPN
iajs-3342	195	12	[	[	X
iajs-3342	195	13	39	39	NUM
iajs-3342	195	14	]	]	PUNCT
iajs-3342	195	15	.	.	PUNCT
iajs-3342	196	1	5	5	X
iajs-3342	196	2	.	.	X
iajs-3342	196	3	conclusions	conclusion	NOUN
iajs-3342	196	4	compared	compare	VERB
iajs-3342	196	5	to	to	ADP
iajs-3342	196	6	prior	prior	ADJ
iajs-3342	196	7	studies	study	NOUN
iajs-3342	196	8	,	,	PUNCT
iajs-3342	196	9	this	this	PRON
iajs-3342	196	10	is	be	AUX
iajs-3342	196	11	the	the	DET
iajs-3342	196	12	first	first	ADJ
iajs-3342	196	13	study	study	NOUN
iajs-3342	196	14	to	to	PART
iajs-3342	196	15	investigate	investigate	VERB
iajs-3342	196	16	the	the	DET
iajs-3342	196	17	relationship	relationship	NOUN
iajs-3342	196	18	between	between	ADP
iajs-3342	196	19	ngf	ngf	NOUN
iajs-3342	196	20	and	and	CCONJ
iajs-3342	196	21	vit	vit	NOUN
iajs-3342	196	22	.	.	PUNCT
iajs-3342	197	1	b12	b12	NOUN
iajs-3342	197	2	in	in	ADP
iajs-3342	197	3	patients	patient	NOUN
iajs-3342	197	4	with	with	ADP
iajs-3342	197	5	sle	sle	PROPN
iajs-3342	197	6	.	.	PUNCT
iajs-3342	198	1	the	the	DET
iajs-3342	198	2	present	present	ADJ
iajs-3342	198	3	results	result	NOUN
iajs-3342	198	4	found	find	VERB
iajs-3342	198	5	that	that	SCONJ
iajs-3342	198	6	serum	serum	VERB
iajs-3342	198	7	ngf	ngf	PROPN
iajs-3342	198	8	levels	level	NOUN
iajs-3342	198	9	in	in	ADP
iajs-3342	198	10	sle	sle	PROPN
iajs-3342	198	11	patients	patient	NOUN
iajs-3342	198	12	were	be	AUX
iajs-3342	198	13	considerably	considerably	ADV
iajs-3342	198	14	increased	increase	VERB
iajs-3342	198	15	with	with	ADP
iajs-3342	198	16	the	the	DET
iajs-3342	198	17	length	length	NOUN
iajs-3342	198	18	of	of	ADP
iajs-3342	198	19	disease	disease	NOUN
iajs-3342	198	20	duration	duration	NOUN
iajs-3342	198	21	.	.	PUNCT
iajs-3342	199	1	therefore	therefore	ADV
iajs-3342	199	2	,	,	PUNCT
iajs-3342	199	3	ngf	ngf	ADV
iajs-3342	199	4	may	may	AUX
iajs-3342	199	5	be	be	AUX
iajs-3342	199	6	a	a	DET
iajs-3342	199	7	diagnostic	diagnostic	ADJ
iajs-3342	199	8	and	and	CCONJ
iajs-3342	199	9	follow	follow	VERB
iajs-3342	199	10	-	-	PUNCT
iajs-3342	199	11	up	up	NOUN
iajs-3342	199	12	marker	marker	NOUN
iajs-3342	199	13	of	of	ADP
iajs-3342	199	14	the	the	DET
iajs-3342	199	15	development	development	NOUN
iajs-3342	199	16	of	of	ADP
iajs-3342	199	17	the	the	DET
iajs-3342	199	18	disease	disease	NOUN
iajs-3342	199	19	.	.	PUNCT
iajs-3342	200	1	in	in	ADP
iajs-3342	200	2	addition	addition	NOUN
iajs-3342	200	3	,	,	PUNCT
iajs-3342	200	4	the	the	DET
iajs-3342	200	5	significant	significant	ADJ
iajs-3342	200	6	negative	negative	ADJ
iajs-3342	200	7	correlation	correlation	NOUN
iajs-3342	200	8	between	between	ADP
iajs-3342	200	9	ngf	ngf	NOUN
iajs-3342	200	10	and	and	CCONJ
iajs-3342	200	11	vit	vit	NOUN
iajs-3342	200	12	.	.	PUNCT
iajs-3342	201	1	b12	b12	NOUN
iajs-3342	201	2	indicates	indicate	VERB
iajs-3342	201	3	that	that	SCONJ
iajs-3342	201	4	sle	sle	PROPN
iajs-3342	201	5	patients	patient	NOUN
iajs-3342	201	6	may	may	AUX
iajs-3342	201	7	be	be	AUX
iajs-3342	201	8	prone	prone	ADJ
iajs-3342	201	9	to	to	ADP
iajs-3342	201	10	nerve	nerve	NOUN
iajs-3342	201	11	damage	damage	NOUN
iajs-3342	201	12	,	,	PUNCT
iajs-3342	201	13	and	and	CCONJ
iajs-3342	201	14	ngf	ngf	ADV
iajs-3342	201	15	may	may	AUX
iajs-3342	201	16	be	be	AUX
iajs-3342	201	17	a	a	DET
iajs-3342	201	18	predictive	predictive	ADJ
iajs-3342	201	19	biochemical	biochemical	ADJ
iajs-3342	201	20	marker	marker	NOUN
iajs-3342	201	21	for	for	ADP
iajs-3342	201	22	the	the	DET
iajs-3342	201	23	development	development	NOUN
iajs-3342	201	24	of	of	ADP
iajs-3342	201	25	nerve	nerve	NOUN
iajs-3342	201	26	damage	damage	NOUN
iajs-3342	201	27	in	in	ADP
iajs-3342	201	28	sle	sle	PROPN
iajs-3342	201	29	patients	patient	NOUN
iajs-3342	201	30	.	.	PUNCT
iajs-3342	202	1	the	the	DET
iajs-3342	202	2	roc	roc	PROPN
iajs-3342	202	3	test	test	NOUN
iajs-3342	202	4	for	for	ADP
iajs-3342	202	5	the	the	DET
iajs-3342	202	6	ngf	ngf	ADJ
iajs-3342	202	7	marker	marker	NOUN
iajs-3342	202	8	in	in	ADP
iajs-3342	202	9	sle	sle	PROPN
iajs-3342	202	10	patients	patient	NOUN
iajs-3342	202	11	and	and	CCONJ
iajs-3342	202	12	control	control	NOUN
iajs-3342	202	13	groups	group	NOUN
iajs-3342	202	14	showed	show	VERB
iajs-3342	202	15	a	a	DET
iajs-3342	202	16	perfect	perfect	ADJ
iajs-3342	202	17	cutoff	cutoff	NOUN
iajs-3342	202	18	value	value	NOUN
iajs-3342	202	19	with	with	ADP
iajs-3342	202	20	99	99	NUM
iajs-3342	202	21	%	%	NOUN
iajs-3342	202	22	sensitivity	sensitivity	NOUN
iajs-3342	202	23	and	and	CCONJ
iajs-3342	202	24	100	100	NUM
iajs-3342	202	25	%	%	NOUN
iajs-3342	202	26	specificity	specificity	NOUN
iajs-3342	202	27	,	,	PUNCT
iajs-3342	202	28	which	which	PRON
iajs-3342	202	29	indicates	indicate	VERB
iajs-3342	202	30	it	it	PRON
iajs-3342	202	31	is	be	AUX
iajs-3342	202	32	considered	consider	VERB
iajs-3342	202	33	a	a	DET
iajs-3342	202	34	good	good	ADJ
iajs-3342	202	35	diagnostic	diagnostic	ADJ
iajs-3342	202	36	marker	marker	NOUN
iajs-3342	202	37	for	for	ADP
iajs-3342	202	38	sle	sle	PROPN
iajs-3342	202	39	patients	patient	NOUN
iajs-3342	202	40	.	.	PUNCT
iajs-3342	203	1	acknowledgment	acknowledgment	NOUN
iajs-3342	203	2	the	the	DET
iajs-3342	203	3	authors	author	NOUN
iajs-3342	203	4	thank	thank	VERB
iajs-3342	203	5	the	the	DET
iajs-3342	203	6	sle	sle	PROPN
iajs-3342	203	7	patients	patient	NOUN
iajs-3342	203	8	who	who	PRON
iajs-3342	203	9	agreed	agree	VERB
iajs-3342	203	10	to	to	PART
iajs-3342	203	11	participate	participate	VERB
iajs-3342	203	12	in	in	ADP
iajs-3342	203	13	the	the	DET
iajs-3342	203	14	current	current	ADJ
iajs-3342	203	15	study	study	NOUN
iajs-3342	203	16	and	and	CCONJ
iajs-3342	203	17	generously	generously	ADV
iajs-3342	203	18	donated	donate	VERB
iajs-3342	203	19	their	their	PRON
iajs-3342	203	20	blood	blood	NOUN
iajs-3342	203	21	,	,	PUNCT
iajs-3342	203	22	and	and	CCONJ
iajs-3342	203	23	many	many	ADJ
iajs-3342	203	24	thanks	thank	NOUN
iajs-3342	203	25	to	to	ADP
iajs-3342	203	26	the	the	DET
iajs-3342	203	27	department	department	NOUN
iajs-3342	203	28	of	of	ADP
iajs-3342	203	29	chemistry	chemistry	NOUN
iajs-3342	203	30	,	,	PUNCT
iajs-3342	203	31	college	college	NOUN
iajs-3342	203	32	of	of	ADP
iajs-3342	203	33	education	education	NOUN
iajs-3342	203	34	for	for	ADP
iajs-3342	203	35	pure	pure	ADJ
iajs-3342	203	36	sciences	science	NOUN
iajs-3342	203	37	(	(	PUNCT
iajs-3342	203	38	ibn	ibn	PROPN
iajs-3342	203	39	al	al	PROPN
iajs-3342	203	40	-	-	PUNCT
iajs-3342	203	41	haitham	haitham	PROPN
iajs-3342	203	42	)	)	PUNCT
iajs-3342	203	43	,	,	PUNCT
iajs-3342	203	44	university	university	NOUN
iajs-3342	203	45	of	of	ADP
iajs-3342	203	46	baghdad	baghdad	PROPN
iajs-3342	203	47	,	,	PUNCT
iajs-3342	203	48	for	for	ADP
iajs-3342	203	49	facilitating	facilitate	VERB
iajs-3342	203	50	the	the	DET
iajs-3342	203	51	work	work	NOUN
iajs-3342	203	52	of	of	ADP
iajs-3342	203	53	the	the	DET
iajs-3342	203	54	practice	practice	NOUN
iajs-3342	203	55	in	in	ADP
iajs-3342	203	56	this	this	DET
iajs-3342	203	57	article	article	NOUN
iajs-3342	203	58	.	.	PUNCT
iajs-3342	204	1	conflict	conflict	NOUN
iajs-3342	204	2	of	of	ADP
iajs-3342	204	3	interest	interest	NOUN
iajs-3342	204	4	the	the	DET
iajs-3342	204	5	authors	author	NOUN
iajs-3342	204	6	declare	declare	VERB
iajs-3342	204	7	that	that	SCONJ
iajs-3342	204	8	they	they	PRON
iajs-3342	204	9	have	have	VERB
iajs-3342	204	10	no	no	DET
iajs-3342	204	11	conflicts	conflict	NOUN
iajs-3342	204	12	of	of	ADP
iajs-3342	204	13	interes	intere	NOUN
iajs-3342	204	14	.	.	PUNCT
iajs-3342	205	1	funding	fund	VERB
iajs-3342	205	2	there	there	PRON
iajs-3342	205	3	is	be	VERB
iajs-3342	205	4	no	no	DET
iajs-3342	205	5	financial	financial	ADJ
iajs-3342	205	6	support	support	NOUN
iajs-3342	205	7	.	.	PUNCT
iajs-3342	206	1	ethical	ethical	ADJ
iajs-3342	206	2	clearance	clearance	NOUN
iajs-3342	206	3	the	the	DET
iajs-3342	206	4	samples	sample	NOUN
iajs-3342	206	5	were	be	AUX
iajs-3342	206	6	gained	gain	VERB
iajs-3342	206	7	according	accord	VERB
iajs-3342	206	8	to	to	ADP
iajs-3342	206	9	local	local	ADJ
iajs-3342	206	10	research	research	NOUN
iajs-3342	206	11	ethics	ethic	NOUN
iajs-3342	206	12	committee	committee	PROPN
iajs-3342	206	13	approval	approval	NOUN
iajs-3342	206	14	in	in	ADP
iajs-3342	206	15	iraqi	iraqi	ADJ
iajs-3342	206	16	ministry	ministry	PROPN
iajs-3342	206	17	of	of	ADP
iajs-3342	206	18	health	health	PROPN
iajs-3342	206	19	no.37755	no.37755	PROPN
iajs-3342	206	20	11\9	11\9	NUM
iajs-3342	206	21	\2022	\2022	NOUN
iajs-3342	206	22	.	.	PUNCT
iajs-3342	207	1	ihjpas	ihjpas	PROPN
iajs-3342	207	2	.	.	PUNCT
iajs-3342	208	1	2024	2024	NUM
iajs-3342	208	2	,	,	PUNCT
iajs-3342	208	3	37	37	NUM
iajs-3342	208	4	(	(	PUNCT
iajs-3342	208	5	3	3	NUM
iajs-3342	208	6	)	)	PUNCT
iajs-3342	208	7	319	319	NUM
iajs-3342	208	8	references	reference	NOUN
iajs-3342	208	9	1	1	NUM
iajs-3342	208	10	.	.	PUNCT
iajs-3342	209	1	kwaben	kwaben	PROPN
iajs-3342	209	2	,	,	PUNCT
iajs-3342	209	3	v.b	v.b	PROPN
iajs-3342	209	4	.	.	PROPN
iajs-3342	209	5	etiological	etiological	ADJ
iajs-3342	209	6	components	component	NOUN
iajs-3342	209	7	and	and	CCONJ
iajs-3342	209	8	patterns	pattern	NOUN
iajs-3342	209	9	contributing	contribute	VERB
iajs-3342	209	10	to	to	ADP
iajs-3342	209	11	the	the	DET
iajs-3342	209	12	development	development	NOUN
iajs-3342	209	13	of	of	ADP
iajs-3342	209	14	systemic	systemic	ADJ
iajs-3342	209	15	lupus	lupus	NOUN
iajs-3342	209	16	erythematosus	erythematosus	NOUN
iajs-3342	209	17	2020	2020	NUM
iajs-3342	209	18	.	.	PUNCT
iajs-3342	210	1	huskiecommons.lib.niu.edu	huskiecommons.lib.niu.edu	PROPN
iajs-3342	210	2	2	2	NUM
iajs-3342	210	3	.	.	PUNCT
iajs-3342	210	4	sirikonda	sirikonda	ADJ
iajs-3342	210	5	,	,	PUNCT
iajs-3342	210	6	a.	a.	NOUN
iajs-3342	210	7	;	;	PUNCT
iajs-3342	210	8	kolli	kolli	PROPN
iajs-3342	210	9	,	,	PUNCT
iajs-3342	210	10	m.	m.	NOUN
iajs-3342	210	11	;	;	PUNCT
iajs-3342	210	12	rao	rao	PROPN
iajs-3342	210	13	,	,	PUNCT
iajs-3342	210	14	m.r	m.r	PROPN
iajs-3342	210	15	.	.	PROPN
iajs-3342	210	16	;	;	PUNCT
iajs-3342	211	1	srujana	srujana	PROPN
iajs-3342	211	2	,	,	PUNCT
iajs-3342	211	3	s.	s.	PROPN
iajs-3342	211	4	a	a	DET
iajs-3342	211	5	study	study	NOUN
iajs-3342	211	6	of	of	ADP
iajs-3342	211	7	clinical	clinical	ADJ
iajs-3342	211	8	profile	profile	NOUN
iajs-3342	211	9	and	and	CCONJ
iajs-3342	211	10	assessment	assessment	NOUN
iajs-3342	211	11	of	of	ADP
iajs-3342	211	12	disease	disease	NOUN
iajs-3342	211	13	activity	activity	NOUN
iajs-3342	211	14	in	in	ADP
iajs-3342	211	15	systemic	systemic	ADJ
iajs-3342	211	16	lupus	lupus	NOUN
iajs-3342	211	17	erythematosus	erythematosus	PROPN
iajs-3342	211	18	patients	patient	NOUN
iajs-3342	211	19	.	.	PUNCT
iajs-3342	212	1	international	international	ADJ
iajs-3342	212	2	archives	archive	NOUN
iajs-3342	212	3	of	of	ADP
iajs-3342	212	4	integrated	integrate	VERB
iajs-3342	212	5	medicine	medicine	NOUN
iajs-3342	212	6	.	.	PUNCT
iajs-3342	213	1	2019	2019	NUM
iajs-3342	213	2	,	,	PUNCT
iajs-3342	213	3	6(10	6(10	NUM
iajs-3342	213	4	)	)	PUNCT
iajs-3342	213	5	,	,	PUNCT
iajs-3342	213	6	22	22	NUM
iajs-3342	213	7	-	-	SYM
iajs-3342	213	8	27	27	NUM
iajs-3342	213	9	.	.	PUNCT
iajs-3342	214	1	3	3	X
iajs-3342	214	2	.	.	X
iajs-3342	214	3	fanouriakis	fanouriaki	NOUN
iajs-3342	214	4	,	,	PUNCT
iajs-3342	214	5	a.	a.	NOUN
iajs-3342	214	6	;	;	PUNCT
iajs-3342	214	7	tziolos	tziolo	NOUN
iajs-3342	214	8	,	,	PUNCT
iajs-3342	214	9	n.	n.	NOUN
iajs-3342	214	10	;	;	PUNCT
iajs-3342	214	11	bertsias	bertsias	PROPN
iajs-3342	214	12	,	,	PUNCT
iajs-3342	214	13	g.	g.	PROPN
iajs-3342	214	14	;	;	PUNCT
iajs-3342	214	15	boumpas	boumpas	PROPN
iajs-3342	214	16	,	,	PUNCT
iajs-3342	214	17	d.t	d.t	PROPN
iajs-3342	214	18	.	.	PROPN
iajs-3342	214	19	update	update	NOUN
iajs-3342	214	20	on	on	ADP
iajs-3342	214	21	the	the	DET
iajs-3342	214	22	diagnosis	diagnosis	NOUN
iajs-3342	214	23	and	and	CCONJ
iajs-3342	214	24	management	management	NOUN
iajs-3342	214	25	of	of	ADP
iajs-3342	214	26	systemic	systemic	ADJ
iajs-3342	214	27	lupus	lupus	PROPN
iajs-3342	214	28	erythematosus	erythematosus	PROPN
iajs-3342	214	29	.	.	PUNCT
iajs-3342	215	1	annals	annal	NOUN
iajs-3342	215	2	of	of	ADP
iajs-3342	215	3	the	the	DET
iajs-3342	215	4	rheumatic	rheumatic	ADJ
iajs-3342	215	5	diseases	disease	NOUN
iajs-3342	215	6	.	.	PUNCT
iajs-3342	215	7	2021	2021	NUM
iajs-3342	215	8	,	,	PUNCT
iajs-3342	215	9	(	(	PUNCT
iajs-3342	215	10	80	80	NUM
iajs-3342	215	11	)	)	PUNCT
iajs-3342	215	12	,	,	PUNCT
iajs-3342	215	13	14	14	NUM
iajs-3342	215	14	–	–	SYM
iajs-3342	215	15	25	25	NUM
iajs-3342	215	16	.	.	PUNCT
iajs-3342	216	1	https://doi.org/10.1136/annrheumdis-2020-218272	https://doi.org/10.1136/annrheumdis-2020-218272	PROPN
iajs-3342	216	2	.	.	PROPN
iajs-3342	217	1	4	4	NUM
iajs-3342	217	2	.	.	X
iajs-3342	218	1	al	al	PROPN
iajs-3342	218	2	-	-	PUNCT
iajs-3342	218	3	hammamy	hammamy	PROPN
iajs-3342	218	4	,	,	PUNCT
iajs-3342	218	5	h.r	h.r	PROPN
iajs-3342	218	6	.	.	PROPN
iajs-3342	218	7	;	;	PUNCT
iajs-3342	218	8	abd	abd	PROPN
iajs-3342	218	9	,	,	PUNCT
iajs-3342	218	10	k.h	k.h	PROPN
iajs-3342	218	11	.	.	PROPN
iajs-3342	218	12	;	;	PUNCT
iajs-3342	218	13	khalil	khalil	PROPN
iajs-3342	218	14	,	,	PUNCT
iajs-3342	218	15	i.a	i.a	PROPN
iajs-3342	218	16	.	.	PROPN
iajs-3342	218	17	;	;	PUNCT
iajs-3342	218	18	mahdi	mahdi	PROPN
iajs-3342	218	19	,	,	PUNCT
iajs-3342	218	20	b.m	b.m	PROPN
iajs-3342	218	21	.	.	PROPN
iajs-3342	218	22	human	human	ADJ
iajs-3342	218	23	leukocyte	leukocyte	NOUN
iajs-3342	218	24	antigens	antigen	NOUN
iajs-3342	218	25	assosiation	assosiation	NOUN
iajs-3342	218	26	with	with	ADP
iajs-3342	218	27	systemic	systemic	ADJ
iajs-3342	218	28	lupus	lupus	NOUN
iajs-3342	218	29	arythematosus	arythematosus	NOUN
iajs-3342	218	30	in	in	ADP
iajs-3342	218	31	iraqi	iraqi	ADJ
iajs-3342	218	32	patients	patient	NOUN
iajs-3342	218	33	.	.	PUNCT
iajs-3342	219	1	al	al	PROPN
iajs-3342	219	2	-	-	PUNCT
iajs-3342	219	3	kindy	kindy	PROPN
iajs-3342	219	4	college	college	PROPN
iajs-3342	219	5	medical	medical	ADJ
iajs-3342	219	6	journal	journal	PROPN
iajs-3342	219	7	.	.	PUNCT
iajs-3342	220	1	2012	2012	NUM
iajs-3342	220	2	,	,	PUNCT
iajs-3342	220	3	8(2	8(2	NUM
iajs-3342	220	4	)	)	PUNCT
iajs-3342	220	5	,	,	PUNCT
iajs-3342	220	6	84–88	84–88	NUM
iajs-3342	220	7	.	.	PUNCT
iajs-3342	221	1	5	5	NUM
iajs-3342	221	2	.	.	PUNCT
iajs-3342	222	1	mcmurray	mcmurray	PROPN
iajs-3342	222	2	,	,	PUNCT
iajs-3342	222	3	r.w	r.w	PROPN
iajs-3342	222	4	.	.	PROPN
iajs-3342	222	5	;	;	PUNCT
iajs-3342	222	6	may	may	AUX
iajs-3342	222	7	,	,	PUNCT
iajs-3342	222	8	w.	w.	NOUN
iajs-3342	222	9	sex	sex	NOUN
iajs-3342	222	10	hormones	hormone	NOUN
iajs-3342	222	11	and	and	CCONJ
iajs-3342	222	12	systemic	systemic	ADJ
iajs-3342	222	13	lupus	lupus	PROPN
iajs-3342	222	14	erythematosus	erythematosus	NOUN
iajs-3342	222	15	:	:	PUNCT
iajs-3342	222	16	review	review	NOUN
iajs-3342	222	17	and	and	CCONJ
iajs-3342	222	18	metaanalysis	metaanalysis	NOUN
iajs-3342	222	19	.	.	PUNCT
iajs-3342	223	1	arthritis	arthritis	NOUN
iajs-3342	223	2	&	&	CCONJ
iajs-3342	223	3	rheumatism	rheumatism	NOUN
iajs-3342	223	4	:	:	PUNCT
iajs-3342	223	5	official	official	ADJ
iajs-3342	223	6	journal	journal	NOUN
iajs-3342	223	7	of	of	ADP
iajs-3342	223	8	the	the	DET
iajs-3342	223	9	american	american	PROPN
iajs-3342	223	10	college	college	PROPN
iajs-3342	223	11	of	of	ADP
iajs-3342	223	12	rheumatology	rheumatology	NOUN
iajs-3342	223	13	.	.	PUNCT
iajs-3342	224	1	2003	2003	NUM
iajs-3342	224	2	,	,	PUNCT
iajs-3342	224	3	48	48	NUM
iajs-3342	224	4	,	,	PUNCT
iajs-3342	224	5	2100–2110	2100–2110	NUM
iajs-3342	224	6	.	.	PUNCT
iajs-3342	225	1	https://doi.org/10.1002/art.11105	https://doi.org/10.1002/art.11105	NOUN
iajs-3342	225	2	.	.	PUNCT
iajs-3342	226	1	6	6	X
iajs-3342	226	2	.	.	X
iajs-3342	226	3	gergianaki	gergianaki	PROPN
iajs-3342	226	4	,	,	PUNCT
iajs-3342	226	5	i.	i.	NOUN
iajs-3342	226	6	;	;	PUNCT
iajs-3342	226	7	fanouriakis	fanouriakis	PROPN
iajs-3342	226	8	,	,	PUNCT
iajs-3342	226	9	a.	a.	NOUN
iajs-3342	226	10	;	;	PUNCT
iajs-3342	226	11	repa	repa	PROPN
iajs-3342	226	12	,	,	PUNCT
iajs-3342	226	13	a.	a.	NOUN
iajs-3342	226	14	;	;	PUNCT
iajs-3342	226	15	tzanakakis	tzanakakis	NOUN
iajs-3342	226	16	,	,	PUNCT
iajs-3342	226	17	m.	m.	NOUN
iajs-3342	226	18	;	;	PUNCT
iajs-3342	226	19	adamichou	adamichou	NOUN
iajs-3342	226	20	,	,	PUNCT
iajs-3342	226	21	c.	c.	PROPN
iajs-3342	226	22	;	;	PUNCT
iajs-3342	226	23	pompieri	pompieri	PROPN
iajs-3342	226	24	,	,	PUNCT
iajs-3342	226	25	a.	a.	NOUN
iajs-3342	226	26	;	;	PUNCT
iajs-3342	226	27	spirou	spirou	NOUN
iajs-3342	226	28	,	,	PUNCT
iajs-3342	226	29	g.	g.	PROPN
iajs-3342	226	30	;	;	PUNCT
iajs-3342	226	31	bertsias	bertsias	PROPN
iajs-3342	226	32	,	,	PUNCT
iajs-3342	226	33	a.	a.	NOUN
iajs-3342	226	34	;	;	PUNCT
iajs-3342	226	35	kabouraki	kabouraki	PROPN
iajs-3342	226	36	,	,	PUNCT
iajs-3342	226	37	e.	e.	PROPN
iajs-3342	226	38	;	;	PUNCT
iajs-3342	226	39	tzanakis	tzanakis	PROPN
iajs-3342	226	40	,	,	PUNCT
iajs-3342	226	41	i.	i.	NOUN
iajs-3342	226	42	epidemiology	epidemiology	NOUN
iajs-3342	226	43	and	and	CCONJ
iajs-3342	226	44	burden	burden	NOUN
iajs-3342	226	45	of	of	ADP
iajs-3342	226	46	systemic	systemic	ADJ
iajs-3342	226	47	lupus	lupus	NOUN
iajs-3342	226	48	erythematosus	erythematosus	NOUN
iajs-3342	226	49	in	in	ADP
iajs-3342	226	50	a	a	DET
iajs-3342	226	51	southern	southern	ADJ
iajs-3342	226	52	european	european	ADJ
iajs-3342	226	53	population	population	NOUN
iajs-3342	226	54	:	:	PUNCT
iajs-3342	226	55	data	datum	NOUN
iajs-3342	226	56	from	from	ADP
iajs-3342	226	57	the	the	DET
iajs-3342	226	58	community	community	NOUN
iajs-3342	226	59	-	-	PUNCT
iajs-3342	226	60	based	base	VERB
iajs-3342	226	61	lupus	lupus	ADJ
iajs-3342	226	62	registry	registry	NOUN
iajs-3342	226	63	of	of	ADP
iajs-3342	226	64	crete	crete	PROPN
iajs-3342	226	65	,	,	PUNCT
iajs-3342	226	66	greece	greece	PROPN
iajs-3342	226	67	.	.	PUNCT
iajs-3342	227	1	annals	annal	NOUN
iajs-3342	227	2	of	of	ADP
iajs-3342	227	3	the	the	DET
iajs-3342	227	4	rheumatic	rheumatic	ADJ
iajs-3342	227	5	diseases	disease	NOUN
iajs-3342	227	6	.	.	PUNCT
iajs-3342	228	1	2017	2017	NUM
iajs-3342	228	2	,	,	PUNCT
iajs-3342	228	3	76(12	76(12	NUM
iajs-3342	228	4	)	)	PUNCT
iajs-3342	228	5	,	,	PUNCT
iajs-3342	228	6	1992–2000	1992–2000	NUM
iajs-3342	228	7	.	.	PUNCT
iajs-3342	229	1	https://doi.org/10.1136/annrheumdis-2017-211206	https://doi.org/10.1136/annrheumdis-2017-211206	NOUN
iajs-3342	229	2	.	.	PUNCT
iajs-3342	230	1	7	7	X
iajs-3342	230	2	.	.	X
iajs-3342	230	3	dahham	dahham	PROPN
iajs-3342	230	4	,	,	PUNCT
iajs-3342	230	5	z.m	z.m	PROPN
iajs-3342	230	6	.	.	PROPN
iajs-3342	230	7	;	;	PUNCT
iajs-3342	230	8	haddad	haddad	PROPN
iajs-3342	230	9	,	,	PUNCT
iajs-3342	230	10	n.i.a	n.i.a	NOUN
iajs-3342	230	11	.	.	PUNCT
iajs-3342	231	1	circulating	circulate	VERB
iajs-3342	231	2	levels	level	NOUN
iajs-3342	231	3	of	of	ADP
iajs-3342	231	4	interferon	interferon	ADJ
iajs-3342	231	5	regulatory	regulatory	ADJ
iajs-3342	231	6	factor-5	factor-5	NUM
iajs-3342	231	7	correlates	correlate	VERB
iajs-3342	231	8	with	with	ADP
iajs-3342	231	9	disease	disease	NOUN
iajs-3342	231	10	activity	activity	NOUN
iajs-3342	231	11	in	in	ADP
iajs-3342	231	12	systemic	systemic	ADJ
iajs-3342	231	13	lupus	lupus	PROPN
iajs-3342	231	14	erythematosus	erythematosus	PROPN
iajs-3342	231	15	iraqi	iraqi	ADJ
iajs-3342	231	16	patients	patient	NOUN
iajs-3342	231	17	.	.	PUNCT
iajs-3342	232	1	journal	journal	PROPN
iajs-3342	232	2	of	of	ADP
iajs-3342	232	3	contemporary	contemporary	PROPN
iajs-3342	232	4	medical	medical	ADJ
iajs-3342	232	5	sciences	science	NOUN
iajs-3342	232	6	.	.	PUNCT
iajs-3342	232	7	2022	2022	NUM
iajs-3342	232	8	,	,	PUNCT
iajs-3342	232	9	8(6	8(6	NUM
iajs-3342	232	10	)	)	PUNCT
iajs-3342	232	11	,	,	PUNCT
iajs-3342	232	12	388–394	388–394	NUM
iajs-3342	232	13	..	..	SYM
iajs-3342	232	14	8	8	NUM
iajs-3342	232	15	.	.	X
iajs-3342	233	1	barcia	barcia	PROPN
iajs-3342	233	2	-	-	PUNCT
iajs-3342	233	3	sixto	sixto	PROPN
iajs-3342	233	4	,	,	PUNCT
iajs-3342	233	5	l.	l.	PROPN
iajs-3342	233	6	;	;	PUNCT
iajs-3342	233	7	isenberg	isenberg	PROPN
iajs-3342	233	8	,	,	PUNCT
iajs-3342	233	9	d.	d.	PROPN
iajs-3342	233	10	systemic	systemic	PROPN
iajs-3342	233	11	lupus	lupus	PROPN
iajs-3342	233	12	erythematosus	erythematosus	PROPN
iajs-3342	233	13	:	:	PUNCT
iajs-3342	233	14	causes	cause	NOUN
iajs-3342	233	15	and	and	CCONJ
iajs-3342	233	16	manifestations	manifestation	NOUN
iajs-3342	233	17	.	.	PUNCT
iajs-3342	234	1	trends	trend	NOUN
iajs-3342	234	2	urol	urol	PROPN
iajs-3342	234	3	.	.	PUNCT
iajs-3342	235	1	men	man	NOUN
iajs-3342	235	2	’s	’s	PART
iajs-3342	235	3	heal	heal	NOUN
iajs-3342	235	4	2020	2020	NUM
iajs-3342	235	5	,	,	PUNCT
iajs-3342	235	6	11	11	NUM
iajs-3342	235	7	,	,	PUNCT
iajs-3342	235	8	26–29	26–29	NOUN
iajs-3342	235	9	.	.	PUNCT
iajs-3342	236	1	https://doi.org/10.1002/tre.732	https://doi.org/10.1002/tre.732	NOUN
iajs-3342	236	2	.	.	NOUN
iajs-3342	236	3	9	9	NUM
iajs-3342	236	4	.	.	X
iajs-3342	236	5	saha	saha	PROPN
iajs-3342	236	6	,	,	PUNCT
iajs-3342	236	7	b.k	b.k	PROPN
iajs-3342	236	8	.	.	PROPN
iajs-3342	236	9	;	;	PUNCT
iajs-3342	236	10	bonnier	bonnier	NOUN
iajs-3342	236	11	,	,	PUNCT
iajs-3342	236	12	a.	a.	NOUN
iajs-3342	236	13	;	;	PUNCT
iajs-3342	236	14	chenna	chenna	ADJ
iajs-3342	236	15	,	,	PUNCT
iajs-3342	236	16	p.	p.	NOUN
iajs-3342	236	17	;	;	PUNCT
iajs-3342	236	18	milman	milman	NOUN
iajs-3342	236	19	,	,	PUNCT
iajs-3342	236	20	n.t	n.t	PROPN
iajs-3342	236	21	.	.	PROPN
iajs-3342	236	22	prevalence	prevalence	NOUN
iajs-3342	236	23	of	of	ADP
iajs-3342	236	24	autoantibodies	autoantibody	NOUN
iajs-3342	236	25	in	in	ADP
iajs-3342	236	26	pediatric	pediatric	ADJ
iajs-3342	236	27	patients	patient	NOUN
iajs-3342	236	28	with	with	ADP
iajs-3342	236	29	idiopathic	idiopathic	ADJ
iajs-3342	236	30	pulmonary	pulmonary	ADJ
iajs-3342	236	31	hemosiderosis	hemosiderosis	NOUN
iajs-3342	236	32	:	:	PUNCT
iajs-3342	236	33	a	a	DET
iajs-3342	236	34	scoping	scope	VERB
iajs-3342	236	35	review	review	NOUN
iajs-3342	236	36	of	of	ADP
iajs-3342	236	37	the	the	DET
iajs-3342	236	38	literature	literature	NOUN
iajs-3342	236	39	in	in	ADP
iajs-3342	236	40	the	the	DET
iajs-3342	236	41	period	period	NOUN
iajs-3342	236	42	1980–2021	1980–2021	NUM
iajs-3342	236	43	.	.	PUNCT
iajs-3342	237	1	clin	clin	PROPN
iajs-3342	237	2	rheumatol	rheumatol	PROPN
iajs-3342	237	3	2022	2022	NUM
iajs-3342	237	4	,	,	PUNCT
iajs-3342	237	5	41(4	41(4	NUM
iajs-3342	237	6	)	)	PUNCT
iajs-3342	237	7	,	,	PUNCT
iajs-3342	237	8	977–990	977–990	NUM
iajs-3342	237	9	.	.	PUNCT
iajs-3342	237	10	https://doi.org/10.1007/s10067-02106029-3	https://doi.org/10.1007/s10067-02106029-3	PROPN
iajs-3342	237	11	.	.	PUNCT
iajs-3342	238	1	10	10	NUM
iajs-3342	238	2	.	.	X
iajs-3342	238	3	barker	barker	PROPN
iajs-3342	238	4	,	,	PUNCT
iajs-3342	238	5	p.a	p.a	PROPN
iajs-3342	238	6	.	.	PROPN
iajs-3342	238	7	;	;	PUNCT
iajs-3342	238	8	mantyh	mantyh	VERB
iajs-3342	238	9	,	,	PUNCT
iajs-3342	238	10	p.	p.	PROPN
iajs-3342	238	11	;	;	PUNCT
iajs-3342	238	12	arendt	arendt	PROPN
iajs-3342	238	13	-	-	PUNCT
iajs-3342	238	14	nielsen	nielsen	PROPN
iajs-3342	238	15	,	,	PUNCT
iajs-3342	238	16	l.	l.	PROPN
iajs-3342	238	17	;	;	PUNCT
iajs-3342	238	18	viktrup	viktrup	NOUN
iajs-3342	238	19	,	,	PUNCT
iajs-3342	238	20	l.	l.	PROPN
iajs-3342	238	21	;	;	PUNCT
iajs-3342	238	22	tive	tive	PROPN
iajs-3342	238	23	,	,	PUNCT
iajs-3342	238	24	l.	l.	PROPN
iajs-3342	238	25	nerve	nerve	PROPN
iajs-3342	238	26	growth	growth	NOUN
iajs-3342	238	27	factor	factor	NOUN
iajs-3342	238	28	signaling	signal	VERB
iajs-3342	238	29	and	and	CCONJ
iajs-3342	238	30	its	its	PRON
iajs-3342	238	31	contribution	contribution	NOUN
iajs-3342	238	32	to	to	ADP
iajs-3342	238	33	pain	pain	NOUN
iajs-3342	238	34	.	.	PUNCT
iajs-3342	239	1	journal	journal	NOUN
iajs-3342	239	2	of	of	ADP
iajs-3342	239	3	pain	pain	NOUN
iajs-3342	239	4	research	research	NOUN
iajs-3342	239	5	.	.	PUNCT
iajs-3342	240	1	2020	2020	NUM
iajs-3342	240	2	,	,	PUNCT
iajs-3342	240	3	1	1	NUM
iajs-3342	240	4	,	,	PUNCT
iajs-3342	240	5	1223–1241	1223–1241	NUM
iajs-3342	240	6	.	.	PUNCT
iajs-3342	241	1	https://doi.org/10.1148/rg.210045	https://doi.org/10.1148/rg.210045	PROPN
iajs-3342	241	2	.	.	PROPN
iajs-3342	242	1	11	11	NUM
iajs-3342	242	2	.	.	X
iajs-3342	243	1	rusher	rusher	ADJ
iajs-3342	243	2	,	,	PUNCT
iajs-3342	243	3	d.r	d.r	PROPN
iajs-3342	243	4	.	.	PROPN
iajs-3342	243	5	;	;	PUNCT
iajs-3342	243	6	pawlak	pawlak	ADJ
iajs-3342	243	7	,	,	PUNCT
iajs-3342	243	8	r.a	r.a	PROPN
iajs-3342	243	9	review	review	NOUN
iajs-3342	243	10	of	of	ADP
iajs-3342	243	11	89	89	NUM
iajs-3342	243	12	published	publish	VERB
iajs-3342	243	13	case	case	NOUN
iajs-3342	243	14	studies	study	NOUN
iajs-3342	243	15	of	of	ADP
iajs-3342	243	16	vitamin	vitamin	NOUN
iajs-3342	243	17	b12	b12	NOUN
iajs-3342	243	18	deficiency	deficiency	NOUN
iajs-3342	243	19	.	.	PUNCT
iajs-3342	244	1	j	j	PROPN
iajs-3342	244	2	hum	hum	PROPN
iajs-3342	244	3	nutr	nutr	PROPN
iajs-3342	244	4	food	food	PROPN
iajs-3342	244	5	sci	sci	PROPN
iajs-3342	244	6	.	.	PROPN
iajs-3342	244	7	2013	2013	NUM
iajs-3342	244	8	,	,	PUNCT
iajs-3342	244	9	1	1	NUM
iajs-3342	244	10	,	,	PUNCT
iajs-3342	244	11	1008	1008	NUM
iajs-3342	244	12	.	.	PUNCT
iajs-3342	245	1	12	12	NUM
iajs-3342	245	2	.	.	PUNCT
iajs-3342	246	1	stabler	stable	ADJ
iajs-3342	246	2	,	,	PUNCT
iajs-3342	246	3	s.p	s.p	PROPN
iajs-3342	246	4	.	.	PUNCT
iajs-3342	246	5	;	;	PUNCT
iajs-3342	246	6	korson	korson	PROPN
iajs-3342	246	7	,	,	PUNCT
iajs-3342	246	8	m.	m.	NOUN
iajs-3342	246	9	;	;	PUNCT
iajs-3342	246	10	jethva	jethva	NOUN
iajs-3342	246	11	,	,	PUNCT
iajs-3342	246	12	r.	r.	PROPN
iajs-3342	246	13	;	;	PUNCT
iajs-3342	246	14	allen	allen	PROPN
iajs-3342	246	15	,	,	PUNCT
iajs-3342	246	16	r.h	r.h	PROPN
iajs-3342	246	17	.	.	PROPN
iajs-3342	246	18	;	;	PUNCT
iajs-3342	246	19	kraus	kraus	PROPN
iajs-3342	246	20	,	,	PUNCT
iajs-3342	246	21	j.p	j.p	PROPN
iajs-3342	246	22	.	.	PROPN
iajs-3342	246	23	;	;	PUNCT
iajs-3342	246	24	spector	spector	PROPN
iajs-3342	246	25	,	,	PUNCT
iajs-3342	246	26	e.b	e.b	PROPN
iajs-3342	246	27	.	.	PROPN
iajs-3342	246	28	;	;	PUNCT
iajs-3342	246	29	wagner	wagner	PROPN
iajs-3342	246	30	,	,	PUNCT
iajs-3342	246	31	c.	c.	PROPN
iajs-3342	246	32	;	;	PUNCT
iajs-3342	246	33	mudd	mudd	PROPN
iajs-3342	246	34	,	,	PUNCT
iajs-3342	246	35	s.h	s.h	PROPN
iajs-3342	246	36	.	.	PROPN
iajs-3342	246	37	metabolic	metabolic	NOUN
iajs-3342	246	38	profiling	profiling	NOUN
iajs-3342	246	39	of	of	ADP
iajs-3342	246	40	total	total	ADJ
iajs-3342	246	41	homocysteine	homocysteine	NOUN
iajs-3342	246	42	and	and	CCONJ
iajs-3342	246	43	related	related	ADJ
iajs-3342	246	44	compounds	compound	NOUN
iajs-3342	246	45	in	in	ADP
iajs-3342	246	46	hyperhomocysteinemia	hyperhomocysteinemia	NOUN
iajs-3342	246	47	:	:	PUNCT
iajs-3342	246	48	utility	utility	NOUN
iajs-3342	246	49	and	and	CCONJ
iajs-3342	246	50	limitations	limitation	NOUN
iajs-3342	246	51	in	in	ADP
iajs-3342	246	52	diagnosing	diagnose	VERB
iajs-3342	246	53	the	the	DET
iajs-3342	246	54	cause	cause	NOUN
iajs-3342	246	55	of	of	ADP
iajs-3342	246	56	puzzling	puzzle	VERB
iajs-3342	246	57	thrombophilia	thrombophilia	NOUN
iajs-3342	246	58	in	in	ADP
iajs-3342	246	59	a	a	DET
iajs-3342	246	60	family	family	NOUN
iajs-3342	246	61	.	.	PUNCT
iajs-3342	247	1	jimd	jimd	PROPN
iajs-3342	247	2	reports	report	VERB
iajs-3342	247	3	2013	2013	NUM
iajs-3342	247	4	,	,	PUNCT
iajs-3342	247	5	11(2013	11(2013	NUM
iajs-3342	247	6	)	)	PUNCT
iajs-3342	247	7	,	,	PUNCT
iajs-3342	247	8	149–163	149–163	NUM
iajs-3342	247	9	.	.	PUNCT
iajs-3342	248	1	https://doi.org/10.1007/8904_2013_235	https://doi.org/10.1007/8904_2013_235	VERB
iajs-3342	248	2	.	.	PROPN
iajs-3342	248	3	13	13	NUM
iajs-3342	248	4	.	.	PUNCT
iajs-3342	249	1	weckerle	weckerle	PROPN
iajs-3342	249	2	,	,	PUNCT
iajs-3342	249	3	c.e	c.e	PROPN
iajs-3342	249	4	.	.	PROPN
iajs-3342	249	5	;	;	PUNCT
iajs-3342	249	6	niewold	niewold	PROPN
iajs-3342	249	7	,	,	PUNCT
iajs-3342	249	8	t.b	t.b	PROPN
iajs-3342	249	9	.	.	PUNCT
iajs-3342	250	1	the	the	DET
iajs-3342	250	2	unexplained	unexplained	ADJ
iajs-3342	250	3	female	female	ADJ
iajs-3342	250	4	predominance	predominance	NOUN
iajs-3342	250	5	of	of	ADP
iajs-3342	250	6	systemic	systemic	ADJ
iajs-3342	250	7	lupus	lupus	PROPN
iajs-3342	250	8	erythematosus	erythematosus	NOUN
iajs-3342	250	9	:	:	PUNCT
iajs-3342	250	10	clues	clue	NOUN
iajs-3342	250	11	from	from	ADP
iajs-3342	250	12	genetic	genetic	ADJ
iajs-3342	250	13	and	and	CCONJ
iajs-3342	250	14	cytokine	cytokine	ADJ
iajs-3342	250	15	studies	study	NOUN
iajs-3342	250	16	.	.	PUNCT
iajs-3342	251	1	clinical	clinical	ADJ
iajs-3342	251	2	reviews	review	NOUN
iajs-3342	251	3	in	in	ADP
iajs-3342	251	4	allergy	allergy	NOUN
iajs-3342	251	5	&	&	CCONJ
iajs-3342	251	6	immunology	immunology	NOUN
iajs-3342	251	7	.	.	PUNCT
iajs-3342	252	1	2011	2011	NUM
iajs-3342	252	2	,	,	PUNCT
iajs-3342	252	3	40(1	40(1	NOUN
iajs-3342	252	4	)	)	PUNCT
iajs-3342	252	5	,	,	PUNCT
iajs-3342	252	6	42	42	NUM
iajs-3342	252	7	-	-	SYM
iajs-3342	252	8	49	49	NUM
iajs-3342	252	9	.	.	PUNCT
iajs-3342	253	1	https://doi.org/10.1007/s12016-009-8192-4	https://doi.org/10.1007/s12016-009-8192-4	NUM
iajs-3342	253	2	.	.	PUNCT
iajs-3342	254	1	14	14	NUM
iajs-3342	254	2	.	.	X
iajs-3342	254	3	leuchten	leuchten	VERB
iajs-3342	254	4	,	,	PUNCT
iajs-3342	254	5	n.	n.	PROPN
iajs-3342	254	6	;	;	PUNCT
iajs-3342	254	7	hoyer	hoyer	PROPN
iajs-3342	254	8	,	,	PUNCT
iajs-3342	254	9	a.	a.	NOUN
iajs-3342	254	10	;	;	PUNCT
iajs-3342	254	11	brinks	brinks	PROPN
iajs-3342	254	12	,	,	PUNCT
iajs-3342	254	13	r.	r.	PROPN
iajs-3342	254	14	;	;	PUNCT
iajs-3342	254	15	schoels	schoel	NOUN
iajs-3342	254	16	,	,	PUNCT
iajs-3342	254	17	m.	m.	NOUN
iajs-3342	254	18	;	;	PUNCT
iajs-3342	254	19	schneider	schneider	NOUN
iajs-3342	254	20	,	,	PUNCT
iajs-3342	254	21	m.	m.	NOUN
iajs-3342	254	22	;	;	PUNCT
iajs-3342	254	23	smolen	smolen	PROPN
iajs-3342	254	24	,	,	PUNCT
iajs-3342	254	25	j.	j.	PROPN
iajs-3342	254	26	;	;	PUNCT
iajs-3342	254	27	johnson	johnson	PROPN
iajs-3342	254	28	,	,	PUNCT
iajs-3342	254	29	s.r	s.r	PROPN
iajs-3342	254	30	.	.	PROPN
iajs-3342	254	31	;	;	PUNCT
iajs-3342	254	32	daikh	daikh	NOUN
iajs-3342	254	33	,	,	PUNCT
iajs-3342	254	34	d.	d.	PROPN
iajs-3342	254	35	;	;	PUNCT
iajs-3342	254	36	doerner	doerner	NOUN
iajs-3342	254	37	,	,	PUNCT
iajs-3342	254	38	t.	t.	PROPN
iajs-3342	254	39	;	;	PUNCT
iajs-3342	254	40	aringer	aringer	NOUN
iajs-3342	254	41	,	,	PUNCT
iajs-3342	254	42	m.	m.	NOUN
iajs-3342	254	43	performance	performance	NOUN
iajs-3342	254	44	of	of	ADP
iajs-3342	254	45	antinuclear	antinuclear	ADJ
iajs-3342	254	46	antibodies	antibody	NOUN
iajs-3342	254	47	for	for	ADP
iajs-3342	254	48	classifying	classify	VERB
iajs-3342	254	49	systemic	systemic	ADJ
iajs-3342	254	50	lupus	lupus	PROPN
iajs-3342	254	51	erythematosus	erythematosus	NOUN
iajs-3342	254	52	:	:	PUNCT
iajs-3342	254	53	a	a	DET
iajs-3342	254	54	systematic	systematic	ADJ
iajs-3342	254	55	literature	literature	NOUN
iajs-3342	254	56	review	review	NOUN
iajs-3342	254	57	and	and	CCONJ
iajs-3342	254	58	meta	meta	NOUN
iajs-3342	254	59	-	-	PUNCT
iajs-3342	254	60	regression	regression	NOUN
iajs-3342	254	61	of	of	ADP
iajs-3342	254	62	diagnostic	diagnostic	ADJ
iajs-3342	254	63	data	datum	NOUN
iajs-3342	254	64	.	.	PUNCT
iajs-3342	255	1	arthritis	arthritis	NOUN
iajs-3342	255	2	care	care	NOUN
iajs-3342	255	3	res	re	NOUN
iajs-3342	255	4	.	.	PUNCT
iajs-3342	256	1	(	(	PUNCT
iajs-3342	256	2	hoboken	hoboken	PROPN
iajs-3342	256	3	)	)	PUNCT
iajs-3342	256	4	2018	2018	NUM
iajs-3342	256	5	,	,	PUNCT
iajs-3342	256	6	70(3	70(3	NOUN
iajs-3342	256	7	)	)	PUNCT
iajs-3342	256	8	,	,	PUNCT
iajs-3342	256	9	428–438	428–438	NUM
iajs-3342	256	10	.	.	PUNCT
iajs-3342	257	1	https://doi.org/10.1002/acr.23292	https://doi.org/10.1002/acr.23292	NOUN
iajs-3342	257	2	.	.	PROPN
iajs-3342	257	3	15	15	NUM
iajs-3342	257	4	.	.	PUNCT
iajs-3342	258	1	noori	noori	PROPN
iajs-3342	258	2	,	,	PUNCT
iajs-3342	258	3	a.s	a.s	PROPN
iajs-3342	258	4	.	.	PROPN
iajs-3342	258	5	;	;	PUNCT
iajs-3342	258	6	jawad	jawad	PROPN
iajs-3342	258	7	,	,	PUNCT
iajs-3342	258	8	a.m.	a.m.	ADV
iajs-3342	258	9	;	;	PUNCT
iajs-3342	258	10	jassim	jassim	PROPN
iajs-3342	258	11	,	,	PUNCT
iajs-3342	258	12	n.a	n.a	PROPN
iajs-3342	258	13	.	.	PROPN
iajs-3342	258	14	;	;	PUNCT
iajs-3342	258	15	gorial	gorial	ADJ
iajs-3342	258	16	,	,	PUNCT
iajs-3342	258	17	f.i	f.i	PROPN
iajs-3342	258	18	.	.	PROPN
iajs-3342	258	19	prevalence	prevalence	NOUN
iajs-3342	258	20	of	of	ADP
iajs-3342	258	21	antiphospholipid	antiphospholipid	PROPN
iajs-3342	258	22	antibodies	antibody	NOUN
iajs-3342	258	23	in	in	ADP
iajs-3342	258	24	sample	sample	NOUN
iajs-3342	258	25	of	of	ADP
iajs-3342	258	26	iraqi	iraqi	ADJ
iajs-3342	258	27	patients	patient	NOUN
iajs-3342	258	28	with	with	ADP
iajs-3342	258	29	systemic	systemic	ADJ
iajs-3342	258	30	lupus	lupus	PROPN
iajs-3342	258	31	erythematosus	erythematosus	NOUN
iajs-3342	258	32	:	:	PUNCT
iajs-3342	258	33	a	a	DET
iajs-3342	258	34	cross	cross	ADJ
iajs-3342	258	35	sectional	sectional	ADJ
iajs-3342	258	36	study	study	NOUN
iajs-3342	258	37	.	.	PUNCT
iajs-3342	259	1	american	american	PROPN
iajs-3342	259	2	journal	journal	PROPN
iajs-3342	259	3	of	of	ADP
iajs-3342	259	4	clinical	clinical	ADJ
iajs-3342	259	5	medicine	medicine	NOUN
iajs-3342	259	6	research	research	NOUN
iajs-3342	259	7	.	.	PUNCT
iajs-3342	260	1	2013	2013	NUM
iajs-3342	260	2	,	,	PUNCT
iajs-3342	260	3	1(4	1(4	NUM
iajs-3342	260	4	)	)	PUNCT
iajs-3342	260	5	,	,	PUNCT
iajs-3342	260	6	61–64	61–64	PROPN
iajs-3342	260	7	.	.	PUNCT
iajs-3342	260	8	https://doi.org/10.12691/ajcmr-1-4-4	https://doi.org/10.12691/ajcmr-1-4-4	PROPN
iajs-3342	260	9	.	.	PUNCT
iajs-3342	261	1	https://doi.org/10.1002/tre.732	https://doi.org/10.1002/tre.732	PROPN
iajs-3342	261	2	https://doi.org/10.1148/rg.210045	https://doi.org/10.1148/rg.210045	ADP
iajs-3342	261	3	https://doi.org/10.1002/acr.23292	https://doi.org/10.1002/acr.23292	NOUN
iajs-3342	261	4	ihjpas	ihjpas	PROPN
iajs-3342	261	5	.	.	PUNCT
iajs-3342	262	1	2024	2024	NUM
iajs-3342	262	2	,	,	PUNCT
iajs-3342	262	3	37	37	NUM
iajs-3342	262	4	(	(	PUNCT
iajs-3342	262	5	3	3	NUM
iajs-3342	262	6	)	)	PUNCT
iajs-3342	262	7	320	320	NUM
iajs-3342	262	8	16	16	NUM
iajs-3342	262	9	.	.	PUNCT
iajs-3342	263	1	alaanzy	alaanzy	PROPN
iajs-3342	263	2	,	,	PUNCT
iajs-3342	263	3	m.t	m.t	PROPN
iajs-3342	263	4	.	.	PROPN
iajs-3342	263	5	;	;	PUNCT
iajs-3342	263	6	alsaffar	alsaffar	ADV
iajs-3342	263	7	,	,	PUNCT
iajs-3342	263	8	j.m.j	j.m.j	PROPN
iajs-3342	263	9	.	.	PUNCT
iajs-3342	263	10	;	;	PUNCT
iajs-3342	263	11	bari	bari	PROPN
iajs-3342	263	12	,	,	PUNCT
iajs-3342	263	13	a.a	a.a	PROPN
iajs-3342	263	14	.	.	PROPN
iajs-3342	263	15	evaluate	evaluate	VERB
iajs-3342	263	16	the	the	DET
iajs-3342	263	17	correlation	correlation	NOUN
iajs-3342	263	18	between	between	ADP
iajs-3342	263	19	antioxidant	antioxidant	ADJ
iajs-3342	263	20	capacity	capacity	NOUN
iajs-3342	263	21	and	and	CCONJ
iajs-3342	263	22	interferon	interferon	ADJ
iajs-3342	263	23	?	?	PUNCT
iajs-3342	264	1	level	level	NOUN
iajs-3342	264	2	with	with	ADP
iajs-3342	264	3	the	the	DET
iajs-3342	264	4	disease	disease	NOUN
iajs-3342	264	5	activity	activity	NOUN
iajs-3342	264	6	of	of	ADP
iajs-3342	264	7	sle	sle	PROPN
iajs-3342	264	8	patients	patient	NOUN
iajs-3342	264	9	in	in	ADP
iajs-3342	264	10	iraqi	iraqi	ADJ
iajs-3342	264	11	woman	woman	NOUN
iajs-3342	264	12	.	.	PUNCT
iajs-3342	265	1	indian	indian	PROPN
iajs-3342	265	2	j	j	PROPN
iajs-3342	265	3	public	public	ADJ
iajs-3342	265	4	heal	heal	NOUN
iajs-3342	265	5	res	re	NOUN
iajs-3342	265	6	dev	dev	PROPN
iajs-3342	265	7	2020	2020	NUM
iajs-3342	265	8	,	,	PUNCT
iajs-3342	265	9	11	11	NUM
iajs-3342	265	10	,	,	PUNCT
iajs-3342	265	11	1278–1282	1278–1282	NUM
iajs-3342	265	12	.	.	PUNCT
iajs-3342	265	13	https://doi.org/10.37506/v11/i1/2020/ijphrd/194018	https://doi.org/10.37506/v11/i1/2020/ijphrd/194018	NOUN
iajs-3342	265	14	1278	1278	NUM
iajs-3342	265	15	.	.	PUNCT
iajs-3342	266	1	17	17	NUM
iajs-3342	266	2	.	.	PUNCT
iajs-3342	267	1	fu	fu	PROPN
iajs-3342	267	2	,	,	PUNCT
iajs-3342	267	3	s.m	s.m	PROPN
iajs-3342	267	4	.	.	PROPN
iajs-3342	267	5	;	;	PUNCT
iajs-3342	267	6	dai	dai	PROPN
iajs-3342	267	7	,	,	PUNCT
iajs-3342	267	8	c.	c.	PROPN
iajs-3342	267	9	;	;	PUNCT
iajs-3342	267	10	zhao	zhao	PROPN
iajs-3342	267	11	,	,	PUNCT
iajs-3342	267	12	z.	z.	PROPN
iajs-3342	267	13	;	;	PUNCT
iajs-3342	267	14	gaskin	gaskin	PROPN
iajs-3342	267	15	,	,	PUNCT
iajs-3342	267	16	f.	f.	PROPN
iajs-3342	267	17	anti	anti	ADJ
iajs-3342	267	18	-	-	ADJ
iajs-3342	267	19	dsdna	dsdna	ADJ
iajs-3342	267	20	antibodies	antibody	NOUN
iajs-3342	267	21	are	be	AUX
iajs-3342	267	22	one	one	NUM
iajs-3342	267	23	of	of	ADP
iajs-3342	267	24	the	the	DET
iajs-3342	267	25	many	many	ADJ
iajs-3342	267	26	autoantibodies	autoantibody	NOUN
iajs-3342	267	27	in	in	ADP
iajs-3342	267	28	systemic	systemic	ADJ
iajs-3342	267	29	lupus	lupus	PROPN
iajs-3342	267	30	erythematosus	erythematosus	PROPN
iajs-3342	267	31	.	.	PUNCT
iajs-3342	267	32	f1000research	f1000research	PROPN
iajs-3342	267	33	2015	2015	NUM
iajs-3342	267	34	,	,	PUNCT
iajs-3342	267	35	4	4	NUM
iajs-3342	267	36	,	,	PUNCT
iajs-3342	267	37	939	939	NUM
iajs-3342	267	38	.	.	PUNCT
iajs-3342	268	1	https://doi.org/12688/f1000research.6875.1	https://doi.org/12688/f1000research.6875.1	PROPN
iajs-3342	268	2	.	.	PUNCT
iajs-3342	269	1	18	18	NUM
iajs-3342	269	2	.	.	X
iajs-3342	269	3	karrar	karrar	PROPN
iajs-3342	269	4	,	,	PUNCT
iajs-3342	269	5	s.	s.	PROPN
iajs-3342	269	6	;	;	PUNCT
iajs-3342	269	7	graham	graham	PROPN
iajs-3342	269	8	,	,	PUNCT
iajs-3342	269	9	d.s.c	d.s.c	PROPN
iajs-3342	269	10	.	.	PUNCT
iajs-3342	269	11	abnormal	abnormal	PROPN
iajs-3342	269	12	b	b	PROPN
iajs-3342	269	13	cell	cell	NOUN
iajs-3342	269	14	development	development	NOUN
iajs-3342	269	15	in	in	ADP
iajs-3342	269	16	systemic	systemic	ADJ
iajs-3342	269	17	lupus	lupus	PROPN
iajs-3342	269	18	erythematosus	erythematosus	NOUN
iajs-3342	269	19	:	:	PUNCT
iajs-3342	269	20	what	what	PRON
iajs-3342	269	21	the	the	DET
iajs-3342	269	22	genetics	genetic	NOUN
iajs-3342	269	23	tell	tell	VERB
iajs-3342	269	24	us	we	PRON
iajs-3342	269	25	.	.	PUNCT
iajs-3342	270	1	arthritis	arthritis	NOUN
iajs-3342	270	2	rheumatol	rheumatol	NOUN
iajs-3342	270	3	.	.	PUNCT
iajs-3342	271	1	(	(	PUNCT
iajs-3342	271	2	hoboken	hoboken	PROPN
iajs-3342	271	3	,	,	PUNCT
iajs-3342	271	4	nj	nj	PROPN
iajs-3342	271	5	)	)	PUNCT
iajs-3342	271	6	2018	2018	NUM
iajs-3342	271	7	,	,	PUNCT
iajs-3342	271	8	70(4	70(4	NUM
iajs-3342	271	9	)	)	PUNCT
iajs-3342	271	10	,	,	PUNCT
iajs-3342	271	11	496	496	NUM
iajs-3342	271	12	.	.	PUNCT
iajs-3342	272	1	https://doi.org/10.1002/art.40396	https://doi.org/10.1002/art.40396	PROPN
iajs-3342	272	2	.	.	PUNCT
iajs-3342	273	1	19	19	NUM
iajs-3342	273	2	.	.	X
iajs-3342	273	3	celhar	celhar	PROPN
iajs-3342	273	4	,	,	PUNCT
iajs-3342	273	5	t.	t.	PROPN
iajs-3342	273	6	;	;	PUNCT
iajs-3342	273	7	fairhurst	fairhurst	ADJ
iajs-3342	273	8	,	,	PUNCT
iajs-3342	273	9	a.-m	a.-m	PROPN
iajs-3342	273	10	.	.	PUNCT
iajs-3342	274	1	toll	toll	NOUN
iajs-3342	274	2	-	-	PUNCT
iajs-3342	274	3	like	like	ADJ
iajs-3342	274	4	receptors	receptor	NOUN
iajs-3342	274	5	in	in	ADP
iajs-3342	274	6	systemic	systemic	ADJ
iajs-3342	274	7	lupus	lupus	PROPN
iajs-3342	274	8	erythematosus	erythematosus	NOUN
iajs-3342	274	9	:	:	PUNCT
iajs-3342	274	10	potential	potential	NOUN
iajs-3342	274	11	for	for	ADP
iajs-3342	274	12	personalized	personalized	ADJ
iajs-3342	274	13	treatment	treatment	NOUN
iajs-3342	274	14	.	.	PUNCT
iajs-3342	275	1	front	front	NOUN
iajs-3342	275	2	.	.	PUNCT
iajs-3342	276	1	pharmacol	pharmacol	PROPN
iajs-3342	276	2	2014	2014	NUM
iajs-3342	276	3	,	,	PUNCT
iajs-3342	276	4	5	5	NUM
iajs-3342	276	5	,	,	PUNCT
iajs-3342	276	6	265	265	NUM
iajs-3342	276	7	.	.	PUNCT
iajs-3342	277	1	https://doi.org/10.3389/fphar.2014.00265	https://doi.org/10.3389/fphar.2014.00265	PROPN
iajs-3342	277	2	.	.	PROPN
iajs-3342	277	3	20	20	NUM
iajs-3342	277	4	.	.	PUNCT
iajs-3342	278	1	chen	chen	PROPN
iajs-3342	278	2	,	,	PUNCT
iajs-3342	278	3	j.	j.	PROPN
iajs-3342	278	4	;	;	PUNCT
iajs-3342	278	5	zhang	zhang	PROPN
iajs-3342	278	6	,	,	PUNCT
iajs-3342	278	7	h.	h.	PROPN
iajs-3342	278	8	;	;	PUNCT
iajs-3342	278	9	chen	chen	PROPN
iajs-3342	278	10	,	,	PUNCT
iajs-3342	278	11	p.	p.	PROPN
iajs-3342	278	12	;	;	PUNCT
iajs-3342	278	13	lin	lin	PROPN
iajs-3342	278	14	,	,	PUNCT
iajs-3342	278	15	q.	q.	PROPN
iajs-3342	278	16	;	;	PUNCT
iajs-3342	278	17	zhu	zhu	PROPN
iajs-3342	278	18	,	,	PUNCT
iajs-3342	278	19	x.	x.	PROPN
iajs-3342	278	20	;	;	PUNCT
iajs-3342	278	21	zhang	zhang	PROPN
iajs-3342	278	22	,	,	PUNCT
iajs-3342	278	23	l.	l.	PROPN
iajs-3342	278	24	;	;	PUNCT
iajs-3342	278	25	xue	xue	PROPN
iajs-3342	278	26	,	,	PUNCT
iajs-3342	278	27	x.	x.	NOUN
iajs-3342	278	28	correlation	correlation	NOUN
iajs-3342	278	29	between	between	ADP
iajs-3342	278	30	systemic	systemic	ADJ
iajs-3342	278	31	lupus	lupus	NOUN
iajs-3342	278	32	erythematosus	erythematosus	NOUN
iajs-3342	278	33	and	and	CCONJ
iajs-3342	278	34	cytomegalovirus	cytomegalovirus	NOUN
iajs-3342	278	35	infection	infection	NOUN
iajs-3342	278	36	detected	detect	VERB
iajs-3342	278	37	by	by	ADP
iajs-3342	278	38	different	different	ADJ
iajs-3342	278	39	methods	method	NOUN
iajs-3342	278	40	.	.	PUNCT
iajs-3342	279	1	clin	clin	PROPN
iajs-3342	279	2	.	.	PUNCT
iajs-3342	280	1	rheumatol	rheumatol	PROPN
iajs-3342	280	2	2015	2015	NUM
iajs-3342	280	3	,	,	PUNCT
iajs-3342	280	4	34(4	34(4	NUM
iajs-3342	280	5	)	)	PUNCT
iajs-3342	280	6	,	,	PUNCT
iajs-3342	280	7	691–698	691–698	NUM
iajs-3342	280	8	.	.	PUNCT
iajs-3342	281	1	https://doi.org/10.1007/s10067-015-2868-3	https://doi.org/10.1007/s10067-015-2868-3	NOUN
iajs-3342	281	2	.	.	PUNCT
iajs-3342	282	1	21	21	NUM
iajs-3342	282	2	.	.	PUNCT
iajs-3342	283	1	molano	molano	PROPN
iajs-3342	283	2	-	-	PUNCT
iajs-3342	283	3	gonzález	gonzález	PROPN
iajs-3342	283	4	,	,	PUNCT
iajs-3342	283	5	n.	n.	PROPN
iajs-3342	283	6	;	;	PUNCT
iajs-3342	283	7	rojas	rojas	PROPN
iajs-3342	283	8	,	,	PUNCT
iajs-3342	283	9	m.	m.	NOUN
iajs-3342	283	10	;	;	PUNCT
iajs-3342	283	11	monsalve	monsalve	NOUN
iajs-3342	283	12	,	,	PUNCT
iajs-3342	283	13	d.m	d.m	PROPN
iajs-3342	283	14	.	.	PUNCT
iajs-3342	283	15	;	;	PUNCT
iajs-3342	283	16	pacheco	pacheco	PROPN
iajs-3342	283	17	,	,	PUNCT
iajs-3342	283	18	y.	y.	PROPN
iajs-3342	283	19	;	;	PUNCT
iajs-3342	283	20	acosta	acosta	PROPN
iajs-3342	283	21	-	-	PUNCT
iajs-3342	283	22	ampudia	ampudia	PROPN
iajs-3342	283	23	,	,	PUNCT
iajs-3342	283	24	y.	y.	PROPN
iajs-3342	283	25	;	;	PUNCT
iajs-3342	283	26	rodríguez	rodríguez	NOUN
iajs-3342	283	27	,	,	PUNCT
iajs-3342	283	28	y.	y.	PROPN
iajs-3342	283	29	;	;	PUNCT
iajs-3342	283	30	rodríguez	rodríguez	PROPN
iajs-3342	283	31	-	-	PUNCT
iajs-3342	283	32	jimenez	jimenez	PROPN
iajs-3342	283	33	,	,	PUNCT
iajs-3342	283	34	m.	m.	NOUN
iajs-3342	283	35	;	;	PUNCT
iajs-3342	283	36	ramírez	ramírez	NOUN
iajs-3342	283	37	-	-	PUNCT
iajs-3342	283	38	santana	santana	PROPN
iajs-3342	283	39	,	,	PUNCT
iajs-3342	283	40	c.	c.	PROPN
iajs-3342	283	41	;	;	PUNCT
iajs-3342	283	42	anaya	anaya	PROPN
iajs-3342	283	43	,	,	PUNCT
iajs-3342	283	44	j.-m	j.-m	PROPN
iajs-3342	283	45	.	.	PUNCT
iajs-3342	284	1	cluster	cluster	NOUN
iajs-3342	284	2	analysis	analysis	NOUN
iajs-3342	284	3	of	of	ADP
iajs-3342	284	4	autoimmune	autoimmune	ADJ
iajs-3342	284	5	rheumatic	rheumatic	ADJ
iajs-3342	284	6	diseases	disease	NOUN
iajs-3342	284	7	based	base	VERB
iajs-3342	284	8	on	on	ADP
iajs-3342	284	9	autoantibodies	autoantibody	NOUN
iajs-3342	284	10	.	.	PUNCT
iajs-3342	285	1	new	new	ADJ
iajs-3342	285	2	insights	insight	NOUN
iajs-3342	285	3	for	for	ADP
iajs-3342	285	4	polyautoimmunity	polyautoimmunity	NOUN
iajs-3342	285	5	.	.	PUNCT
iajs-3342	286	1	j.	j.	PROPN
iajs-3342	286	2	autoimmun	autoimmun	PROPN
iajs-3342	286	3	.	.	PROPN
iajs-3342	287	1	2019	2019	NUM
iajs-3342	287	2	,	,	PUNCT
iajs-3342	287	3	98	98	NUM
iajs-3342	287	4	,	,	PUNCT
iajs-3342	287	5	24–32	24–32	NUM
iajs-3342	287	6	.	.	PUNCT
iajs-3342	288	1	https://doi.org/10.1016/j.jaut.2018.11.002	https://doi.org/10.1016/j.jaut.2018.11.002	NOUN
iajs-3342	288	2	.	.	PUNCT
iajs-3342	289	1	22	22	NUM
iajs-3342	289	2	.	.	PUNCT
iajs-3342	290	1	gonzález	gonzález	PROPN
iajs-3342	290	2	,	,	PUNCT
iajs-3342	290	3	l.a	l.a	PROPN
iajs-3342	290	4	.	.	PROPN
iajs-3342	290	5	;	;	PUNCT
iajs-3342	290	6	santamaría	santamaría	NOUN
iajs-3342	290	7	-	-	PUNCT
iajs-3342	290	8	alza	alza	VERB
iajs-3342	290	9	,	,	PUNCT
iajs-3342	290	10	y.	y.	PROPN
iajs-3342	290	11	;	;	PUNCT
iajs-3342	290	12	alarcón	alarcón	PROPN
iajs-3342	290	13	,	,	PUNCT
iajs-3342	290	14	g.s	g.s	PROPN
iajs-3342	290	15	.	.	PROPN
iajs-3342	290	16	organ	organ	NOUN
iajs-3342	290	17	damage	damage	NOUN
iajs-3342	290	18	in	in	ADP
iajs-3342	290	19	systemic	systemic	ADJ
iajs-3342	290	20	lupus	lupus	PROPN
iajs-3342	290	21	erythematosus	erythematosus	PROPN
iajs-3342	290	22	.	.	PUNCT
iajs-3342	291	1	revista	revista	PROPN
iajs-3342	291	2	colombiana	colombiana	PROPN
iajs-3342	291	3	de	de	X
iajs-3342	291	4	reumatología	reumatología	PROPN
iajs-3342	291	5	.	.	PUNCT
iajs-3342	292	1	2021	2021	NUM
iajs-3342	292	2	,	,	PUNCT
iajs-3342	292	3	28(1	28(1	NOUN
iajs-3342	292	4	)	)	PUNCT
iajs-3342	292	5	,	,	PUNCT
iajs-3342	292	6	66–81	66–81	NUM
iajs-3342	292	7	.	.	PUNCT
iajs-3342	292	8	https://doi.org/10.1016/j.rcreu.2021.01.008	https://doi.org/10.1016/j.rcreu.2021.01.008	PROPN
iajs-3342	292	9	.	.	PROPN
iajs-3342	293	1	23	23	NUM
iajs-3342	293	2	.	.	PUNCT
iajs-3342	294	1	imam	imam	PROPN
iajs-3342	294	2	,	,	PUNCT
iajs-3342	294	3	m.h	m.h	PROPN
iajs-3342	294	4	.	.	PROPN
iajs-3342	294	5	;	;	PUNCT
iajs-3342	294	6	koriem	koriem	PROPN
iajs-3342	294	7	,	,	PUNCT
iajs-3342	294	8	h.k	h.k	PROPN
iajs-3342	294	9	.	.	PROPN
iajs-3342	294	10	;	;	PUNCT
iajs-3342	295	1	hassan	hassan	PROPN
iajs-3342	295	2	,	,	PUNCT
iajs-3342	295	3	m.m	m.m	PROPN
iajs-3342	295	4	.	.	PROPN
iajs-3342	295	5	;	;	PUNCT
iajs-3342	295	6	el	el	PROPN
iajs-3342	295	7	-	-	PUNCT
iajs-3342	295	8	hadidi	hadidi	PROPN
iajs-3342	295	9	,	,	PUNCT
iajs-3342	295	10	a.s	a.s	PROPN
iajs-3342	295	11	.	.	PROPN
iajs-3342	295	12	;	;	PUNCT
iajs-3342	295	13	ibrahim	ibrahim	PROPN
iajs-3342	295	14	,	,	PUNCT
iajs-3342	295	15	n.a	n.a	PROPN
iajs-3342	295	16	.	.	PROPN
iajs-3342	295	17	pattern	pattern	NOUN
iajs-3342	295	18	of	of	ADP
iajs-3342	295	19	peripheral	peripheral	ADJ
iajs-3342	295	20	neuropathy	neuropathy	ADJ
iajs-3342	295	21	in	in	ADP
iajs-3342	295	22	systemic	systemic	ADJ
iajs-3342	295	23	lupus	lupus	PROPN
iajs-3342	295	24	erythematosus	erythematosus	NOUN
iajs-3342	295	25	:	:	PUNCT
iajs-3342	295	26	clinical	clinical	ADJ
iajs-3342	295	27	,	,	PUNCT
iajs-3342	295	28	electrophysiological	electrophysiological	ADJ
iajs-3342	295	29	,	,	PUNCT
iajs-3342	295	30	and	and	CCONJ
iajs-3342	295	31	laboratory	laboratory	NOUN
iajs-3342	295	32	properties	property	NOUN
iajs-3342	295	33	and	and	CCONJ
iajs-3342	295	34	their	their	PRON
iajs-3342	295	35	association	association	NOUN
iajs-3342	295	36	with	with	ADP
iajs-3342	295	37	disease	disease	NOUN
iajs-3342	295	38	activity	activity	NOUN
iajs-3342	295	39	.	.	PUNCT
iajs-3342	296	1	egypt	egypt	PROPN
iajs-3342	296	2	rheumatol	rheumatol	PROPN
iajs-3342	296	3	rehabil	rehabil	VERB
iajs-3342	296	4	2019	2019	NUM
iajs-3342	296	5	,	,	PUNCT
iajs-3342	296	6	46	46	NUM
iajs-3342	296	7	,	,	PUNCT
iajs-3342	296	8	285	285	NUM
iajs-3342	296	9	–	–	PUNCT
iajs-3342	296	10	298	298	NUM
iajs-3342	296	11	.	.	PUNCT
iajs-3342	297	1	https://doi.org/10.4103/err.err_28_19	https://doi.org/10.4103/err.err_28_19	PROPN
iajs-3342	297	2	.	.	PUNCT
iajs-3342	298	1	24	24	NUM
iajs-3342	298	2	.	.	PUNCT
iajs-3342	298	3	ben	ben	PROPN
iajs-3342	298	4	salem	salem	PROPN
iajs-3342	298	5	,	,	PUNCT
iajs-3342	298	6	t.	t.	PROPN
iajs-3342	298	7	;	;	PUNCT
iajs-3342	298	8	belfeki	belfeki	PROPN
iajs-3342	298	9	,	,	PUNCT
iajs-3342	298	10	n.	n.	NOUN
iajs-3342	298	11	;	;	PUNCT
iajs-3342	298	12	lamloum	lamloum	NOUN
iajs-3342	298	13	,	,	PUNCT
iajs-3342	298	14	m.	m.	NOUN
iajs-3342	298	15	peripheral	peripheral	ADJ
iajs-3342	298	16	neuropathies	neuropathy	NOUN
iajs-3342	298	17	in	in	ADP
iajs-3342	298	18	patients	patient	NOUN
iajs-3342	298	19	with	with	ADP
iajs-3342	298	20	systemic	systemic	ADJ
iajs-3342	298	21	lupus	lupus	PROPN
iajs-3342	298	22	erythematosus	erythematosus	PROPN
iajs-3342	298	23	.	.	PUNCT
iajs-3342	299	1	j	j	PROPN
iajs-3342	299	2	neurol	neurol	PROPN
iajs-3342	299	3	neurosci	neurosci	PROPN
iajs-3342	299	4	.	.	PUNCT
iajs-3342	300	1	2016	2016	NUM
iajs-3342	300	2	,	,	PUNCT
iajs-3342	300	3	7	7	NUM
iajs-3342	300	4	,	,	PUNCT
iajs-3342	300	5	s3	s3	PROPN
iajs-3342	300	6	.	.	PUNCT
iajs-3342	300	7	https://doi.org/10.21767/2171-6625.1000127	https://doi.org/10.21767/2171-6625.1000127	PROPN
iajs-3342	300	8	25	25	NUM
iajs-3342	300	9	.	.	PUNCT
iajs-3342	301	1	ramos	ramo	NOUN
iajs-3342	301	2	-	-	NOUN
iajs-3342	301	3	casals	casal	NOUN
iajs-3342	301	4	,	,	PUNCT
iajs-3342	301	5	m.	m.	NOUN
iajs-3342	301	6	;	;	PUNCT
iajs-3342	301	7	nardi	nardi	PROPN
iajs-3342	301	8	,	,	PUNCT
iajs-3342	301	9	n.	n.	NOUN
iajs-3342	301	10	;	;	PUNCT
iajs-3342	301	11	lagrutta	lagrutta	NOUN
iajs-3342	301	12	,	,	PUNCT
iajs-3342	301	13	m.	m.	NOUN
iajs-3342	301	14	;	;	PUNCT
iajs-3342	301	15	brito	brito	PROPN
iajs-3342	301	16	-	-	PROPN
iajs-3342	301	17	zerón	zerón	PROPN
iajs-3342	301	18	,	,	PUNCT
iajs-3342	301	19	p.	p.	PROPN
iajs-3342	301	20	;	;	PUNCT
iajs-3342	301	21	bové	bové	NOUN
iajs-3342	301	22	,	,	PUNCT
iajs-3342	301	23	a.	a.	NOUN
iajs-3342	301	24	;	;	PUNCT
iajs-3342	301	25	delgado	delgado	PROPN
iajs-3342	301	26	,	,	PUNCT
iajs-3342	301	27	g.	g.	PROPN
iajs-3342	301	28	;	;	PUNCT
iajs-3342	301	29	cervera	cervera	NOUN
iajs-3342	301	30	,	,	PUNCT
iajs-3342	301	31	r.	r.	PROPN
iajs-3342	301	32	;	;	PUNCT
iajs-3342	301	33	ingelmo	ingelmo	NOUN
iajs-3342	301	34	,	,	PUNCT
iajs-3342	301	35	m.	m.	NOUN
iajs-3342	301	36	;	;	PUNCT
iajs-3342	301	37	font	font	NOUN
iajs-3342	301	38	,	,	PUNCT
iajs-3342	301	39	j.	j.	PROPN
iajs-3342	301	40	vasculitis	vasculitis	PROPN
iajs-3342	301	41	in	in	ADP
iajs-3342	301	42	systemic	systemic	ADJ
iajs-3342	301	43	lupus	lupus	PROPN
iajs-3342	301	44	erythematosus	erythematosus	NOUN
iajs-3342	301	45	:	:	PUNCT
iajs-3342	301	46	prevalence	prevalence	NOUN
iajs-3342	301	47	and	and	CCONJ
iajs-3342	301	48	clinical	clinical	ADJ
iajs-3342	301	49	characteristics	characteristic	NOUN
iajs-3342	301	50	in	in	ADP
iajs-3342	301	51	670	670	NUM
iajs-3342	301	52	patients	patient	NOUN
iajs-3342	301	53	.	.	PUNCT
iajs-3342	302	1	medicine	medicine	NOUN
iajs-3342	302	2	(	(	PUNCT
iajs-3342	302	3	baltimore	baltimore	PROPN
iajs-3342	302	4	)	)	PUNCT
iajs-3342	302	5	.	.	PUNCT
iajs-3342	303	1	2006	2006	NUM
iajs-3342	303	2	,	,	PUNCT
iajs-3342	303	3	85(2	85(2	NUM
iajs-3342	303	4	)	)	PUNCT
iajs-3342	303	5	,	,	PUNCT
iajs-3342	303	6	95–104	95–104	NOUN
iajs-3342	303	7	.	.	PUNCT
iajs-3342	304	1	https://doi.org/10.1097/01.md.0000216817.35937.70	https://doi.org/10.1097/01.md.0000216817.35937.70	X
iajs-3342	304	2	.	.	PUNCT
iajs-3342	305	1	26	26	NUM
iajs-3342	305	2	.	.	PUNCT
iajs-3342	306	1	bortoluzzi	bortoluzzi	NOUN
iajs-3342	306	2	,	,	PUNCT
iajs-3342	306	3	a.	a.	NOUN
iajs-3342	306	4	;	;	PUNCT
iajs-3342	306	5	silvagni	silvagni	NOUN
iajs-3342	306	6	,	,	PUNCT
iajs-3342	306	7	e.	e.	PROPN
iajs-3342	306	8	;	;	PUNCT
iajs-3342	306	9	furini	furini	PROPN
iajs-3342	306	10	,	,	PUNCT
iajs-3342	306	11	f.	f.	PROPN
iajs-3342	306	12	;	;	PUNCT
iajs-3342	306	13	piga	piga	PROPN
iajs-3342	306	14	,	,	PUNCT
iajs-3342	306	15	m.	m.	NOUN
iajs-3342	306	16	;	;	PUNCT
iajs-3342	306	17	govoni	govoni	NOUN
iajs-3342	306	18	,	,	PUNCT
iajs-3342	306	19	m.	m.	NOUN
iajs-3342	306	20	peripheral	peripheral	ADJ
iajs-3342	306	21	nervous	nervous	ADJ
iajs-3342	306	22	system	system	NOUN
iajs-3342	306	23	involvement	involvement	NOUN
iajs-3342	306	24	in	in	ADP
iajs-3342	306	25	systemic	systemic	ADJ
iajs-3342	306	26	lupus	lupus	PROPN
iajs-3342	306	27	erythematosus	erythematosus	NOUN
iajs-3342	306	28	:	:	PUNCT
iajs-3342	306	29	a	a	DET
iajs-3342	306	30	review	review	NOUN
iajs-3342	306	31	of	of	ADP
iajs-3342	306	32	the	the	DET
iajs-3342	306	33	evidence	evidence	NOUN
iajs-3342	306	34	.	.	PUNCT
iajs-3342	307	1	clinical	clinical	ADJ
iajs-3342	307	2	and	and	CCONJ
iajs-3342	307	3	experimental	experimental	ADJ
iajs-3342	307	4	rheumatology	rheumatology	NOUN
iajs-3342	307	5	2019	2019	NUM
iajs-3342	307	6	,	,	PUNCT
iajs-3342	307	7	37(1	37(1	NUM
iajs-3342	307	8	)	)	PUNCT
iajs-3342	307	9	,	,	PUNCT
iajs-3342	307	10	146–155	146–155	NUM
iajs-3342	307	11	.	.	PUNCT
iajs-3342	307	12	27	27	NUM
iajs-3342	307	13	.	.	PUNCT
iajs-3342	308	1	moisset	moisset	VERB
iajs-3342	308	2	,	,	PUNCT
iajs-3342	308	3	x.	x.	NOUN
iajs-3342	308	4	;	;	PUNCT
iajs-3342	308	5	bouhassira	bouhassira	PROPN
iajs-3342	308	6	,	,	PUNCT
iajs-3342	308	7	d.	d.	PROPN
iajs-3342	308	8	brain	brain	PROPN
iajs-3342	308	9	imaging	imaging	NOUN
iajs-3342	308	10	of	of	ADP
iajs-3342	308	11	neuropathic	neuropathic	ADJ
iajs-3342	308	12	pain	pain	NOUN
iajs-3342	308	13	.	.	PUNCT
iajs-3342	309	1	neuroimage	neuroimage	NOUN
iajs-3342	309	2	2007	2007	NUM
iajs-3342	309	3	,	,	PUNCT
iajs-3342	309	4	37(1	37(1	NUM
iajs-3342	309	5	)	)	PUNCT
iajs-3342	309	6	,	,	PUNCT
iajs-3342	309	7	s80	s80	PROPN
iajs-3342	309	8	–	–	PUNCT
iajs-3342	309	9	s88	s88	NOUN
iajs-3342	309	10	.	.	PUNCT
iajs-3342	310	1	https://doi.org/10.1016/j.neuroimage.2007.03.054	https://doi.org/10.1016/j.neuroimage.2007.03.054	PROPN
iajs-3342	310	2	28	28	NUM
iajs-3342	310	3	.	.	PUNCT
iajs-3342	311	1	seidel	seidel	PROPN
iajs-3342	311	2	,	,	PUNCT
iajs-3342	311	3	m.f	m.f	PROPN
iajs-3342	311	4	.	.	PUNCT
iajs-3342	311	5	;	;	PUNCT
iajs-3342	311	6	herguijuela	herguijuela	PROPN
iajs-3342	311	7	,	,	PUNCT
iajs-3342	311	8	m.	m.	NOUN
iajs-3342	311	9	;	;	PUNCT
iajs-3342	311	10	forkert	forkert	PROPN
iajs-3342	311	11	,	,	PUNCT
iajs-3342	311	12	r.	r.	PROPN
iajs-3342	311	13	;	;	PUNCT
iajs-3342	311	14	otten	otten	PROPN
iajs-3342	311	15	,	,	PUNCT
iajs-3342	311	16	u.	u.	PROPN
iajs-3342	311	17	nerve	nerve	NOUN
iajs-3342	311	18	growth	growth	NOUN
iajs-3342	311	19	factor	factor	NOUN
iajs-3342	311	20	in	in	ADP
iajs-3342	311	21	rheumatic	rheumatic	ADJ
iajs-3342	311	22	diseases	disease	NOUN
iajs-3342	311	23	.	.	PUNCT
iajs-3342	312	1	in	in	ADP
iajs-3342	312	2	proceedings	proceeding	NOUN
iajs-3342	312	3	of	of	ADP
iajs-3342	312	4	the	the	DET
iajs-3342	312	5	seminars	seminar	NOUN
iajs-3342	312	6	in	in	ADP
iajs-3342	312	7	arthritis	arthritis	NOUN
iajs-3342	312	8	and	and	CCONJ
iajs-3342	312	9	rheumatism	rheumatism	NOUN
iajs-3342	312	10	.	.	PUNCT
iajs-3342	313	1	elsevier	elsevier	PROPN
iajs-3342	313	2	2010	2010	NUM
iajs-3342	313	3	,	,	PUNCT
iajs-3342	313	4	40(2),109–126	40(2),109–126	PROPN
iajs-3342	313	5	.	.	PUNCT
iajs-3342	313	6	https://doi.org/10.1016/j.semarthrit.2009.03.002	https://doi.org/10.1016/j.semarthrit.2009.03.002	PROPN
iajs-3342	313	7	.	.	PUNCT
iajs-3342	314	1	29	29	NUM
iajs-3342	314	2	.	.	PUNCT
iajs-3342	315	1	evans	evans	PROPN
iajs-3342	315	2	,	,	PUNCT
iajs-3342	315	3	l.j	l.j	PROPN
iajs-3342	315	4	.	.	PROPN
iajs-3342	315	5	;	;	PUNCT
iajs-3342	315	6	loescher	loescher	PROPN
iajs-3342	315	7	,	,	PUNCT
iajs-3342	315	8	a.r	a.r	PROPN
iajs-3342	315	9	.	.	PROPN
iajs-3342	315	10	;	;	PUNCT
iajs-3342	315	11	boissonade	boissonade	PROPN
iajs-3342	315	12	,	,	PUNCT
iajs-3342	315	13	f.m	f.m	PROPN
iajs-3342	315	14	.	.	PROPN
iajs-3342	315	15	;	;	PUNCT
iajs-3342	315	16	whawell	whawell	VERB
iajs-3342	315	17	,	,	PUNCT
iajs-3342	315	18	s.a	s.a	PROPN
iajs-3342	315	19	.	.	PROPN
iajs-3342	315	20	;	;	PUNCT
iajs-3342	316	1	robinson	robinson	PROPN
iajs-3342	316	2	,	,	PUNCT
iajs-3342	316	3	p.p	p.p	PROPN
iajs-3342	316	4	.	.	PROPN
iajs-3342	316	5	;	;	PUNCT
iajs-3342	316	6	andrew	andrew	PROPN
iajs-3342	316	7	,	,	PUNCT
iajs-3342	316	8	d.	d.	PROPN
iajs-3342	316	9	temporal	temporal	PROPN
iajs-3342	316	10	mismatch	mismatch	NOUN
iajs-3342	316	11	between	between	ADP
iajs-3342	316	12	pain	pain	NOUN
iajs-3342	316	13	behaviour	behaviour	NOUN
iajs-3342	316	14	,	,	PUNCT
iajs-3342	316	15	skin	skin	NOUN
iajs-3342	316	16	nerve	nerve	NOUN
iajs-3342	316	17	growth	growth	NOUN
iajs-3342	316	18	factor	factor	NOUN
iajs-3342	316	19	and	and	CCONJ
iajs-3342	316	20	intra	intra	ADJ
iajs-3342	316	21	-	-	ADJ
iajs-3342	316	22	epidermal	epidermal	ADJ
iajs-3342	316	23	nerve	nerve	NOUN
iajs-3342	316	24	fibre	fibre	NOUN
iajs-3342	316	25	density	density	NOUN
iajs-3342	316	26	in	in	ADP
iajs-3342	316	27	trigeminal	trigeminal	ADJ
iajs-3342	316	28	neuropathic	neuropathic	ADJ
iajs-3342	316	29	pain	pain	NOUN
iajs-3342	316	30	.	.	PUNCT
iajs-3342	317	1	bmc	bmc	ADJ
iajs-3342	317	2	neuroscience	neuroscience	NOUN
iajs-3342	317	3	.	.	PUNCT
iajs-3342	318	1	2014	2014	NUM
iajs-3342	318	2	,	,	PUNCT
iajs-3342	318	3	15	15	NUM
iajs-3342	318	4	,	,	PUNCT
iajs-3342	318	5	1–15	1–15	NUM
iajs-3342	318	6	.	.	PUNCT
iajs-3342	319	1	https://doi.org/10.1186/1471-2202-15-1	https://doi.org/10.1186/1471-2202-15-1	NOUN
iajs-3342	319	2	.	.	PUNCT
iajs-3342	320	1	30	30	NUM
iajs-3342	320	2	.	.	PUNCT
iajs-3342	321	1	wieske	wieske	PROPN
iajs-3342	321	2	,	,	PUNCT
iajs-3342	321	3	l.	l.	PROPN
iajs-3342	321	4	;	;	PUNCT
iajs-3342	321	5	smyth	smyth	PROPN
iajs-3342	321	6	,	,	PUNCT
iajs-3342	321	7	d.	d.	PROPN
iajs-3342	321	8	;	;	PUNCT
iajs-3342	321	9	lunn	lunn	PROPN
iajs-3342	321	10	,	,	PUNCT
iajs-3342	321	11	m.p	m.p	PROPN
iajs-3342	321	12	.	.	PROPN
iajs-3342	321	13	;	;	PUNCT
iajs-3342	321	14	eftimov	eftimov	PROPN
iajs-3342	321	15	,	,	PUNCT
iajs-3342	321	16	f.	f.	PROPN
iajs-3342	321	17	;	;	PUNCT
iajs-3342	321	18	teunissen	teunissen	PROPN
iajs-3342	321	19	,	,	PUNCT
iajs-3342	321	20	c.e	c.e	PROPN
iajs-3342	321	21	.	.	PROPN
iajs-3342	321	22	fluid	fluid	ADJ
iajs-3342	321	23	biomarkers	biomarker	NOUN
iajs-3342	321	24	for	for	ADP
iajs-3342	321	25	monitoring	monitor	VERB
iajs-3342	321	26	structural	structural	ADJ
iajs-3342	321	27	changes	change	NOUN
iajs-3342	321	28	in	in	ADP
iajs-3342	321	29	polyneuropathies	polyneuropathie	NOUN
iajs-3342	321	30	:	:	PUNCT
iajs-3342	321	31	their	their	PRON
iajs-3342	321	32	use	use	NOUN
iajs-3342	321	33	in	in	ADP
iajs-3342	321	34	clinical	clinical	ADJ
iajs-3342	321	35	practice	practice	NOUN
iajs-3342	321	36	and	and	CCONJ
iajs-3342	321	37	trials	trial	NOUN
iajs-3342	321	38	.	.	PUNCT
iajs-3342	322	1	neurotherapeutics	neurotherapeutics	PROPN
iajs-3342	322	2	.	.	PROPN
iajs-3342	322	3	2021	2021	NUM
iajs-3342	322	4	,	,	PUNCT
iajs-3342	322	5	18(4	18(4	NUM
iajs-3342	322	6	)	)	PUNCT
iajs-3342	322	7	,	,	PUNCT
iajs-3342	322	8	2351–2367	2351–2367	NUM
iajs-3342	322	9	.	.	PUNCT
iajs-3342	323	1	https://doi.org/10.1007/s13311-021-01136-0	https://doi.org/10.1007/s13311-021-01136-0	NUM
iajs-3342	323	2	.	.	PUNCT
iajs-3342	324	1	31	31	NUM
iajs-3342	324	2	.	.	X
iajs-3342	325	1	mckelvey	mckelvey	PROPN
iajs-3342	325	2	,	,	PUNCT
iajs-3342	325	3	l.	l.	PROPN
iajs-3342	325	4	;	;	PUNCT
iajs-3342	325	5	shorten	shorten	ADJ
iajs-3342	325	6	,	,	PUNCT
iajs-3342	325	7	g.d	g.d	PROPN
iajs-3342	325	8	.	.	PROPN
iajs-3342	325	9	;	;	PUNCT
iajs-3342	325	10	o’keeffe	o’keeffe	PROPN
iajs-3342	325	11	,	,	PUNCT
iajs-3342	325	12	g.w	g.w	PROPN
iajs-3342	325	13	.	.	PROPN
iajs-3342	325	14	nerve	nerve	NOUN
iajs-3342	325	15	growth	growth	NOUN
iajs-3342	325	16	factor‐mediated	factor‐mediate	VERB
iajs-3342	325	17	regulation	regulation	NOUN
iajs-3342	325	18	of	of	ADP
iajs-3342	325	19	pain	pain	NOUN
iajs-3342	325	20	signalling	signal	VERB
iajs-3342	325	21	and	and	CCONJ
iajs-3342	325	22	proposed	propose	VERB
iajs-3342	325	23	new	new	ADJ
iajs-3342	325	24	intervention	intervention	NOUN
iajs-3342	325	25	strategies	strategy	NOUN
iajs-3342	325	26	in	in	ADP
iajs-3342	325	27	clinical	clinical	ADJ
iajs-3342	325	28	pain	pain	NOUN
iajs-3342	325	29	management	management	NOUN
iajs-3342	325	30	.	.	PUNCT
iajs-3342	326	1	j	j	PROPN
iajs-3342	326	2	neurochem	neurochem	PROPN
iajs-3342	326	3	2013	2013	NUM
iajs-3342	326	4	,	,	PUNCT
iajs-3342	326	5	124(3	124(3	NUM
iajs-3342	326	6	)	)	PUNCT
iajs-3342	326	7	,	,	PUNCT
iajs-3342	326	8	276–289	276–289	NUM
iajs-3342	326	9	.	.	PUNCT
iajs-3342	327	1	https://doi.org/10.1111/jnc.12093	https://doi.org/10.1111/jnc.12093	PROPN
iajs-3342	327	2	.	.	PUNCT
iajs-3342	328	1	https://doi.org/10.1007/s10067-015-2868-3	https://doi.org/10.1007/s10067-015-2868-3	NUM
iajs-3342	328	2	.	.	PUNCT
iajs-3342	329	1	https://doi.org/10.1016/j.neuroimage.2007.03.054	https://doi.org/10.1016/j.neuroimage.2007.03.054	NOUN
iajs-3342	330	1	https://doi.org/10.1111/jnc.12093	https://doi.org/10.1111/jnc.12093	PROPN
iajs-3342	330	2	ihjpas	ihjpas	PROPN
iajs-3342	330	3	.	.	PUNCT
iajs-3342	331	1	2024	2024	NUM
iajs-3342	331	2	,	,	PUNCT
iajs-3342	331	3	37	37	NUM
iajs-3342	331	4	(	(	PUNCT
iajs-3342	331	5	3	3	NUM
iajs-3342	331	6	)	)	PUNCT
iajs-3342	331	7	321	321	NUM
iajs-3342	331	8	32	32	NUM
iajs-3342	331	9	.	.	PUNCT
iajs-3342	332	1	wang	wang	PROPN
iajs-3342	332	2	,	,	PUNCT
iajs-3342	332	3	d.	d.	PROPN
iajs-3342	332	4	;	;	PUNCT
iajs-3342	332	5	zhang	zhang	PROPN
iajs-3342	332	6	,	,	PUNCT
iajs-3342	332	7	p.	p.	PROPN
iajs-3342	332	8	;	;	PUNCT
iajs-3342	332	9	li	li	PROPN
iajs-3342	332	10	,	,	PUNCT
iajs-3342	332	11	z.	z.	PROPN
iajs-3342	332	12	;	;	PUNCT
iajs-3342	332	13	liu	liu	PROPN
iajs-3342	332	14	,	,	PUNCT
iajs-3342	332	15	y.	y.	NOUN
iajs-3342	332	16	effects	effect	NOUN
iajs-3342	332	17	of	of	ADP
iajs-3342	332	18	mecobalamin	mecobalamin	NOUN
iajs-3342	332	19	on	on	ADP
iajs-3342	332	20	bax	bax	PROPN
iajs-3342	332	21	and	and	CCONJ
iajs-3342	332	22	bcl-2	bcl-2	VERB
iajs-3342	332	23	in	in	ADP
iajs-3342	332	24	neurons	neuron	NOUN
iajs-3342	332	25	after	after	ADP
iajs-3342	332	26	peripheral	peripheral	ADJ
iajs-3342	332	27	nerve	nerve	NOUN
iajs-3342	332	28	injury	injury	NOUN
iajs-3342	332	29	.	.	PUNCT
iajs-3342	333	1	zhonghua	zhonghua	PROPN
iajs-3342	333	2	lao	lao	PROPN
iajs-3342	333	3	dong	dong	PROPN
iajs-3342	333	4	wei	wei	PROPN
iajs-3342	333	5	sheng	sheng	PROPN
iajs-3342	333	6	zhi	zhi	PROPN
iajs-3342	333	7	ye	ye	PROPN
iajs-3342	333	8	bing	bing	VERB
iajs-3342	333	9	za	za	PROPN
iajs-3342	333	10	zhi=	zhi=	PROPN
iajs-3342	333	11	zhonghua	zhonghua	PROPN
iajs-3342	333	12	laodong	laodong	PROPN
iajs-3342	333	13	weisheng	weisheng	PROPN
iajs-3342	333	14	zhiyebing	zhiyebe	VERB
iajs-3342	333	15	zazhi=	zazhi=	NUM
iajs-3342	333	16	chinese	chinese	ADJ
iajs-3342	333	17	journal	journal	NOUN
iajs-3342	333	18	of	of	ADP
iajs-3342	333	19	industrial	industrial	ADJ
iajs-3342	333	20	hygiene	hygiene	NOUN
iajs-3342	333	21	and	and	CCONJ
iajs-3342	333	22	occupational	occupational	ADJ
iajs-3342	333	23	diseases	disease	NOUN
iajs-3342	333	24	.	.	PUNCT
iajs-3342	334	1	2015	2015	NUM
iajs-3342	334	2	,	,	PUNCT
iajs-3342	334	3	33(11	33(11	NUM
iajs-3342	334	4	)	)	PUNCT
iajs-3342	334	5	,	,	PUNCT
iajs-3342	334	6	841–843	841–843	NUM
iajs-3342	334	7	.	.	PUNCT
iajs-3342	335	1	33	33	NUM
iajs-3342	335	2	.	.	PUNCT
iajs-3342	335	3	keenan	keenan	PROPN
iajs-3342	335	4	,	,	PUNCT
iajs-3342	335	5	r.t	r.t	PROPN
iajs-3342	335	6	.	.	PROPN
iajs-3342	335	7	;	;	PUNCT
iajs-3342	335	8	swearingen	swearingen	PROPN
iajs-3342	335	9	,	,	PUNCT
iajs-3342	335	10	c.j	c.j	PROPN
iajs-3342	335	11	.	.	PROPN
iajs-3342	335	12	;	;	PUNCT
iajs-3342	335	13	yazici	yazici	NOUN
iajs-3342	335	14	,	,	PUNCT
iajs-3342	335	15	y.	y.	PROPN
iajs-3342	335	16	erythrocyte	erythrocyte	PROPN
iajs-3342	335	17	sedimentation	sedimentation	NOUN
iajs-3342	335	18	rate	rate	NOUN
iajs-3342	335	19	and	and	CCONJ
iajs-3342	335	20	c	c	NOUN
iajs-3342	335	21	-	-	PUNCT
iajs-3342	335	22	reactive	reactive	ADJ
iajs-3342	335	23	protein	protein	NOUN
iajs-3342	335	24	levels	level	NOUN
iajs-3342	335	25	are	be	AUX
iajs-3342	335	26	poorly	poorly	ADV
iajs-3342	335	27	correlated	correlate	VERB
iajs-3342	335	28	with	with	ADP
iajs-3342	335	29	clinical	clinical	ADJ
iajs-3342	335	30	measures	measure	NOUN
iajs-3342	335	31	of	of	ADP
iajs-3342	335	32	disease	disease	NOUN
iajs-3342	335	33	activity	activity	NOUN
iajs-3342	335	34	in	in	ADP
iajs-3342	335	35	rheumatoid	rheumatoid	NOUN
iajs-3342	335	36	arthritis	arthritis	NOUN
iajs-3342	335	37	,	,	PUNCT
iajs-3342	335	38	systemic	systemic	ADJ
iajs-3342	335	39	lupus	lupus	NOUN
iajs-3342	335	40	erythematosus	erythematosus	NOUN
iajs-3342	335	41	and	and	CCONJ
iajs-3342	335	42	osteoarthritis	osteoarthritis	NOUN
iajs-3342	335	43	patients	patient	NOUN
iajs-3342	335	44	.	.	PUNCT
iajs-3342	336	1	clin	clin	PROPN
iajs-3342	336	2	exp	exp	PROPN
iajs-3342	336	3	rheumatol	rheumatol	PROPN
iajs-3342	336	4	2008	2008	NUM
iajs-3342	336	5	,	,	PUNCT
iajs-3342	336	6	26(5	26(5	NUM
iajs-3342	336	7	)	)	PUNCT
iajs-3342	336	8	,	,	PUNCT
iajs-3342	336	9	814	814	NUM
iajs-3342	336	10	.	.	PUNCT
iajs-3342	337	1	pmid	pmid	NOUN
iajs-3342	337	2	:	:	PUNCT
iajs-3342	337	3	19032813	19032813	NUM
iajs-3342	337	4	.	.	PUNCT
iajs-3342	338	1	34	34	NUM
iajs-3342	338	2	.	.	PUNCT
iajs-3342	338	3	aringer	aringer	PROPN
iajs-3342	338	4	,	,	PUNCT
iajs-3342	338	5	m.	m.	NOUN
iajs-3342	338	6	inflammatory	inflammatory	ADJ
iajs-3342	338	7	markers	marker	NOUN
iajs-3342	338	8	in	in	ADP
iajs-3342	338	9	systemic	systemic	ADJ
iajs-3342	338	10	lupus	lupus	PROPN
iajs-3342	338	11	erythematosus	erythematosus	PROPN
iajs-3342	338	12	.	.	PUNCT
iajs-3342	339	1	journal	journal	PROPN
iajs-3342	339	2	of	of	ADP
iajs-3342	339	3	autoimmunity	autoimmunity	NOUN
iajs-3342	339	4	2020	2020	NUM
iajs-3342	339	5	,	,	PUNCT
iajs-3342	339	6	110	110	NUM
iajs-3342	339	7	,	,	PUNCT
iajs-3342	339	8	102374	102374	NUM
iajs-3342	339	9	.	.	PUNCT
iajs-3342	340	1	https://doi.org/10.1016/j.jaut.2019.102374	https://doi.org/10.1016/j.jaut.2019.102374	NOUN
iajs-3342	340	2	.	.	PUNCT
iajs-3342	341	1	35	35	NUM
iajs-3342	341	2	.	.	PUNCT
iajs-3342	341	3	aringer	aringer	PROPN
iajs-3342	341	4	,	,	PUNCT
iajs-3342	341	5	m.	m.	NOUN
iajs-3342	341	6	;	;	PUNCT
iajs-3342	341	7	costenbader	costenbader	NOUN
iajs-3342	341	8	,	,	PUNCT
iajs-3342	341	9	k.	k.	PROPN
iajs-3342	341	10	;	;	PUNCT
iajs-3342	341	11	daikh	daikh	NOUN
iajs-3342	341	12	,	,	PUNCT
iajs-3342	341	13	d.	d.	PROPN
iajs-3342	341	14	;	;	PUNCT
iajs-3342	341	15	brinks	brinks	PROPN
iajs-3342	341	16	,	,	PUNCT
iajs-3342	341	17	r.	r.	PROPN
iajs-3342	341	18	;	;	PUNCT
iajs-3342	341	19	mosca	mosca	PROPN
iajs-3342	341	20	,	,	PUNCT
iajs-3342	341	21	m.	m.	NOUN
iajs-3342	341	22	;	;	PUNCT
iajs-3342	341	23	ramsey	ramsey	PROPN
iajs-3342	341	24	-	-	PUNCT
iajs-3342	341	25	goldman	goldman	PROPN
iajs-3342	341	26	,	,	PUNCT
iajs-3342	341	27	r.	r.	PROPN
iajs-3342	341	28	;	;	PUNCT
iajs-3342	341	29	smolen	smolen	PROPN
iajs-3342	341	30	,	,	PUNCT
iajs-3342	341	31	j.s	j.s	PROPN
iajs-3342	341	32	.	.	PUNCT
iajs-3342	341	33	;	;	PUNCT
iajs-3342	341	34	wofsy	wofsy	PROPN
iajs-3342	341	35	,	,	PUNCT
iajs-3342	341	36	d.	d.	PROPN
iajs-3342	341	37	;	;	PUNCT
iajs-3342	341	38	boumpas	boumpas	PROPN
iajs-3342	341	39	,	,	PUNCT
iajs-3342	341	40	d.t	d.t	PROPN
iajs-3342	341	41	.	.	PROPN
iajs-3342	341	42	;	;	PUNCT
iajs-3342	341	43	kamen	kamen	PROPN
iajs-3342	341	44	,	,	PUNCT
iajs-3342	341	45	d.l	d.l	PROPN
iajs-3342	341	46	.	.	PROPN
iajs-3342	341	47	;	;	PUNCT
iajs-3342	341	48	jayne	jayne	PROPN
iajs-3342	341	49	,	,	PUNCT
iajs-3342	341	50	d.	d.	PROPN
iajs-3342	341	51	;	;	PUNCT
iajs-3342	341	52	cervera	cervera	NOUN
iajs-3342	341	53	,	,	PUNCT
iajs-3342	341	54	r.	r.	PROPN
iajs-3342	341	55	;	;	PUNCT
iajs-3342	341	56	costedoat	costedoat	PROPN
iajs-3342	341	57	-	-	PUNCT
iajs-3342	341	58	chalumeau	chalumeau	PROPN
iajs-3342	341	59	,	,	PUNCT
iajs-3342	341	60	n.	n.	NOUN
iajs-3342	341	61	;	;	PUNCT
iajs-3342	341	62	diamond	diamond	PROPN
iajs-3342	341	63	,	,	PUNCT
iajs-3342	341	64	b.	b.	PROPN
iajs-3342	341	65	;	;	PUNCT
iajs-3342	341	66	gladman	gladman	NOUN
iajs-3342	341	67	,	,	PUNCT
iajs-3342	341	68	d.d	d.d	PROPN
iajs-3342	341	69	.	.	PROPN
iajs-3342	341	70	;	;	PUNCT
iajs-3342	341	71	hahn	hahn	PROPN
iajs-3342	341	72	,	,	PUNCT
iajs-3342	341	73	b.	b.	PROPN
iajs-3342	341	74	;	;	PUNCT
iajs-3342	341	75	hiepe	hiepe	ADV
iajs-3342	341	76	,	,	PUNCT
iajs-3342	341	77	f.	f.	PROPN
iajs-3342	341	78	;	;	PUNCT
iajs-3342	341	79	jacobsen	jacobsen	PROPN
iajs-3342	341	80	,	,	PUNCT
iajs-3342	341	81	s.	s.	PROPN
iajs-3342	341	82	;	;	PUNCT
iajs-3342	341	83	khanna	khanna	PROPN
iajs-3342	341	84	,	,	PUNCT
iajs-3342	341	85	d.	d.	PROPN
iajs-3342	341	86	;	;	PUNCT
iajs-3342	341	87	lerstrøm	lerstrøm	PROPN
iajs-3342	341	88	,	,	PUNCT
iajs-3342	341	89	k.	k.	PROPN
iajs-3342	341	90	;	;	PUNCT
iajs-3342	341	91	massarotti	massarotti	PROPN
iajs-3342	341	92	,	,	PUNCT
iajs-3342	341	93	e.	e.	PROPN
iajs-3342	341	94	;	;	PUNCT
iajs-3342	341	95	mccune	mccune	PROPN
iajs-3342	341	96	,	,	PUNCT
iajs-3342	341	97	j.	j.	PROPN
iajs-3342	341	98	;	;	PUNCT
iajs-3342	341	99	ruiz	ruiz	NOUN
iajs-3342	341	100	-	-	PUNCT
iajs-3342	341	101	irastorza	irastorza	PROPN
iajs-3342	341	102	,	,	PUNCT
iajs-3342	341	103	g.	g.	PROPN
iajs-3342	341	104	;	;	PUNCT
iajs-3342	341	105	sanchez	sanchez	PROPN
iajs-3342	341	106	-	-	PUNCT
iajs-3342	341	107	guerrero	guerrero	PROPN
iajs-3342	341	108	,	,	PUNCT
iajs-3342	341	109	j.	j.	PROPN
iajs-3342	341	110	;	;	PUNCT
iajs-3342	341	111	schneider	schneider	PROPN
iajs-3342	341	112	,	,	PUNCT
iajs-3342	341	113	m.	m.	NOUN
iajs-3342	341	114	;	;	PUNCT
iajs-3342	341	115	urowitz	urowitz	NOUN
iajs-3342	341	116	,	,	PUNCT
iajs-3342	341	117	m.	m.	NOUN
iajs-3342	341	118	;	;	PUNCT
iajs-3342	341	119	bertsias	bertsias	PROPN
iajs-3342	341	120	,	,	PUNCT
iajs-3342	341	121	g.	g.	PROPN
iajs-3342	341	122	;	;	PUNCT
iajs-3342	341	123	hoyer	hoyer	PROPN
iajs-3342	341	124	,	,	PUNCT
iajs-3342	341	125	b.f	b.f	PROPN
iajs-3342	341	126	.	.	PROPN
iajs-3342	341	127	;	;	PUNCT
iajs-3342	341	128	leuchten	leuchten	VERB
iajs-3342	341	129	,	,	PUNCT
iajs-3342	341	130	n.	n.	NOUN
iajs-3342	341	131	;	;	PUNCT
iajs-3342	341	132	tani	tani	PROPN
iajs-3342	341	133	,	,	PUNCT
iajs-3342	341	134	ch	ch	NOUN
iajs-3342	341	135	.	.	PROPN
iajs-3342	341	136	;	;	PUNCT
iajs-3342	342	1	tedeschi	tedeschi	PROPN
iajs-3342	342	2	,	,	PUNCT
iajs-3342	342	3	s.k	s.k	PROPN
iajs-3342	342	4	.	.	PROPN
iajs-3342	342	5	;	;	PUNCT
iajs-3342	342	6	touma	touma	PROPN
iajs-3342	342	7	,	,	PUNCT
iajs-3342	342	8	z.	z.	PROPN
iajs-3342	342	9	;	;	PUNCT
iajs-3342	342	10	schmajuk	schmajuk	NOUN
iajs-3342	342	11	,	,	PUNCT
iajs-3342	342	12	g.	g.	PROPN
iajs-3342	342	13	;	;	PUNCT
iajs-3342	342	14	anic	anic	PROPN
iajs-3342	342	15	,	,	PUNCT
iajs-3342	342	16	b.	b.	PROPN
iajs-3342	342	17	;	;	PUNCT
iajs-3342	342	18	assan	assan	PROPN
iajs-3342	342	19	,	,	PUNCT
iajs-3342	342	20	f.	f.	PROPN
iajs-3342	342	21	;	;	PUNCT
iajs-3342	342	22	chan	chan	PROPN
iajs-3342	342	23	,	,	PUNCT
iajs-3342	342	24	t.m	t.m	PROPN
iajs-3342	342	25	.	.	PROPN
iajs-3342	342	26	clarke	clarke	PROPN
iajs-3342	342	27	,	,	PUNCT
iajs-3342	342	28	a.e	a.e	PROPN
iajs-3342	342	29	.	.	PROPN
iajs-3342	342	30	;	;	PUNCT
iajs-3342	342	31	crow	crow	NOUN
iajs-3342	342	32	,	,	PUNCT
iajs-3342	342	33	mk	mk	PROPN
iajs-3342	342	34	.	.	PROPN
iajs-3342	342	35	czirják	czirják	PROPN
iajs-3342	342	36	,	,	PUNCT
iajs-3342	342	37	l.	l.	PROPN
iajs-3342	342	38	;	;	PUNCT
iajs-3342	342	39	doria	doria	PROPN
iajs-3342	342	40	,	,	PUNCT
iajs-3342	342	41	a.	a.	PROPN
iajs-3342	342	42	;	;	PUNCT
iajs-3342	342	43	graninger	graninger	PROPN
iajs-3342	342	44	,	,	PUNCT
iajs-3342	342	45	w.	w.	PROPN
iajs-3342	342	46	;	;	PUNCT
iajs-3342	342	47	halda	halda	NOUN
iajs-3342	342	48	-	-	PUNCT
iajs-3342	342	49	kiss	kiss	NOUN
iajs-3342	342	50	,	,	PUNCT
iajs-3342	342	51	b.	b.	PROPN
iajs-3342	342	52	;	;	PUNCT
iajs-3342	342	53	hasni	hasni	NOUN
iajs-3342	342	54	,	,	PUNCT
iajs-3342	342	55	s	s	PART
iajs-3342	342	56	,	,	PUNCT
iajs-3342	342	57	;	;	PUNCT
iajs-3342	342	58	izmirly	izmirly	ADV
iajs-3342	342	59	,	,	PUNCT
iajs-3342	342	60	p.m.	p.m.	ADV
iajs-3342	342	61	;	;	PUNCT
iajs-3342	342	62	jung	jung	PROPN
iajs-3342	342	63	,	,	PUNCT
iajs-3342	342	64	m.	m.	NOUN
iajs-3342	342	65	;	;	PUNCT
iajs-3342	342	66	kumánovics	kumánovic	NOUN
iajs-3342	342	67	,	,	PUNCT
iajs-3342	342	68	g.	g.	PROPN
iajs-3342	342	69	;	;	PUNCT
iajs-3342	342	70	mariette	mariette	PROPN
iajs-3342	342	71	,	,	PUNCT
iajs-3342	342	72	x.	x.	PROPN
iajs-3342	342	73	;	;	PUNCT
iajs-3342	342	74	padjen	padjen	PROPN
iajs-3342	342	75	,	,	PUNCT
iajs-3342	342	76	i.	i.	PROPN
iajs-3342	342	77	;	;	PUNCT
iajs-3342	342	78	pego	pego	NOUN
iajs-3342	342	79	-	-	PUNCT
iajs-3342	342	80	reigosa	reigosa	PROPN
iajs-3342	342	81	,	,	PUNCT
iajs-3342	342	82	j.m	j.m	PROPN
iajs-3342	342	83	.	.	PROPN
iajs-3342	342	84	;	;	PUNCT
iajs-3342	342	85	romero	romero	PROPN
iajs-3342	342	86	-	-	PUNCT
iajs-3342	342	87	diaz	diaz	PROPN
iajs-3342	342	88	,	,	PUNCT
iajs-3342	342	89	j.	j.	PROPN
iajs-3342	342	90	;	;	PUNCT
iajs-3342	342	91	fernández	fernández	PROPN
iajs-3342	342	92	,	,	PUNCT
iajs-3342	342	93	i.r	i.r	PROPN
iajs-3342	342	94	-	-	PROPN
iajs-3342	342	95	f.	f.	PROPN
iajs-3342	342	96	;	;	PUNCT
iajs-3342	342	97	seror	seror	NOUN
iajs-3342	342	98	,	,	PUNCT
iajs-3342	342	99	g.h	g.h	PROPN
iajs-3342	342	100	.	.	PROPN
iajs-3342	342	101	;	;	PUNCT
iajs-3342	342	102	stummvoll	stummvoll	NOUN
iajs-3342	342	103	,	,	PUNCT
iajs-3342	342	104	r.	r.	PROPN
iajs-3342	342	105	;	;	PUNCT
iajs-3342	342	106	]	]	PUNCT
iajs-3342	342	107	tanaka	tanaka	PROPN
iajs-3342	342	108	,	,	PUNCT
iajs-3342	342	109	y.	y.	PROPN
iajs-3342	342	110	;	;	PUNCT
iajs-3342	342	111	tektonidou	tektonidou	NOUN
iajs-3342	342	112	,	,	PUNCT
iajs-3342	342	113	m.g	m.g	PROPN
iajs-3342	342	114	.	.	PROPN
iajs-3342	342	115	;	;	PUNCT
iajs-3342	342	116	vasconcelos	vasconcelos	PROPN
iajs-3342	342	117	,	,	PUNCT
iajs-3342	342	118	c.	c.	PROPN
iajs-3342	342	119	;	;	PUNCT
iajs-3342	342	120	vital	vital	ADJ
iajs-3342	342	121	,	,	PUNCT
iajs-3342	342	122	e.m	e.m	PROPN
iajs-3342	342	123	.	.	PROPN
iajs-3342	342	124	;	;	PUNCT
iajs-3342	342	125	wallace	wallace	PROPN
iajs-3342	342	126	,	,	PUNCT
iajs-3342	342	127	d.j	d.j	PROPN
iajs-3342	342	128	.	.	PROPN
iajs-3342	342	129	;	;	PUNCT
iajs-3342	342	130	yavuz	yavuz	PROPN
iajs-3342	342	131	,	,	PUNCT
iajs-3342	342	132	s.	s.	PROPN
iajs-3342	342	133	;	;	PUNCT
iajs-3342	342	134	meroni	meroni	PROPN
iajs-3342	342	135	,	,	PUNCT
iajs-3342	342	136	p.l	p.l	PROPN
iajs-3342	342	137	.	.	PROPN
iajs-3342	342	138	;	;	PUNCT
iajs-3342	342	139	fritzler	fritzler	PROPN
iajs-3342	342	140	,	,	PUNCT
iajs-3342	342	141	m.j	m.j	PROPN
iajs-3342	342	142	.	.	PROPN
iajs-3342	342	143	;	;	PUNCT
iajs-3342	342	144	naden	naden	PROPN
iajs-3342	342	145	,	,	PUNCT
iajs-3342	342	146	r.	r.	PROPN
iajs-3342	342	147	;	;	PUNCT
iajs-3342	342	148	dörner	dörner	NOUN
iajs-3342	342	149	,	,	PUNCT
iajs-3342	342	150	t.	t.	PROPN
iajs-3342	342	151	;	;	PUNCT
iajs-3342	342	152	johnson	johnson	PROPN
iajs-3342	342	153	,	,	PUNCT
iajs-3342	342	154	r.s	r.s	PROPN
iajs-3342	342	155	.	.	PROPN
iajs-3342	342	156	2019	2019	NUM
iajs-3342	343	1	european	european	PROPN
iajs-3342	343	2	league	league	PROPN
iajs-3342	343	3	against	against	ADP
iajs-3342	343	4	rheumatism	rheumatism	NOUN
iajs-3342	343	5	/	/	SYM
iajs-3342	343	6	american	american	PROPN
iajs-3342	343	7	college	college	PROPN
iajs-3342	343	8	of	of	ADP
iajs-3342	343	9	rheumatology	rheumatology	NOUN
iajs-3342	343	10	classification	classification	NOUN
iajs-3342	343	11	criteria	criterion	NOUN
iajs-3342	343	12	for	for	ADP
iajs-3342	343	13	systemic	systemic	ADJ
iajs-3342	343	14	lupus	lupus	PROPN
iajs-3342	343	15	erythematosus	erythematosus	PROPN
iajs-3342	343	16	.	.	PUNCT
iajs-3342	344	1	arthritis	arthritis	PROPN
iajs-3342	344	2	&	&	CCONJ
iajs-3342	344	3	rheumatology	rheumatology	NOUN
iajs-3342	344	4	.	.	PUNCT
iajs-3342	345	1	2019	2019	NUM
iajs-3342	345	2	,	,	PUNCT
iajs-3342	345	3	71(9	71(9	NOUN
iajs-3342	345	4	)	)	PUNCT
iajs-3342	345	5	,	,	PUNCT
iajs-3342	345	6	1400	1400	NUM
iajs-3342	345	7	-	-	SYM
iajs-3342	345	8	1412	1412	NUM
iajs-3342	345	9	.	.	PUNCT
iajs-3342	346	1	https://doi.org/10.1002/art.40930	https://doi.org/10.1002/art.40930	NOUN
iajs-3342	346	2	.	.	PUNCT
iajs-3342	347	1	36	36	NUM
iajs-3342	347	2	.	.	PUNCT
iajs-3342	348	1	curtiss	curtiss	PROPN
iajs-3342	348	2	,	,	PUNCT
iajs-3342	348	3	p.	p.	PROPN
iajs-3342	348	4	;	;	PUNCT
iajs-3342	348	5	liebman	liebman	PROPN
iajs-3342	348	6	,	,	PUNCT
iajs-3342	348	7	t.	t.	PROPN
iajs-3342	348	8	;	;	PUNCT
iajs-3342	348	9	khorolsky	khorolsky	ADJ
iajs-3342	348	10	,	,	PUNCT
iajs-3342	348	11	c.	c.	NOUN
iajs-3342	348	12	;	;	PUNCT
iajs-3342	348	13	brinster	brinster	ADJ
iajs-3342	348	14	,	,	PUNCT
iajs-3342	348	15	n.	n.	PROPN
iajs-3342	348	16	;	;	PUNCT
iajs-3342	348	17	beasley	beasley	PROPN
iajs-3342	348	18	,	,	PUNCT
iajs-3342	348	19	j.	j.	PROPN
iajs-3342	348	20	;	;	PUNCT
iajs-3342	348	21	sicco	sicco	PROPN
iajs-3342	348	22	,	,	PUNCT
iajs-3342	348	23	k.	k.	PROPN
iajs-3342	348	24	lo	lo	PROPN
iajs-3342	349	1	systemic	systemic	ADJ
iajs-3342	349	2	lupus	lupus	PROPN
iajs-3342	349	3	erythematosus	erythematosus	NOUN
iajs-3342	349	4	and	and	CCONJ
iajs-3342	349	5	antineutrophil	antineutrophil	PROPN
iajs-3342	349	6	cytoplasmic	cytoplasmic	ADJ
iajs-3342	349	7	antibody	antibody	NOUN
iajs-3342	349	8	–	–	PUNCT
iajs-3342	349	9	associated	associated	ADJ
iajs-3342	349	10	vasculitis	vasculitis	PROPN
iajs-3342	349	11	:	:	PUNCT
iajs-3342	349	12	an	an	DET
iajs-3342	349	13	emerging	emerge	VERB
iajs-3342	349	14	overlap	overlap	NOUN
iajs-3342	349	15	syndrome	syndrome	NOUN
iajs-3342	349	16	with	with	ADP
iajs-3342	349	17	cutaneous	cutaneous	ADJ
iajs-3342	349	18	manifestations	manifestation	NOUN
iajs-3342	349	19	.	.	PUNCT
iajs-3342	350	1	jaad	jaad	NOUN
iajs-3342	350	2	case	case	NOUN
iajs-3342	350	3	reports	report	VERB
iajs-3342	350	4	2018	2018	NUM
iajs-3342	350	5	,	,	PUNCT
iajs-3342	350	6	4(5),493	4(5),493	NUM
iajs-3342	350	7	-	-	PUNCT
iajs-3342	350	8	496	496	NUM
iajs-3342	350	9	https://doi.org/10.1016/j.jdcr.2018.01.021	https://doi.org/10.1016/j.jdcr.2018.01.021	NUM
iajs-3342	350	10	.	.	PUNCT
iajs-3342	351	1	37	37	NUM
iajs-3342	351	2	.	.	PUNCT
iajs-3342	352	1	voulgarelis	voulgarelis	PROPN
iajs-3342	352	2	,	,	PUNCT
iajs-3342	352	3	m.	m.	NOUN
iajs-3342	352	4	;	;	PUNCT
iajs-3342	352	5	kokori	kokori	PROPN
iajs-3342	352	6	,	,	PUNCT
iajs-3342	352	7	s.i	s.i	PROPN
iajs-3342	352	8	.	.	PROPN
iajs-3342	352	9	;	;	PUNCT
iajs-3342	352	10	ioannidis	ioannidis	PROPN
iajs-3342	352	11	,	,	PUNCT
iajs-3342	352	12	j.p	j.p	PROPN
iajs-3342	352	13	.	.	PROPN
iajs-3342	352	14	;	;	PUNCT
iajs-3342	352	15	tzioufas	tzioufas	NOUN
iajs-3342	352	16	,	,	PUNCT
iajs-3342	352	17	a.g	a.g	PROPN
iajs-3342	352	18	.	.	PROPN
iajs-3342	352	19	;	;	PUNCT
iajs-3342	352	20	kyriaki	kyriaki	PROPN
iajs-3342	352	21	,	,	PUNCT
iajs-3342	352	22	d.	d.	PROPN
iajs-3342	352	23	;	;	PUNCT
iajs-3342	352	24	moutsopoulos	moutsopoulos	PROPN
iajs-3342	352	25	,	,	PUNCT
iajs-3342	352	26	h.m	h.m	PROPN
iajs-3342	352	27	.	.	PROPN
iajs-3342	352	28	anaemia	anaemia	NOUN
iajs-3342	352	29	in	in	ADP
iajs-3342	352	30	systemic	systemic	ADJ
iajs-3342	352	31	lupus	lupus	PROPN
iajs-3342	352	32	erythematosus	erythematosus	NOUN
iajs-3342	352	33	:	:	PUNCT
iajs-3342	352	34	aetiological	aetiological	ADJ
iajs-3342	352	35	profile	profile	NOUN
iajs-3342	352	36	and	and	CCONJ
iajs-3342	352	37	the	the	DET
iajs-3342	352	38	role	role	NOUN
iajs-3342	352	39	of	of	ADP
iajs-3342	352	40	erythropoietin	erythropoietin	PROPN
iajs-3342	352	41	.	.	PUNCT
iajs-3342	353	1	annals	annal	NOUN
iajs-3342	353	2	of	of	ADP
iajs-3342	353	3	the	the	DET
iajs-3342	353	4	rheumatic	rheumatic	ADJ
iajs-3342	353	5	diseases	disease	NOUN
iajs-3342	353	6	.	.	PUNCT
iajs-3342	354	1	2000	2000	NUM
iajs-3342	354	2	,	,	PUNCT
iajs-3342	354	3	59(3	59(3	NUM
iajs-3342	354	4	)	)	PUNCT
iajs-3342	354	5	,	,	PUNCT
iajs-3342	354	6	217–222	217–222	NUM
iajs-3342	354	7	.	.	PUNCT
iajs-3342	354	8	https://doi.org/10.1136/ard.59.3.217	https://doi.org/10.1136/ard.59.3.217	NOUN
iajs-3342	354	9	.	.	PUNCT
iajs-3342	355	1	38	38	NUM
iajs-3342	355	2	.	.	PUNCT
iajs-3342	356	1	sultan	sultan	PROPN
iajs-3342	356	2	,	,	PUNCT
iajs-3342	356	3	s.m	s.m	PROPN
iajs-3342	356	4	.	.	PROPN
iajs-3342	356	5	;	;	PUNCT
iajs-3342	356	6	begum	begum	PROPN
iajs-3342	356	7	,	,	PUNCT
iajs-3342	356	8	s.	s.	PROPN
iajs-3342	356	9	;	;	PUNCT
iajs-3342	356	10	isenberg	isenberg	PROPN
iajs-3342	356	11	,	,	PUNCT
iajs-3342	356	12	d.a	d.a	PROPN
iajs-3342	356	13	.	.	PROPN
iajs-3342	356	14	prevalence	prevalence	NOUN
iajs-3342	356	15	,	,	PUNCT
iajs-3342	356	16	patterns	pattern	NOUN
iajs-3342	356	17	of	of	ADP
iajs-3342	356	18	disease	disease	NOUN
iajs-3342	356	19	and	and	CCONJ
iajs-3342	356	20	outcome	outcome	NOUN
iajs-3342	356	21	in	in	ADP
iajs-3342	356	22	patients	patient	NOUN
iajs-3342	356	23	with	with	ADP
iajs-3342	356	24	systemic	systemic	ADJ
iajs-3342	356	25	lupus	lupus	NOUN
iajs-3342	356	26	erythematosus	erythematosus	NOUN
iajs-3342	356	27	who	who	PRON
iajs-3342	356	28	develop	develop	VERB
iajs-3342	356	29	severe	severe	ADJ
iajs-3342	356	30	haematological	haematological	ADJ
iajs-3342	356	31	problems	problem	NOUN
iajs-3342	356	32	.	.	PUNCT
iajs-3342	357	1	rheumatology	rheumatology	NOUN
iajs-3342	357	2	2003	2003	NUM
iajs-3342	357	3	,	,	PUNCT
iajs-3342	357	4	42(2	42(2	PROPN
iajs-3342	357	5	)	)	PUNCT
iajs-3342	357	6	,	,	PUNCT
iajs-3342	357	7	230	230	NUM
iajs-3342	357	8	-	-	SYM
iajs-3342	357	9	234	234	NUM
iajs-3342	357	10	.	.	PUNCT
iajs-3342	358	1	https://doi.org/10.1093/rheumatology/keg069	https://doi.org/10.1093/rheumatology/keg069	NOUN
iajs-3342	358	2	.	.	PUNCT
iajs-3342	359	1	39	39	NUM
iajs-3342	359	2	.	.	PUNCT
iajs-3342	360	1	aleem	aleem	PROPN
iajs-3342	360	2	,	,	PUNCT
iajs-3342	360	3	a.	a.	NOUN
iajs-3342	360	4	;	;	PUNCT
iajs-3342	360	5	al	al	PROPN
iajs-3342	360	6	arfaj	arfaj	PROPN
iajs-3342	360	7	,	,	PUNCT
iajs-3342	360	8	a.s	a.s	PROPN
iajs-3342	360	9	.	.	PROPN
iajs-3342	360	10	;	;	PUNCT
iajs-3342	360	11	khalil	khalil	PROPN
iajs-3342	360	12	,	,	PUNCT
iajs-3342	360	13	n.	n.	PROPN
iajs-3342	360	14	;	;	PUNCT
iajs-3342	360	15	alarfaj	alarfaj	PROPN
iajs-3342	360	16	,	,	PUNCT
iajs-3342	360	17	h.	h.	PROPN
iajs-3342	360	18	haematological	haematological	ADJ
iajs-3342	360	19	abnormalities	abnormality	NOUN
iajs-3342	360	20	in	in	ADP
iajs-3342	360	21	systemic	systemic	ADJ
iajs-3342	360	22	lupus	lupus	PROPN
iajs-3342	360	23	erythematosus	erythematosus	PROPN
iajs-3342	360	24	.	.	PUNCT
iajs-3342	361	1	acta	acta	PROPN
iajs-3342	361	2	reumatol	reumatol	PROPN
iajs-3342	361	3	port	port	PROPN
iajs-3342	361	4	2014	2014	NUM
iajs-3342	361	5	,	,	PUNCT
iajs-3342	361	6	39(3	39(3	NUM
iajs-3342	361	7	)	)	PUNCT
iajs-3342	361	8	,	,	PUNCT
iajs-3342	361	9	236–241	236–241	NUM
iajs-3342	361	10	.	.	PUNCT
iajs-3342	362	1	https://doi.org/10	https://doi.org/10	PROPN
iajs-3342	362	2	.	.	PROPN
iajs-3342	362	3	1136/	1136/	NUM
iajs-3342	362	4	annrheumdis	annrheumdis	PROPN
iajs-3342	362	5	2020218272	2020218272	NUM
iajs-3342	362	6	.	.	PUNCT
iajs-3342	363	1	https://pubmed.ncbi.nlm.nih.gov/?term=jayne+d&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=jayne+d&cauthor_id=31385462	NOUN
iajs-3342	363	2	https://pubmed.ncbi.nlm.nih.gov/?term=cervera+r&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=cervera+r&cauthor_id=31385462	PROPN
iajs-3342	363	3	https://pubmed.ncbi.nlm.nih.gov/?term=costedoat-chalumeau+n&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=costedoat-chalumeau+n&cauthor_id=31385462	NOUN
iajs-3342	363	4	https://pubmed.ncbi.nlm.nih.gov/?term=diamond+b&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=diamond+b&cauthor_id=31385462	INTJ
iajs-3342	364	1	https://pubmed.ncbi.nlm.nih.gov/?term=gladman+dd&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=gladman+dd&cauthor_id=31385462	PROPN
iajs-3342	364	2	https://pubmed.ncbi.nlm.nih.gov/?term=hahn+b&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=hahn+b&cauthor_id=31385462	NOUN
iajs-3342	364	3	https://pubmed.ncbi.nlm.nih.gov/?term=hiepe+f&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=hiepe+f&cauthor_id=31385462	NOUN
iajs-3342	364	4	https://pubmed.ncbi.nlm.nih.gov/?term=jacobsen+s&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=jacobsen+s&cauthor_id=31385462	NOUN
iajs-3342	364	5	https://pubmed.ncbi.nlm.nih.gov/?term=khanna+d&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=khanna+d&cauthor_id=31385462	NOUN
iajs-3342	365	1	https://pubmed.ncbi.nlm.nih.gov/?term=lerstr%c3%b8m+k&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=lerstr%c3%b8m+k&cauthor_id=31385462	PROPN
iajs-3342	365	2	https://pubmed.ncbi.nlm.nih.gov/?term=massarotti+e&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=massarotti+e&cauthor_id=31385462	NOUN
iajs-3342	365	3	https://pubmed.ncbi.nlm.nih.gov/?term=mccune+j&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=mccune+j&cauthor_id=31385462	NOUN
iajs-3342	365	4	https://pubmed.ncbi.nlm.nih.gov/?term=ruiz-irastorza+g&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=ruiz-irastorza+g&cauthor_id=31385462	NOUN
iajs-3342	365	5	https://pubmed.ncbi.nlm.nih.gov/?term=sanchez-guerrero+j&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=sanchez-guerrero+j&cauthor_id=31385462	NOUN
iajs-3342	365	6	https://pubmed.ncbi.nlm.nih.gov/?term=schneider+m&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=schneider+m&cauthor_id=31385462	PROPN
iajs-3342	365	7	https://pubmed.ncbi.nlm.nih.gov/?term=urowitz+m&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=urowitz+m&cauthor_id=31385462	NOUN
iajs-3342	365	8	https://pubmed.ncbi.nlm.nih.gov/?term=bertsias+g&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=bertsias+g&cauthor_id=31385462	NOUN
iajs-3342	366	1	https://pubmed.ncbi.nlm.nih.gov/?term=hoyer+bf&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=hoyer+bf&cauthor_id=31385462	PROPN
iajs-3342	366	2	https://pubmed.ncbi.nlm.nih.gov/?term=leuchten+n&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=leuchten+n&cauthor_id=31385462	NOUN
iajs-3342	366	3	https://pubmed.ncbi.nlm.nih.gov/?term=tani+c&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=tani+c&cauthor_id=31385462	PROPN
iajs-3342	367	1	https://pubmed.ncbi.nlm.nih.gov/?term=tedeschi+sk&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=tedeschi+sk&cauthor_id=31385462	PROPN
iajs-3342	367	2	https://pubmed.ncbi.nlm.nih.gov/?term=touma+z&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=touma+z&cauthor_id=31385462	PROPN
iajs-3342	367	3	https://pubmed.ncbi.nlm.nih.gov/?term=schmajuk+g&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=schmajuk+g&cauthor_id=31385462	PROPN
iajs-3342	367	4	https://pubmed.ncbi.nlm.nih.gov/?term=anic+b&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=anic+b&cauthor_id=31385462	PROPN
iajs-3342	368	1	https://pubmed.ncbi.nlm.nih.gov/?term=assan+f&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=assan+f&cauthor_id=31385462	PROPN
iajs-3342	369	1	https://pubmed.ncbi.nlm.nih.gov/?term=chan+tm&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=chan+tm&cauthor_id=31385462	PROPN
iajs-3342	370	1	https://pubmed.ncbi.nlm.nih.gov/?term=clarke+ae&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=clarke+ae&cauthor_id=31385462	PROPN
iajs-3342	370	2	https://pubmed.ncbi.nlm.nih.gov/?term=crow+mk&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=crow+mk&cauthor_id=31385462	PROPN
iajs-3342	371	1	https://pubmed.ncbi.nlm.nih.gov/?term=czirj%c3%a1k+l&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=czirj%c3%a1k+l&cauthor_id=31385462	PROPN
iajs-3342	371	2	https://pubmed.ncbi.nlm.nih.gov/?term=doria+a&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=doria+a&cauthor_id=31385462	NOUN
iajs-3342	371	3	https://pubmed.ncbi.nlm.nih.gov/?term=graninger+w&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=graninger+w&cauthor_id=31385462	INTJ
iajs-3342	372	1	https://pubmed.ncbi.nlm.nih.gov/?term=halda-kiss+b&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=halda-kiss+b&cauthor_id=31385462	PROPN
iajs-3342	373	1	https://pubmed.ncbi.nlm.nih.gov/?term=hasni+s&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=hasni+s&cauthor_id=31385462	INTJ
iajs-3342	374	1	https://pubmed.ncbi.nlm.nih.gov/?term=izmirly+pm&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=izmirly+pm&cauthor_id=31385462	INTJ
iajs-3342	374	2	https://pubmed.ncbi.nlm.nih.gov/?term=jung+m&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=jung+m&cauthor_id=31385462	PROPN
iajs-3342	375	1	https://pubmed.ncbi.nlm.nih.gov/?term=kum%c3%a1novics+g&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=kum%c3%a1novics+g&cauthor_id=31385462	NOUN
iajs-3342	375	2	https://pubmed.ncbi.nlm.nih.gov/?term=mariette+x&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=mariette+x&cauthor_id=31385462	NOUN
iajs-3342	375	3	https://pubmed.ncbi.nlm.nih.gov/?term=padjen+i&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=padjen+i&cauthor_id=31385462	PROPN
iajs-3342	375	4	https://pubmed.ncbi.nlm.nih.gov/?term=pego-reigosa+jm&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=pego-reigosa+jm&cauthor_id=31385462	PROPN
iajs-3342	375	5	https://pubmed.ncbi.nlm.nih.gov/?term=romero-diaz+j&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=romero-diaz+j&cauthor_id=31385462	PROPN
iajs-3342	375	6	https://pubmed.ncbi.nlm.nih.gov/?term=r%c3%baa-figueroa+fern%c3%a1ndez+%c3%8d&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=r%c3%baa-figueroa+fern%c3%a1ndez+%c3%8d&cauthor_id=31385462	NOUN
iajs-3342	375	7	https://pubmed.ncbi.nlm.nih.gov/?term=seror+r&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=seror+r&cauthor_id=31385462	NOUN
iajs-3342	376	1	https://pubmed.ncbi.nlm.nih.gov/?term=stummvoll+gh&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=stummvoll+gh&cauthor_id=31385462	NOUN
iajs-3342	376	2	https://pubmed.ncbi.nlm.nih.gov/?term=tanaka+y&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=tanaka+y&cauthor_id=31385462	NOUN
iajs-3342	376	3	https://pubmed.ncbi.nlm.nih.gov/?term=tanaka+y&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=tanaka+y&cauthor_id=31385462	PROPN
iajs-3342	377	1	https://pubmed.ncbi.nlm.nih.gov/?term=tektonidou+mg&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=tektonidou+mg&cauthor_id=31385462	PROPN
iajs-3342	377	2	https://pubmed.ncbi.nlm.nih.gov/?term=vasconcelos+c&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=vasconcelos+c&cauthor_id=31385462	INTJ
iajs-3342	378	1	https://pubmed.ncbi.nlm.nih.gov/?term=vital+em&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=vital+em&cauthor_id=31385462	PROPN
iajs-3342	379	1	https://pubmed.ncbi.nlm.nih.gov/?term=wallace+dj&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=wallace+dj&cauthor_id=31385462	INTJ
iajs-3342	379	2	https://pubmed.ncbi.nlm.nih.gov/?term=yavuz+s&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=yavuz+s&cauthor_id=31385462	INTJ
iajs-3342	380	1	https://pubmed.ncbi.nlm.nih.gov/?term=meroni+pl&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=meroni+pl&cauthor_id=31385462	INTJ
iajs-3342	381	1	https://pubmed.ncbi.nlm.nih.gov/?term=fritzler+mj&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=fritzler+mj&cauthor_id=31385462	INTJ
iajs-3342	381	2	https://pubmed.ncbi.nlm.nih.gov/?term=naden+r&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=naden+r&cauthor_id=31385462	INTJ
iajs-3342	382	1	https://pubmed.ncbi.nlm.nih.gov/?term=d%c3%b6rner+t&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=d%c3%b6rner+t&cauthor_id=31385462	PROPN
iajs-3342	382	2	https://pubmed.ncbi.nlm.nih.gov/?term=johnson+sr&cauthor_id=31385462	https://pubmed.ncbi.nlm.nih.gov/?term=johnson+sr&cauthor_id=31385462	PROPN
iajs-3342	382	3	https://doi.org/10.1016/j.jdcr.2018.01.021	https://doi.org/10.1016/j.jdcr.2018.01.021	NUM
iajs-3342	382	4	.	.	PUNCT
iajs-3342	383	1	https://doi.org/10.1136/ard.59.3.217	https://doi.org/10.1136/ard.59.3.217	NOUN
iajs-3342	383	2	.	.	PUNCT
iajs-3342	384	1	https://doi.org/10.1093/rheumatology/keg069	https://doi.org/10.1093/rheumatology/keg069	NOUN
iajs-3342	384	2	.	.	PUNCT
iajs-3342	385	1	https://doi.org/10.%201136/%20annrheumdishttps://doi.org/10.%201136/%20annrheumdis	https://doi.org/10.%201136/%20annrheumdishttps://doi.org/10.%201136/%20annrheumdi	NOUN